Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"				"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.1	30.9	24.2	14.8	11.5	14.0	15.5	11.6	12.6	29.2	16.9	21.0	21.6	24.4	20.0	14.7	14.8	42.1	31.0	17.3	15.4	27.2	19.8	13.7	21.1	11.7	17.5	15.0	13.3	15.6	19.4	18.9	23.0	26.2	28.3	14.1	32.9	27.4	18.1	16.6	21.6	27.0	16.1	27.3	20.7	8.4	13.0	16.5	8.5	19.4	9.0	24.8	15.3	10.4	13.9	21.1	11.0	12.2	12.7	16.0	22.1	11.2	15.2	16.0	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol				Vesicles	"Centrosome, Cytosol"	"HPA063601: "	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.5	1.2	2.1	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.1	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.6	10.2	0.4	1.5	3.0	4.1	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0
AC008695.1		ENSG00000273217			5	131425891-131796983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 6.9;HL-60: 1.3;HMC-1: 2.7;U-937: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 11.1"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "																		4.0	2.5	3.6	2.4	4.3	3.8	2.9	3.4	4.1	2.7	2.7	3.8	2.1	2.4	3.5	2.4	2.5	2.5	2.4	2.6	2.5	2.5	2.5	2.5	2.6	3.5	5.8	2.6	4.0	2.5	2.4	6.1	4.5	3.5	2.5	2.4	1.4	2.5	2.4	4.2	2.5	2.5	3.0	3.3	2.5	2.5	4.2	5.2	2.4	2.5	1.1	2.4	3.0	4.0	2.0	0.3	2.3	0.9	2.4	11.1	2.8	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	1.3	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	1.6	0.0	0.6	0.9	2.3	3.3	0.4	5.7	1.4	3.6	3.8	0.3	2.0	11.1	5.0	0.6	2.4	0.9	0.0	2.8	2.8	3.6	4.3	3.4	4.1	2.5	2.5	5.8	2.6	3.5	5.2
AC134980.5		ENSG00000285472			15	22015233-22095857	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	103	"testis: 10.2"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Approved	Centrosome				Centrosome		"HPA057442: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	10.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC135068.3		ENSG00000279408			15	21651844-21652968	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 1.0;testis: 2.2"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome				Centrosome		"HPA057442: "																		0.0	0.0		0.0		0.0	0.0		1.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.2			0.0		0.0	0.0		0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0										
AC171558.1		ENSG00000274792			Unmapped	386278-387620	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	4	"testis: 1.6"	"Group enriched"	"Detected in some"	11	"NTERA-2: 1.0;U-2 OS: 1.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome				Centrosome		"HPA057442: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.3	0.0	0.0		0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	1.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA065236: "	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favourable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.4	7.9	15.6	12.9	12.8	16.2	11.7	15.3	19.5	20.7	16.5	12.4	7.9	19.7	4.5	20.9	5.5	11.7	10.5	19.6	7.9	4.9	19.6	12.4	13.2	15.2	20.8	17.5	12.7	10.8	21.4	13.4	15.9	8.8	6.9	20.8	7.5	6.9	12.4	14.5	12.7	9.1	9.8	11.7	15.6	18.0	4.6	13.4	9.9	8.7	8.7	5.6	11.6	10.8	15.8	10.3	14.5	13.7	19.3	24.5	20.1	11.7	15.2	9.8	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favourable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	15.9	11.5	2.7	12.7	10.0	11.4	16.4	8.3	10.1	8.7	5.8	10.5	11.3	21.4	12.6	5.8	13.2	13.8	9.4	2.6	15.8	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	28.9	4.9	6.9	7.4	7.9	10.5	3.1	19.9	22.4	7.4	4.0	12.5	17.7	0.1	10.4	4.7	16.0	10.8	7.5	11.4	16.6	11.4	14.7	6.1	7.8	10.9	3.8	18.0	16.0	7.3	11.2	15.8	16.0	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052612, HPA054617"			Enhanced	Centrosome			49000	Centrosome		"HPA052612: , HPA054617: "	"prognostic favourable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavourable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.5	4.4	4.1	11.9	1.2	0.7	2.0	2.8	4.5	2.7	4.9	0.2	1.3	0.0	2.8	1.2	0.4	1.8	0.2	0.4	3.1	1.8	0.0	20.5	0.0	0.1	0.0	1.5	0.7	0.3	3.8	0.0	0.4	0.4	0.1	3.0	0.4	7.8	0.1	5.1	1.3	11.9	0.4	0.4	0.0	5.6	3.1	15.0	6.4	0.4	0.5	17.3	0.0	0.1	2.1	16.9	0.3	0.7	0.0	0.0	0.4	6.6	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3
ADPGK	"ADP-GK, DKFZp434B195"	ENSG00000159322	"ADP dependent glucokinase"	Q9BRR6	15	72751369-72785846	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045194, HPA058525"	Approved		Approved	Centrosome	"Intracellular and membrane"		35000	Centrosome		"HPA045194: AB_10964638, HPA058525: "	"unprognostic (5.96e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.22e-4)"	"prognostic unfavourable (4.52e-7)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-2)"	15.3	13.5	6.7	16.4	10.7	23.1	13.2	7.8	11.7	10.2	11.3	14.9	11.2	8.9	9.5	14.3	11.1	11.0	12.0	9.3	7.0	9.0	13.3	12.8	18.7	19.8	11.7	6.3	10.7	15.2	4.9	9.1	18.2	13.4	14.2	13.7	20.4	15.8	9.8	7.5	10.9	13.1	8.9	9.8	21.4	10.5	10.7	8.8	19.6	12.0	7.8	21.2	12.3	9.6	14.2	32.0	22.2	30.3	13.8	13.0	22.6	6.6	14.0	7.5	8.8	17.0	12.9	10.1	19.6	19.1	20.5	28.5	7.9	17.7	12.7	14.6	12.2	18.2	21.2	10.2	15.4	12.4	14.5	9.4	4.1	7.4	10.9	21.7	14.1	14.0	6.0	10.8	10.1	11.9	9.9	21.7	12.4	4.2	6.7	9.7	11.1	6.6	7.9	12.2	17.5	10.6	7.8	5.4	5.6	17.9	7.4	9.4	7.1	26.3	9.7	10.3	8.6	39.0	17.7	22.0	41.9	12.6	18.1	21.4	17.1	22.2	30.3	21.9	10.6	21.0	13.0	14.2	9.7	10.7	32.0	12.5	8.5	9.8	12.0	13.8	17.1	24.4	7.6	22.6	6.7	10.7	7.8	11.7	7.0	9.0	11.7	6.3	13.4	8.8
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome				Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.6	20.6	2.4	11.4	17.7	5.5	10.4	9.7	7.7	6.7	5.1	23.3	29.0	4.8	21.9	5.5	39.7	3.4	6.0	0.7	50.0	15.8	7.1	8.5	5.1	12.2	7.5	17.5	5.3	8.4	5.7	3.0	3.4	8.6	0.8	2.8	26.4	0.5	23.3	6.2	37.5	10.9	8.8	26.6	7.8	9.3	5.5	8.8	12.6	13.3	15.9	8.4	29.5	6.8	8.9	9.1	2.8	6.2	1.2	0.1	3.1	0.1	16.1	8.8	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9
AHI1	"FLJ20069, JBTS3, ORF1"	ENSG00000135541	"Abelson helper integration site 1"	Q8N157	6	135283532-135497776	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"	"Developmental protein"	"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 54.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031698, HPA046684"	Approved		Approved	Centrosome				Centrosome		"HPA031698: , HPA046684: "	"unprognostic (4.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.58e-2)"	"prognostic favourable (7.51e-5)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (4.07e-9)"	"unprognostic (2.49e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.19e-3)"	6.7	16.2	16.8	6.4	16.5	5.9	12.5	35.3	26.5	11.7	8.7	4.2	13.2	4.9	14.4	32.1	7.8	9.0	9.0	7.6	15.9	19.9	8.4	6.8	8.1	6.0	11.4	19.6	13.9	11.6	11.5	54.2	8.3	18.2	16.3	13.1	10.0	8.2	15.9	6.7	6.1	5.7	11.1	18.5	4.3	10.7	29.2	13.1	3.3	11.6	5.0	6.3	8.9	12.0	10.6	16.6	4.8	1.7	3.8	4.2	0.5	5.2	7.1	8.4	10.8	13.7	14.9	3.7	9.6	12.1	9.7	14.9	2.7	5.6	8.1	4.7	9.3	4.0	6.3	3.0	14.5	6.4	8.4	2.9	20.2	5.2	5.9	15.1	3.3	7.0	4.9	15.0	8.2	8.0	13.4	0.5	13.1	5.5	14.3	3.4	5.0	4.4	7.2	3.4	2.7	4.9	5.2	14.6	7.8	12.8	4.7	5.7	3.8	6.8	7.5	8.4	10.4	14.4	7.5	10.6	9.8	3.8	11.9	2.2	10.0	4.8	1.7	0.6	4.2	0.5	2.6	8.2	4.0	4.2	2.6	10.6	3.2	4.1	0.1	3.8	0.5	16.6	2.4	0.5	16.8	16.5	35.3	26.5	15.9	19.9	11.4	19.6	18.2	13.1
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"				"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.2	9.6	12.6	16.8	20.7	13.8	23.7	26.0	9.8	12.8	15.9	26.8	14.9	37.0	24.6	11.8	5.8	19.7	12.4	19.6	15.1	9.5	18.2	20.5	20.4	16.9	21.6	7.9	8.0	16.4	12.7	18.3	8.3	17.0	12.2	16.4	20.0	19.9	14.6	10.5	6.4	23.4	15.7	20.5	20.1	14.1	6.5	6.4	13.4	10.8	18.6	11.5	24.4	10.9	9.6	15.4	17.9	21.5	14.7	30.6	32.8	12.4	31.8	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940867-92110673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"				"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	13.7	15.9	18.0	22.6	17.1	14.9	15.6	35.8	17.5	14.4	24.5	4.7	17.2	25.5	13.0	17.1	15.3	12.4	15.0	14.8	13.3	7.0	19.5	25.1	19.9	13.2	12.4	12.3	22.3	21.3	22.1	40.5	12.9	14.0	11.9	25.3	11.1	20.1	25.9	29.6	16.1	29.1	12.0	11.1	10.4	15.0	6.9	14.4	10.3	14.9	15.7	8.6	14.0	14.2	34.4	39.5	31.9	16.6	10.6	20.3	3.4	11.2	7.0	10.4	6.6	14.9	11.0	7.4	8.4	5.7	4.3	5.5	11.9	9.8	10.2	12.2	7.4	10.4	10.0	5.5	8.1	9.2	8.5	11.2	12.2	7.8	6.1	18.5	11.9	6.9	8.8	8.9	10.2	9.3	16.6	16.7	7.3	16.3	12.6	7.3	8.0	8.7	7.7	17.4	8.2	5.9	12.4	17.0	11.9	17.8	20.0	8.6	5.2	9.0	17.1	8.7	11.2	15.2	11.4	12.0	13.2	13.7	7.7	9.4	9.8	31.9	16.6	21.4	18.4	9.3	15.4	31.4	18.7	16.7	7.2	34.4	20.3	19.3	23.2	10.6	16.3	39.5	14.9	3.4	18.0	17.1	35.8	17.5	13.3	7.0	12.4	12.3	14.0	14.4
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;MOLT-4: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA052367: , HPA063993: "	"unprognostic (5.19e-3)"	"prognostic favourable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favourable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.7	1.4	7.9	1.5	1.9	1.5	1.2	2.7	1.6	17.2	1.6	1.4	3.3	1.2	0.4	0.5	31.6	0.7	1.8	0.7	1.7	15.1	16.7	18.9	2.5	2.8	1.3	1.4	2.7	1.6	20.8	0.6	2.4	30.0	21.7	6.8	1.7	18.6	0.3	3.9	14.4	0.8	0.9	1.7	0.4	1.4	4.6	3.9	9.2	4.3	0.8	1.7	0.3	1.4	4.4	4.8	14.6	1.0	8.5	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;RPTEC TERT1: 6.3"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Supported	Centrosome			24000	Centrosome		"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.0	1.5	0.8	0.5	0.2	1.4	0.4	0.5	0.1	0.9	0.5	0.7	0.4	0.5	0.0	1.1	1.1	0.0	0.8	1.2	5.5	3.6	3.8	5.2	0.6	1.4	2.0	1.5	1.8	0.4	0.9	0.4	5.3	2.2	0.2	0.0	1.7	2.3	0.3	1.1	0.1	0.5	0.5	6.3	0.8	1.6	0.5	0.3	0.1	1.3	0.9	0.3	0.4	0.8	3.1	1.2	1.5	5.5	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3
ALMS1	KIAA0328	ENSG00000116127	"ALMS1, centrosome and basal body associated protein"		2	73385758-73610793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 23.2"	"Cell line enhanced"	"Detected in all"		"RH-30: 23.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035276, HPA035277, HPA043200"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Centrosome, Cytosol"	Nucleoplasm	"HPA035276: , HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	3.4	1.7	3.0	6.5	5.5	6.3	3.9	5.5	4.5	6.0	4.0	5.4	4.3	2.0	7.4	3.9	2.2	7.9	4.3	1.6	3.4		3.5	2.1	2.7	2.5	2.0	5.0	11.0	4.0	6.1	6.6	3.2	3.6	3.6	3.3	4.7	2.3	5.8	2.3	1.8	2.4	4.2	3.2	2.1	2.8	23.2	3.4	6.7	5.1	1.9	3.2	2.9	4.1	0.8	1.3	1.3	0.4	0.5	1.2	0.0	8.4	3.3	6.2	4.5	2.4	4.0	3.9	2.9	3.2	4.8	3.6	3.7	1.1	7.9	1.8	4.8	3.7	10.4	3.2	7.2	4.7	2.9	5.3	3.7	2.9	2.1	7.3	2.6	3.1	1.9	6.6	3.3	4.2	5.9	4.2	4.0	2.5	6.9	3.3	8.0	3.1	7.7	23.8	3.3	1.2	3.0	5.1	6.0	6.6	1.1	2.7	1.4	1.8	2.6	6.7	7.0	5.3	6.9	4.9	2.5	8.5	2.5	4.2	3.0	0.0	0.1	1.3	1.2	0.2	0.3	0.2	0.6	0.1	0.1	0.8	0.4	0.6	0.0	0.5	0.4	1.3	0.1	0.0										
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA027435, HPA027443"	Approved		Approved	Centrosome				Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.17e-4)"	15.1	10.6	5.3	8.3	7.7	17.3	9.3	1.3	5.9	10.8	9.5	5.8	3.0	4.5	9.8	9.2	8.8	9.2	7.5	6.1	6.1	2.3	10.8	13.4	13.2	11.4	9.7	1.0	17.4	9.7	11.0	14.0	11.5	6.6	14.0	7.8	9.6	10.4	6.8	5.0	11.8	12.1	11.3	16.6	16.2	7.4	4.2	8.5	13.7	12.4	4.7	13.7	13.6	11.6	0.9	3.2	16.3	4.3	0.4	0.8	1.2	1.6	5.0	1.5	0.3	6.5	10.4	2.0	1.9	3.4	2.6	3.2	0.5	7.6	5.0	3.3	3.2	1.1	1.7	3.0	3.8	6.4	1.7	3.6	2.0	0.4	10.5	2.2	2.2	12.9	8.5	3.7	7.8	1.0	0.9	8.8	4.9	3.0	1.2	2.0	0.4	1.2	0.6	1.1	1.6	3.8	1.8	0.5	0.8	1.8	6.5	2.8	2.9	4.0	1.9	2.3	2.1	3.7	1.2	2.2	0.7	4.3	5.7	4.5	2.1	1.3	3.2	1.4	0.2	4.3	0.6	0.8	0.6	0.1	3.2	0.9	0.8	0.6	16.3	0.4	1.9	0.5	0.0	1.2	5.3	7.7	1.3	5.9	6.1	2.3	9.7	1.0	6.6	8.5
AMN1		ENSG00000151743	"Antagonist of mitotic exit network 1 homolog"	Q8IY45	12	31671137-31729174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046157, HPA062290"	Approved		Approved	Centrosome				Centrosome		"HPA046157: AB_10965846, HPA062290: "	"unprognostic (2.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.60e-3)"	"unprognostic (4.08e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	5.3	9.9	24.8	6.1	20.9	3.1	9.0	13.8	28.3	9.6	4.3	11.1	2.9	3.8	10.8	7.9	6.0	17.0	6.9	10.1	22.4	20.9	11.3	5.8	6.5	10.3	19.6	15.2	16.0	8.2	8.5	16.1	5.4	14.8	8.9	4.3	8.9	5.9	7.8	12.8	5.4	4.1	7.3	19.4	8.4	8.4	46.5	16.2	11.7	7.9	4.2	9.0	7.7	5.5	12.3	6.6	27.4	2.7	4.7	9.8	3.4	4.0	8.8	7.2	0.8	7.0	9.0	4.2	4.2	6.6	3.0	5.8	4.6	16.1	2.0	9.7	3.7	2.3	3.3	5.1	6.1	3.4	4.3	7.0	3.2	6.5	12.6	3.7	3.7	6.0	8.3	5.1	7.3	17.0	6.1	6.7	11.4	2.5	2.1	3.0	9.9	4.3	3.1	11.6	3.3	6.9	9.1	11.6	9.6	5.6	1.5	8.8	13.5	4.2	9.5	5.1	4.2	4.2	7.7	7.3	6.9	7.2	6.4	3.5	9.5	4.3	2.7	3.3	4.3	1.9	4.3	12.3	4.5	4.6	2.1	11.5	9.8	5.9	27.4	4.7	1.6	6.6	6.7	3.4	24.8	20.9	13.8	28.3	22.4	20.9	19.6	15.2	14.8	16.2
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: , HPA067561: "	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.0	32.0	42.1	36.3	14.8	13.0	28.0	13.7	18.5	27.0	22.8	26.4	49.1	84.6	25.8	15.5	38.3	97.4	28.1	32.5	38.1	33.1	64.0	27.1	33.0	9.2	50.3	34.6	10.4	19.9	14.8	29.6	39.2	46.5	33.1	23.1	18.2	50.5	41.3	37.4	16.2	70.9	39.1	50.2	23.8	41.2	55.9	34.7	20.9	23.6	38.7	31.4	66.0	17.5	28.0	44.6	19.3	36.7	20.1	55.7	98.0	18.6	84.7	25.6	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: , HPA067561: , HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	70.9	38.4	42.8	35.7	24.1	42.7	39.0	36.9	32.7	39.7	33.5	48.1	34.9	87.1	22.1	24.7	47.0	57.7	41.6	45.6	56.5	32.5	75.3	33.0	51.9	31.0	129.1	43.9	32.3	30.5	31.8	65.8	34.4	144.9	61.7	30.5	94.8	97.4	114.8	16.7	38.2	58.2	66.8	41.4	25.9	29.8	34.6	30.2	43.3	42.3	37.8	23.9	48.3	41.7	25.9	42.0	32.5	38.7	56.0	63.2	52.6	24.0	51.8	48.2	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: , HPA067561: "		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0										
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: , HPA067561: "	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	33.7	21.9	45.7	22.7	3.6	5.3	17.4	18.2	10.3	17.6	16.9	16.1	24.0	61.6	16.2	10.4	11.8	25.7	11.3	25.3	70.5	15.6	42.7	27.2	23.2	3.4	85.6	21.7	4.3	1.8	16.4	15.2	13.0	40.8	36.5	16.1	35.1	34.9	22.3	46.1	10.0	37.2	25.4	32.4	12.5	13.6	15.0	25.8	38.0	6.1	10.7	16.5	43.8	13.4	9.0	25.5	9.3	36.4	47.2	47.3	60.4	10.3	61.9	16.4	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227737-57273468	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"naive B-cell: 20.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011138, HPA073477"	Approved		Uncertain	"Mitotic spindle,Centrosome"			28000	"Mitotic spindle, Centrosome"		"HPA011138: AB_1844959, HPA073477: "	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favourable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	18.3	14.0	20.9	15.3	17.9	13.7	22.5	25.2	23.7	18.5	15.7	12.8	16.8	12.6	19.2	14.5	21.0	16.0	13.2	23.7	15.8	15.4	17.0	14.3	15.3	24.3	15.4	18.8	24.0	38.2	28.4	20.4	14.1	18.8	15.7	14.4	11.0	18.0	22.2	40.5	19.9	14.5	20.5	16.7	15.0	16.3	10.5	15.7	20.9	20.0	15.2	18.9	17.7	20.8	20.7	12.0	2.5	3.9	4.7	3.5	1.7	14.6	6.4	6.3	22.8	10.8	15.2	13.2	7.8	4.8	7.9	9.0	7.4	8.8	23.8	3.2	12.0	2.9	16.7	13.4	13.5	17.9	7.5	13.4	10.2	7.8	11.7	29.8	9.9	11.2	12.3	10.0	10.9	12.5	4.5	15.0	8.8	5.0	23.5	7.3	9.8	11.0	0.8	25.5	12.7	13.8	8.3	6.3	13.5	10.7	16.0	10.2	7.8	19.4	11.8	13.0	9.2	18.9	15.0	13.8	20.2	16.7	14.1	14.4	8.4	1.6	3.9	2.5	2.6	3.0	3.5	11.3	2.8	2.4	7.2	20.7	2.6	1.9	1.0	4.7	2.5	12.0	1.1	1.7	20.9	17.9	25.2	23.7	15.8	15.4	15.4	18.8	18.8	15.7
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 47.6;hTERT-HME1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	47.6	2.0	2.9	0.0	10.4	24.7	10.6	16.0	26.1	13.6	19.8	5.7	2.4	0.0	36.1	32.1	10.2	0.1	10.9	28.0	0.0	1.5	0.2	2.7	2.5	1.0	0.0	0.0	4.8	2.0	10.3	43.0	36.5	0.0	0.0	13.4	1.6	0.9	0.0	3.9	32.9	0.6	2.4	0.0	28.6	4.2	0.0	0.6	9.8	7.7	0.7	2.3	0.1	32.8	8.2	11.3	12.6	12.3	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Group enriched"	"Detected in some"	8	"RPTEC TERT1: 16.0;SK-BR-3: 8.9;T-47d: 9.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA036510: AB_10672357, HPA045484: "	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	16.0	0.0	0.0	0.0	0.0	8.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714407	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome			17000	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: "	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.8	13.8	24.8	6.6	29.4	2.9	11.4	24.1	32.9	14.1	8.9	9.6	8.2	6.8	17.1	16.7	10.2	23.0	8.3	29.9	19.9	21.4	22.7	8.1	9.6	5.5	20.2	16.0	25.2	9.9	18.9	21.0	7.7	17.6	12.1	7.7	21.5	8.8	14.5	7.9	7.9	6.4	13.4	14.2	5.3	9.0	13.6	9.3	4.1	17.3	5.5	7.2	16.0	13.8	5.0	7.8	14.9	8.1	4.5	11.1	5.8	8.5	14.8	20.4	14.9	9.5	14.2	3.6	6.8	10.4	8.3	9.1	5.1	4.4	3.6	6.6	11.0	6.4	7.7	9.1	10.4	9.3	8.0	5.8	10.6	4.8	10.3	2.7	5.8	7.2	7.7	11.5	6.8	9.5	2.6	3.6	13.8	8.8	5.4	4.3	7.8	5.9	4.6	15.1	3.1	11.0	4.6	7.2	15.7	5.2	1.1	8.0	27.2	2.7	5.4	5.7	8.0	11.5	9.3	2.6	5.1	6.6	15.0	8.0	4.9	2.3	8.1	2.7	4.5	6.5	11.1	5.0	7.8	6.5	7.8	3.5	4.8	5.7	14.9	4.5	5.5	5.7	5.2	5.8	24.8	29.4	24.1	25.6	19.9	21.4	20.2	16.0	17.6	9.3
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"			25000	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: , HPA048565: "	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (5.63e-8)"	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	34.1	17.2	10.5	9.5	12.5	29.7	19.8	6.4	21.8	19.3	8.9	9.1	6.6	4.4	15.6	18.9	10.5	11.8	14.5	17.5	10.0	11.0	7.9	7.6	26.2	12.9	11.3	8.0	15.2	6.8	21.7	8.2	27.3	15.2	9.9	7.2	13.9	6.2	13.9	13.0	12.1	8.4	16.6	11.9	26.1	8.0	21.7	9.7	5.6	12.3	10.6	14.5	12.9	21.2	1.5	4.1	13.0	6.6	0.7	1.6	1.1	15.3	11.5	16.8	9.5	14.6	21.7	13.5	16.4	28.7	20.1	21.5	5.8	5.8	3.5	11.7	23.8	3.9	8.6	14.4	28.1	5.5	5.2	6.1	6.7	7.4	37.6	2.6	1.9	20.4	4.8	10.6	17.7	21.0	3.1	14.1	17.5	4.6	3.5	2.7	4.2	10.5	4.9	3.0	2.4	5.1	8.3	4.8	15.7	12.1	7.4	8.7	6.2	6.0	61.6	16.1	7.8	6.3	24.1	13.0	3.0	2.5	11.9	3.8	17.9	0.0	2.4	1.6	0.7	2.4	0.4	1.5	1.2	1.0	4.1	1.3	1.6	1.0	13.0	0.7	6.6	0.4	0.8	1.1	10.5	12.5	6.4	14.6	10.0	11.0	11.3	8.0	15.2	9.7
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavourable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	18.0	28.5	16.1	15.6	17.2	9.4	21.4	16.0	21.4	23.0	20.9	10.5	14.1	16.9	21.5	23.2	16.7	20.6	12.8	14.0	15.1	15.4	20.5	23.6	15.4	18.1	14.7	15.8	21.0	16.7	12.8	23.3	26.9	17.0	22.9	20.6	11.0	16.5	21.7	20.4	10.9	28.6	19.7	14.9	20.3	16.4	13.0	10.2	23.3	24.9	14.7	18.0	20.7	21.0	7.3	6.8	11.6	10.5	6.5	12.9	4.9	8.2	3.6	6.0	8.1	13.9	15.0	6.3	8.8	14.1	13.0	16.0	3.5	5.0	5.8	7.1	13.4	5.9	8.7	12.9	23.0	2.5	4.9	6.8	4.5	4.4	14.9	8.0	3.5	11.6	14.4	9.3	11.8	13.7	9.7	5.8	14.7	3.7	3.3	9.7	6.9	4.9	3.4	14.2	4.5	14.0	5.9	4.6	4.3	5.4	10.2	8.0	5.0	15.5	11.3	5.1	2.9	5.9	15.0	2.4	2.3	5.4	18.9	11.0	9.2	5.1	6.5	11.6	4.8	7.7	12.9	7.3	8.5	6.6	6.8	5.2	9.3	7.9	5.5	6.5	10.5	2.6	9.0	4.9	16.1	17.2	16.0	21.4	15.1	15.4	14.7	15.8	17.0	10.2
AUNIP	"AIBp, C1orf135, MGC2603"	ENSG00000127423	"Aurora kinase A and ninein interacting protein"	Q9H7T9	1	25831913-25859458	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 35.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028730	Uncertain		Supported	Centrosome				Centrosome		"HPA028730: AB_10670830"	"unprognostic (8.05e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.96e-3)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.70e-6)"	"unprognostic (5.00e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-6)"	"unprognostic (3.61e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.62e-1)"	0.4	1.6	2.5	3.4	1.4	7.2	0.6	2.1	4.0	0.5	1.1	0.2	0.1	1.3	0.5	0.8	2.1	0.5	0.4	0.8	2.8	0.9	0.6	0.8	0.6	1.6	0.9	1.4	0.5	0.5	0.2	0.7	7.0	2.6	0.6	1.3	0.0	0.6	1.7	0.9	0.8	1.1	0.5	0.5	1.2	0.8	35.3	0.0	5.3	0.5	3.2	2.3	0.9	0.9	1.4	2.0	4.4	3.5	1.5	2.3	1.1	11.5	3.3	5.3	6.7	0.2	0.4	5.2	6.7	3.1	13.4	11.0	2.8	8.9	11.5	5.1	2.3	9.4	14.3	6.5	10.8	6.4	11.5	25.2	5.4	4.3	0.1	12.2	11.1	0.3	3.3	8.2	5.7	3.0	15.5	5.7	3.7	6.3	8.9	10.4	9.4	4.2	7.3	10.4	7.1	4.1	3.8	7.7	3.6	9.3	10.5	7.3	3.8	6.3	1.2	3.9	6.1	8.1	5.9	2.2	4.5	8.6	2.7	20.6	6.3	4.4	2.5	1.7	0.6	3.5	0.4	0.9	1.0	0.8	2.0	1.4	0.9	1.3	2.2	1.5	2.1	1.6	2.3	1.1	2.5	1.4	2.1	4.0	2.8	0.9	0.9	1.4	2.6	0.0
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	32.5	24.0	16.1	11.3	0.9	2.1	20.4	26.7	12.5	64.7	27.3	67.2	22.8	10.7	18.4	10.9	26.3	28.5	17.9	69.0	9.6	10.9	19.0	24.6	41.8	0.5	25.4	26.8	1.0	1.9	22.4	20.1	15.1	21.5	8.5	27.5	33.2	15.2	19.7	14.7	24.8	11.6	31.1	11.8	10.3	8.6	13.9	7.5	37.3	43.0	17.9	25.5	15.9	8.6	28.1	27.9	15.5	37.6	11.9	13.8	18.5	15.2	14.8	23.2	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33866227-34039176	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	11.0	11.1	7.1	8.7	7.7	5.2	16.1	14.4	8.8	9.6	12.4	6.8	8.6	9.0	13.4	9.5	11.5	8.9	10.6	35.0	6.9	8.7	5.8	16.7	8.0	6.0	8.6	6.8	10.3	41.0	3.6	9.0	15.0	8.3	10.6	12.2	5.4	9.8	11.8	25.7	9.3	9.9	15.3	8.1	7.3	10.9	14.1	6.1	9.9	5.4	11.6	9.4	11.6	15.0	1.2	6.1	0.2	1.7	1.2	2.3	0.3	8.3	13.6	14.1	4.6	11.5	13.1	8.4	21.3	19.1	17.1	11.0	3.7	5.9	7.8	13.2	17.9	5.7	6.4	13.9	14.1	7.6	4.2	13.5	8.9	10.4	17.2	13.5	9.9	10.9	27.5	10.0	24.4	18.3	13.3	11.5	23.7	8.9	5.3	23.3	6.6	4.7	8.1	7.9	16.7	13.9	11.0	7.5	9.1	11.8	6.2	5.8	6.7	15.0	12.9	15.1	5.2	6.4	17.6	11.3	8.9	16.5	7.2	15.9	8.0	0.0	0.8	0.0	1.6	1.7	2.0	1.2	1.7	0.6	0.6	0.6	0.8	1.1	0.2	1.2	0.7	6.1	2.3	0.3	7.1	7.7	14.4	8.8	6.9	8.7	8.6	6.8	8.3	6.1
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavourable (8.41e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic unfavourable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.1	6.5	12.2	0.9	5.3	4.2	10.5	15.6	27.3	12.9	8.0	1.1	11.3	2.4	5.4	24.1	9.4	0.3	20.2	11.3	1.0	0.3	0.0	4.7	2.8	9.5	0.1	0.0	4.9	22.4	13.3	45.4	14.2	0.4	0.0	34.9	2.3	0.2	0.0	3.8	22.5	1.0	17.6	0.3	33.8	19.2	0.4	1.0	7.6	8.1	9.7	9.1	0.6	16.7	19.2	5.0	8.2	20.6	1.3	0.5	0.3	2.8	0.0	7.0	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"				"Nuclear speckles, Centrosome"		"HPA067881: "	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (4.27e-4)"	"prognostic favourable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	18.9	6.9	14.4	13.6	7.7	9.0	21.6	14.3	11.0	19.0	19.6	9.7	7.8	16.9	19.8	9.2	9.3	16.7	14.1	26.5	15.2	15.0	8.8	13.8	14.0	13.9	22.2	9.6	8.1	15.5	19.6	24.3	12.4	16.9	12.7	15.6	116.3	19.8	16.6	24.9	15.8	14.2	25.4	11.8	13.3	16.6	18.8	12.5	17.8	13.8	21.9	12.2	17.6	10.8	11.6	15.5	23.3	26.8	13.8	14.2	27.3	22.7	18.6	43.9	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427297-66493529	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.5;BEWO: 4.8;RPTEC TERT1: 8.4;U-87 MG: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053851: "	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	1.2	1.2	2.9	1.1	2.5	2.9	1.2	6.9	9.6	1.2	0.7	0.1	0.0	0.6	1.2	1.9	1.8	1.9	1.4	3.0	4.6	4.1	0.9	1.1	1.4	0.9	2.3	3.2	1.4	1.9	0.1	0.4	4.5	11.6	1.0	0.9	5.0	1.9	0.4	3.6	3.2	0.8	0.8	1.7	1.2	1.2	3.1	0.2	0.0	1.9	3.1	0.9	1.0	1.0	0.3	2.4	5.2	0.5	0.4	0.2	0.1	0.8	0.9	1.0	9.5	0.3	0.1	4.8	0.3	0.0	0.1	0.1	0.0	1.0	0.1	0.5	0.3	0.2	0.1	0.1	0.3	0.0	0.6	0.0	0.2	0.7	0.7	0.1	0.0	0.7	1.9	0.6	0.3	0.0	0.1	0.3	0.2	0.5	0.0	0.4	0.3	0.5	0.1	0.2	0.5	8.4	0.6	0.1	0.2	0.2	0.2	1.4	0.2	0.1	0.3	0.4	2.6	0.1	0.4	0.5	0.1	0.1	5.5	0.2	1.3	0.4	0.5	1.9	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	5.2	0.4	0.2	2.4	0.1	0.1	2.9	2.5	6.9	9.6	4.6	4.1	2.3	3.2	11.6	0.2
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: , HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188333-8190907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA045415: AB_10964575, HPA060791: "	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	3.1	4.5	3.5	3.8	3.4	2.8	2.6	3.2	3.9	2.3	4.4			6.3	3.7	2.9	5.5	2.3	1.6	4.4	3.4	2.6	3.9	3.7	3.7	4.8	3.7		2.3	8.4	4.7	2.1	3.0		2.9	1.9		4.3	4.3	11.5	6.2	5.5	2.1	2.8	6.8	3.9	2.1			2.7		3.7	3.3	2.9	13.4	11.3	27.0	12.0	14.5	17.4	10.5	4.7	5.4	1.9	3.9	4.0	3.0	7.6	3.5	3.8	3.3	3.6	3.0	3.3	4.2	7.7	2.7	6.8	2.9	3.9	1.1	12.7	11.9	3.3	5.3	4.7	4.6	1.9	7.2	3.1	4.2	3.0	3.4	5.2	3.5	9.0	2.0	5.2	6.4	5.5	1.3	6.3	7.8	2.4	6.4	4.5	2.7	2.3	5.2	3.6	2.7	2.9	4.0	3.0	4.3	2.1	1.8	3.4	3.6	13.8	6.1	2.0	3.0	6.9	2.5	21.4	10.1	27.0	16.2	10.3	13.1	12.8	13.7	17.4	11.3	13.4	13.2	14.6	9.5	14.5	12.0	9.9	12.4	10.5										
BRMS1	DKFZP564A063	ENSG00000174744	"Breast cancer metastasis suppressor 1"	Q9HCU9	11	66337333-66345125	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010824, HPA019637"	Approved		Approved	Centrosome				Centrosome		"CAB010824: , HPA019637: AB_1845448"	"unprognostic (1.75e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.54e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-1)"	17.2	18.9	16.7	23.4	24.5	37.0	20.5	9.1	18.7	13.7	19.7	14.5	24.7	21.0	14.6	21.0	24.1	16.1	26.0	13.7	16.6	10.7	23.4	22.2	16.7	25.8	20.1	16.1	14.0	37.6	17.6	12.6	24.1	17.6	22.3	16.0	12.8	23.9	29.8	24.2	26.1	22.6	13.0	16.2	26.3	19.6	37.4	20.9	25.3	20.8	29.3	21.4	16.2	17.5	38.5	32.1	50.7	38.0	22.2	37.2	28.9	24.2	31.8	10.7	17.9	11.4	11.9	15.2	16.7	18.6	30.7	20.6	25.9	16.0	16.4	25.3	16.6	28.6	20.4	30.9	14.5	19.4	17.0	14.9	17.0	18.8	21.3	21.5	17.5	13.4	33.3	30.9	23.2	18.8	17.7	7.7	18.2	39.1	26.2	51.4	23.2	30.0	22.3	19.7	30.7	19.0	14.1	22.7	18.2	21.0	21.7	54.5	26.4	13.4	18.1	23.1	21.9	37.1	21.0	16.0	15.8	25.9	29.9	14.1	24.7	19.0	38.0	36.7	31.1	36.2	33.2	38.5	33.5	29.6	29.8	36.1	29.7	28.0	50.7	22.2	31.0	32.1	37.2	28.9	16.7	24.5	9.1	18.7	16.6	10.7	20.1	16.1	17.6	20.9
BUD31	"Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W"	ENSG00000106245	"BUD31 homolog"	P41223	7	99408641-99419616	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028943	Approved		Approved	Nucleoplasm,Microtubules,Centrosome				Nucleoplasm	"Microtubules, Centrosome"	"HPA028943: AB_10602396"	"unprognostic (1.68e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (9.66e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.71e-1)"	26.4	31.9	43.6	26.1	44.8	66.6	29.5	28.3	36.4	25.6	31.3	25.6	31.6	27.0	25.1	32.2	35.2	35.7	28.1	30.8	39.2	36.3	37.9	33.2	26.2	34.5	39.5	27.4	28.8	31.4	21.0	35.2	33.7	32.3	27.3	22.7	22.0	31.5	28.9	20.7	23.5	31.2	25.4	34.5	29.1	26.7	51.2	27.0	24.1	40.1	29.0	31.6	35.3	26.5	39.1	32.2	91.2	42.7	34.1	37.6	56.6	25.0	29.6	16.6	37.1	16.6	18.7	16.1	24.1	23.1	27.7	30.4	34.5	25.0	19.2	29.5	23.2	15.0	18.2	22.0	23.2	23.2	24.7	14.0	21.1	22.6	34.7	23.8	18.5	18.3	27.3	25.2	47.6	21.5	34.3	44.1	25.4	65.8	31.2	64.6	36.4	37.1	16.4	16.7	33.2	24.1	20.0	29.1	35.0	23.8	27.5	50.0	17.3	30.1	17.5	26.4	33.6	52.2	37.6	27.7	46.5	51.3	23.3	35.6	47.7	59.1	39.3	91.2	34.1	40.5	31.9	39.1	32.8	33.0	32.2	36.6	27.9	29.2	83.0	34.1	42.7	31.1	37.6	56.6	43.6	44.8	28.3	36.4	39.2	36.3	39.5	27.4	32.3	27.0
C11orf70	MGC13040	ENSG00000137691	"Chromosome 11 open reading frame 70"	Q9BRQ4	11	102047443-102084560	"Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.5;testis: 54.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038585	Enhanced		Approved	Centrosome				Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.5	3.7	2.9	1.1	4.2	0.1	3.1	0.7	1.4	5.9	1.6	5.4	11.6	0.8	5.3	11.9	2.3	25.5	4.9	1.7	3.9	4.5	3.0	0.3	7.2	1.2	1.7	1.3	7.5	0.8	3.7	13.7	4.0	16.0	5.6	0.8	4.2	1.1	7.0	0.5	1.6	0.8	5.5	1.9	0.2	1.6	54.7	2.2	0.0	3.3	1.1	0.8	3.8	2.5	0.6	0.3	2.3	0.6	0.3	0.4	0.2	0.0	6.6	6.7	0.0	6.1	14.7	0.2	2.6	6.7	3.6	5.2	0.5	8.6	0.0	1.6	5.1	1.6	1.6	0.8	2.6	0.0	1.0	0.0	1.1	0.0	4.3	0.0	0.0	6.2	8.4	9.4	6.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	9.9	1.8	7.4	0.0	8.5	0.1	0.0	7.5	0.0	1.0	0.9	2.8	8.8	2.1	0.1	0.0	0.0	3.0	0.0	0.4	1.6	0.6	0.4	0.3	0.2	0.2	0.5	0.3	0.3	0.1	0.6	0.4	0.3	2.3	0.3	0.2	0.3	0.2	0.2	2.9	4.2	0.7	1.4	3.9	4.5	1.7	1.3	16.0	2.2
C11orf80	"FLJ22531, TOPOVIBL"	ENSG00000173715	"Chromosome 11 open reading frame 80"	Q8N6T0	11	66744451-66843328	"Predicted intracellular proteins"	Meiosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA038932, HPA038933"	Approved		Approved	Centrosome				Centrosome		"HPA038932: , HPA038933: AB_10671867"	"unprognostic (2.81e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.98e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.26e-1)"	2.8	7.6	15.0	12.9	15.0	4.8	10.3	26.2	11.9	7.1	10.1	1.7	4.7	7.7	5.9	13.3	16.4	5.4	4.6	4.2	8.3	7.2	13.4	2.2	4.4	5.8	5.0	11.9	3.3	4.7	10.9	12.4	3.9	8.0	10.0	9.0	5.5	10.7	9.5	1.3	35.6	17.3	4.2	2.7	6.8	5.1	15.2	2.5	15.1	3.6	7.6	15.3	4.8	8.8	10.6	9.7	3.1	1.0	1.7	4.2	0.7	9.0	4.8	9.9	6.7	0.5	3.2	1.8	3.8	4.6	4.5	5.7	16.7	11.1	14.8	2.2	3.1	16.6	4.6	5.8	4.6	3.7	2.6	2.4	6.0	4.2	1.1	1.6	2.8	0.8	20.1	3.5	6.7	14.4	4.3	5.7	2.7	10.0	5.9	5.3	15.7	6.7	3.5	4.6	11.4	19.7	3.1	7.4	7.4	6.3	17.4	13.4	12.0	1.1	6.3	3.2	5.9	3.4	5.5	4.0	8.8	10.7	3.6	2.9	4.1	1.9	0.9	3.1	2.1	0.5	3.7	10.6	3.8	3.0	0.5	8.9	4.2	3.5	2.3	1.7	1.0	9.7	4.0	0.7	15.0	15.0	26.2	11.9	8.3	7.2	5.0	11.9	8.0	2.5
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favourable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.2	16.9	10.4	4.9	6.5	11.0	6.5	3.9	7.2	5.9	11.9	5.2	7.1	8.6	3.9	9.6	10.1	8.2	5.5	10.1	20.4	10.7	16.3	14.9	7.2	15.7	9.8	5.7	9.5	3.6	6.4	6.6	13.7	4.9	6.6	6.8	17.4	23.7	8.2	19.1	10.1	6.3	7.0	9.5	8.1	27.8	9.5	6.5	11.4	15.0	19.4	8.5	3.4	8.9	5.0	6.6	6.6	13.2	20.2	14.8	10.1	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.7;hTCEpi: 28.8;T-47d: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA049367: "	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.0	4.0	0.1	1.6	1.8	2.0	5.0	1.5	1.9	4.7	1.3	3.1	11.3	0.1	17.1	1.1	17.4	0.7	33.7	2.7	0.0	2.7	0.0	1.8	0.3	5.1	0.3	0.0	4.5	28.8	4.5	19.8	15.3	0.0	0.0	0.1	10.1	0.0	18.4	1.1	11.6	0.5	0.0	1.0	0.0	13.7	3.8	1.0	6.1	3.1	3.1	30.0	5.1	15.6	3.0	7.9	1.3	4.3	4.2	3.0	13.2	0.0	4.3	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347751-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 26.0;U-138 MG: 11.6;U-2 OS: 6.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"			"Golgi apparatus, Centrosome"		"HPA061290: "	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	5.5	2.1	2.1	1.9	5.2	0.6	5.6	4.4	4.9	9.5	4.9	1.1	1.3	3.4	10.9	6.9	6.8	4.9	9.3	8.5	2.0	1.8	1.3	1.0	5.0	1.1	1.4	3.0	2.9	0.9	0.6	1.2	2.4	1.0	7.7	3.4	14.3	3.4	9.6	4.8	3.0	4.6	6.4	1.3	1.7	4.3	5.8	1.5	0.0	4.3	12.1	1.3	6.0	5.8	0.6	0.4	3.7	0.1	1.0	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	2.9	3.9	0.7	2.5	0.1	0.6	0.0	0.1	1.0	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	26.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.2	11.6	6.3	1.1	3.1	0.1	0.0	0.0	0.4	0.0	5.1	3.7	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.6	0.2	0.2	1.1	1.0	0.1	0.4	0.1	0.1	2.1	5.2	4.4	4.9	2.0	1.8	1.4	3.0	1.0	1.5
C21orf33	"D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Chromosome 21 open reading frame 33"	P30042	21	44133605-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.0;U-266/70: 36.5;U-266/84: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"		1800000	Mitochondria	Centrosome	"HPA018517: "	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	16.0	9.6	9.1	6.1	11.4	2.2	7.2	7.9	16.6	5.1	11.7	11.6	12.4	3.0	6.6	22.8	7.6	7.3	5.2	29.2	8.4	8.7	31.6	36.8	8.5	9.9	10.9	9.2	6.7	15.7	2.0	6.5	5.6	8.3	11.0	1.9	6.6	8.8	8.0	45.9	13.4	7.7	7.6	7.3	8.9	13.7	11.8	5.1	5.8	7.1	21.0	15.2	5.1	4.7	22.5	12.3	8.9	20.7	14.7	15.6	23.9	0.4	1.6	0.9	0.2	9.3	8.9	13.9	18.1	10.3	14.3	10.9	21.7	0.2	43.0	0.3	0.1	0.2	0.1	8.6	6.4	9.5	20.9	1.2	3.5	11.6	10.4	0.6	0.3	0.1	0.9	3.9	0.7	0.7	8.1	13.6	5.0	1.6	0.4	1.2	0.4	0.6	0.4	0.1	15.2	0.9	0.3	14.3	0.2	0.2	0.5	14.0	1.0	1.5	8.8	5.5	0.3	10.8	0.1	36.5	30.4	0.9	0.5	2.8	6.5	8.9	11.3	6.8	13.0	13.3	11.3	22.5	15.5	15.6	4.6	21.6	14.8	12.8	5.1	14.7	20.7	12.3	14.6	23.9	9.1	11.4	7.9	16.6	8.4	8.7	10.9	9.2	8.3	5.1
C2orf74	LOC339804	ENSG00000237651	"Chromosome 2 open reading frame 74"	A8MZ97	2	61145068-61164829	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA026826	Approved		Approved	Centrosome				Centrosome		"HPA026826: AB_10671091"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.54e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.22e-2)"	15.8	19.4	32.2	10.7	38.5	2.4	19.1	12.6	33.7	15.4	11.5	13.6	10.0	3.6	12.7	30.2	9.6	13.6	8.6	25.3	25.8	26.1	26.0	22.7	11.4	12.3	26.9	18.4	17.1	8.9	12.5	26.0	11.2	26.0	13.0	6.0	5.8	8.7	12.5	15.0	5.4	5.7	12.7	22.3	13.5	9.9	27.4	22.5	5.7	20.5	12.5	10.1	9.9	10.0	20.1	10.8	17.0	10.4	18.4	20.6	6.8	5.7	10.0	10.4	0.0	22.3	22.8	9.4	15.1	17.4	14.5	12.0	0.0	9.8	7.2	21.1	12.3	7.8	0.0	12.4	24.9	9.1	6.2	0.0	9.5	11.5	9.0	8.6	8.1	23.4	20.4	10.8	22.1	8.0	0.0	5.5	22.1	10.5	0.0	16.5	9.9	6.3	13.0	12.9	12.1	19.8	4.5	21.6	8.3	1.9	1.9	12.6	7.9	8.7	4.2	12.3	5.3	7.3	18.3	23.1	10.5	27.3	16.2	6.2	10.8	9.9	4.9	17.0	11.4	10.4	14.5	20.1	12.5	11.6	10.8	13.0	20.6	16.3	1.1	18.4	10.1	8.9	16.1	6.8	32.2	38.5	12.6	33.7	25.8	26.1	26.9	18.4	26.0	22.5
C6orf106	"dJ391O22.4, FLJ22195"	ENSG00000196821	"Chromosome 6 open reading frame 106"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Approved	"Nuclear speckles,Centrosome"				"Nuclear speckles"	Centrosome	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	16.5	10.7	12.5	13.7	12.7	7.5	15.2	22.5	18.7	9.5	22.4	6.3	6.7	9.1	9.0	15.5	13.7	8.6	15.9	60.4	11.2	10.0	23.9	35.2	16.9	10.1	14.4	6.8	11.6	12.0	14.1	7.3	11.1	9.0	9.0	9.5	10.3	12.6	16.1	66.3	10.4	14.9	12.3	7.8	9.1	10.0	20.7	8.2	5.8	15.7	26.6	13.3	13.4	11.4	8.6	4.1	18.2	7.3	5.7	9.2	4.7	29.5	13.4	13.5	19.6	32.1	17.7	15.8	20.1	23.6	24.0	30.1	26.3	13.9	33.8	15.2	19.9	29.4	38.9	16.9	30.6	47.6	15.2	28.3	15.7	25.1	31.4	23.7	31.6	11.9	35.4	24.1	22.0	18.9	31.8	14.4	13.5	17.6	16.6	16.4	12.3	12.1	13.1	17.1	18.0	18.8	29.6	16.0	12.5	30.0	14.7	29.5	18.6	20.0	19.1	19.9	15.3	20.7	19.9	20.6	46.7	26.3	7.1	21.1	23.1	18.2	3.5	7.3	9.1	6.3	4.8	6.7	6.6	7.2	4.1	8.6	3.6	5.7	4.5	5.7	7.3	2.2	9.2	4.7	12.5	12.7	22.5	18.7	11.2	10.0	14.4	6.8	9.0	8.2
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946581-74952886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol			290000	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	6.2	4.0	8.3	9.7	8.0	9.0	18.8	8.1	12.4	5.1	9.9	5.6	2.8	14.3	5.2	3.0	5.2	3.6	5.0	3.6	7.4	8.4	4.1	5.1	2.8	8.4	8.4	5.6	4.2	3.5	6.6	4.4	6.5	6.7	3.9	9.2	2.2	3.0	4.8	4.7	3.5	18.7	4.9	11.2	5.4	3.6	31.1	5.1	10.5	3.0	3.4	8.0	5.0	16.0	1.8	0.9	5.3	0.5	0.0	2.1	0.3	16.7	3.7	9.6	3.9	3.9	5.0	17.9	13.4	4.2	9.3	10.1	1.0	5.2	15.1	4.0	3.3	5.0	7.5	0.7	15.0	20.4	11.6	8.0	6.7	6.4	3.1	9.6	12.8	2.4	5.1	5.2	3.7	2.8	11.3	10.3	12.1	4.7	16.9	11.3	11.3	11.3	15.9	7.6	3.6	3.9	4.1	10.5	4.6	5.8	5.0	4.0	6.0	7.4	3.7	8.5	9.5	11.5	11.6	19.8	14.8	9.6	6.4	10.8	9.0	1.8	0.2	5.3	1.0	0.4	0.4	1.8	1.1	1.0	0.2	1.3	2.1	1.3	0.5	0.0	0.5	0.9	1.2	0.3	8.3	8.0	8.1	12.4	7.4	8.4	8.4	5.6	6.7	5.1
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662961-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 33.1;testis: 18.6"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.79e-4)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3.0	1.0	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10.0	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3.0	14.8	1.9	0.9	18.6	5.6	0.0	1.9	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.4	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA050835: , HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.1	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.1	2.6	2.7	0.4	0.5	0.4	2.7	0.2	1.4	0.7	0.4	1.5	9.1	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.6	0.4	1.9	0.0	0.0	3.3	0.4	5.9	0.1	0.1	7.9	3.6	18.7	5.4	1.5	0.6	2.1	19.6	4.2	1.8	0.5	0.1	6.0	0.1	0.0	20.4	8.9	1.9	3.3	2.2	3.3	2.7	4.7	1.1	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595902-7618304	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;Hep G2: 11.2;SK-BR-3: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: "	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.8	2.8	8.0	1.9	9.2	0.9	4.1	12.0	15.5	4.5	11.4	0.8	13.5	20.9	1.5	8.0	14.7	4.8	7.6	0.9	5.2	4.8	9.7	14.2	4.5	1.1	2.6	6.5	1.0	15.7	4.2	6.2	3.6	7.0	6.7	4.1	8.8	22.1	16.0	1.1	33.9	17.7	1.0	1.0	1.1	14.5	9.1	1.1	0.9	9.6	2.5	5.7	4.1	6.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	8.3	1.3	0.2	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	19.7	4.4	2.3	3.6	0.0	7.4	3.2	2.1	0.0	1.5	7.6	0.0	0.3	11.2	0.0	0.0	3.4	0.0	4.2	0.0	0.3	0.0	0.7	0.0	0.0	9.4	0.1	0.1	5.1	3.6	0.5	0.0	2.7	1.5	4.4	6.4	6.8	1.0	9.7	0.0	8.0	1.3	0.0	0.0	1.6	0.0	0.3	3.9	0.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.0	9.2	12.0	15.5	5.2	4.8	2.6	6.5	7.0	1.1
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (8.36e-4)"	5.5	7.8	12.5	5.3	20.6	9.3	5.0	19.9	15.7	7.3	5.3	4.4	9.5	4.0	8.6	10.5	3.6	4.9	6.1	17.4	11.8	19.0	6.5	5.3	6.5	5.4	11.2	11.6	8.3	5.5	22.4	11.0	4.2	18.2	7.4	5.7	6.1	3.1	10.0	5.6	10.6	4.6	8.4	11.5	6.7	6.5	22.3	9.4	4.3	5.7	3.9	5.0	6.1	8.1	4.1	4.2	7.5	1.5	2.6	5.4	0.9	4.6	3.2	6.1	5.2	6.1	6.5	3.7	8.6	7.3	3.7	5.1	1.7	3.0	2.7	7.6	9.0	3.7	3.2	14.0	6.8	4.0	3.6	11.3	5.3	6.5	3.4	1.7	1.1	7.4	5.6	12.0	9.7	8.4	0.7	2.7	8.8	0.9	2.2	2.9	7.2	9.9	1.0	9.2	1.3	1.6	16.7	7.7	4.7	3.2	2.3	3.7	2.1	0.5	11.4	7.2	4.0	22.0	15.8	5.3	3.7	2.4	8.8	0.5	4.7	7.5	1.5	1.2	4.4	0.6	5.4	3.7	2.8	4.6	0.6	4.1	3.1	2.8	0.3	2.6	0.7	4.2	1.8	0.9	12.5	20.6	19.9	13.7	11.8	19.0	11.2	11.6	18.2	9.4
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell line enhanced"	"Detected in many"		"A549: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.8	5.0	1.4	0.4	2.5	1.9	0.2	1.0	0.2	2.7	2.9	0.0	2.3	0.5	4.4	0.7	1.1	0.0	2.2	1.9	1.7	0.8	2.1	0.8	0.0	0.0	0.3	0.0	0.8	1.3	2.3	0.5	0.3	0.4	0.8	3.5	0.1	2.4	2.0	0.7	0.7	0.0	0.0	0.2	3.5	0.0	2.9	1.4	0.2	0.1	1.6	1.7	0.7	1.1	2.5	1.1	0.6	0.4	0.2	0.0	0.0	2.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5
CCDC13	FLJ25467	ENSG00000244607	"Coiled-coil domain containing 13"	Q8IYE1	3	42692663-42773253	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.2;fallopian tube: 13.6;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Daudi: 1.2;HDLM-2: 2.9;NTERA-2: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA047429	Approved		Supported	Centrosome				Centrosome		"HPA047429: "	"unprognostic (3.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.83e-7)"	"unprognostic (6.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.04e-2)"	0.7	1.0	3.0	0.7	12.2	0.6	0.7	0.8	4.0	1.3	0.9	6.3	2.3	1.1	2.1	7.0	0.7	13.6	1.5	1.7	3.7	2.7	1.1	1.7	2.5	0.7	1.9	4.6	1.5	2.0	1.0	3.7	0.7	8.1	0.7	1.4	1.5	1.6	1.1	2.0	0.6	1.1	0.9	3.4	0.8	0.8	15.0	2.5	0.0	1.9	0.3	0.6	0.7	0.5	0.0	0.0	0.1	0.2	0.5	1.2	0.2	0.0	0.0	0.0	1.1	2.3	0.9	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.1	2.9	0.8	0.0	0.3	0.0	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	3.0	12.2	0.8	4.0	3.7	2.7	1.9	4.6	8.1	2.5
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	Centrosome				Centrosome		"HPA035278: , HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favourable (5.27e-4)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (4.76e-4)"	"prognostic unfavourable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favourable (2.72e-5)"	11.3	9.7	13.6	22.4	15.2	30.0	19.1	8.0	16.2	14.5	18.8	10.8	7.7	12.0	20.4	31.9	10.2	15.8	14.9	9.1	13.6	8.7	13.3	13.7	14.1	14.3	14.3	13.0	20.6	15.4	7.8	24.4	9.7	14.5	17.2	31.8	9.6	14.3	9.8	5.9	20.2	15.9	13.6	17.4	13.7	12.8	22.5	16.0	36.5	14.0	11.2	13.3	12.7	13.0	2.1	4.5	3.0	2.2	6.0	5.6	1.9	16.5	9.7	30.1	11.9	4.2	6.2	14.1	33.4	11.0	16.2	18.7	7.6	11.9	4.9	8.6	6.9	18.9	10.9	5.5	22.0	4.1	7.7	19.7	17.9	7.1	3.9	12.9	12.7	6.2	3.5	8.4	9.0	7.7	10.2	9.1	11.1	8.2	11.2	6.1	9.0	11.4	19.3	12.5	5.6	9.3	13.6	10.5	12.5	19.6	4.9	12.7	11.7	9.5	10.0	39.2	20.4	12.0	10.8	8.6	6.0	14.8	13.2	9.9	13.6	2.8	1.6	3.0	3.9	2.2	2.6	2.1	3.4	3.3	1.0	2.0	3.8	3.2	0.3	6.0	0.6	4.5	5.6	1.9	13.6	15.2	8.0	16.2	13.6	8.7	14.3	13.0	14.5	16.0
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria				"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	9.9	14.9	10.1	7.1	12.7	4.5	9.6	10.4	15.9	8.9	12.8	7.5	12.4	11.6	8.2	11.4	15.9	9.7	8.4	12.3	9.2	8.2	15.2	17.8	7.1	9.0	9.9	15.4	8.7	8.5	9.4	7.4	8.5	10.6	7.7	15.1	9.9	11.0	11.2	16.3	10.9	8.8	11.6	8.8	14.7	7.9	10.7	8.9	10.4	11.3	16.1	12.0	8.8	9.7	19.2	18.2	4.8	10.4	10.6	14.8	9.7	9.6	11.8	7.1	8.3	10.5	11.1	19.5	6.4	5.9	12.9	10.6	18.6	16.2	21.0	9.2	5.1	14.1	17.4	21.0	7.9	9.8	11.4	17.9	18.7	13.9	16.2	8.7	8.2	8.4	47.7	16.0	17.5	7.3	9.9	6.1	12.2	9.2	10.1	11.3	15.5	19.1	7.0	8.3	16.2	17.5	12.1	5.9	12.3	10.6	11.6	17.2	12.5	13.5	5.5	7.5	10.2	18.6	12.3	9.9	14.5	10.9	10.0	18.9	7.0	2.0	10.4	4.8	12.0	10.2	12.1	19.2	11.2	14.8	18.2	15.4	11.7	13.4	4.5	10.6	6.1	15.2	13.4	9.7	10.1	12.7	10.4	15.9	9.2	8.2	9.9	15.4	10.6	8.9
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340223-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA026652	Approved		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"			Centrosome	"Nucleoplasm, Cytosol"	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	3.5	2.5	5.2	29.5	5.4	32.5	2.7	23.7	2.8	2.6	6.1	4.5	6.9	3.2	2.0	1.3	4.2	2.5	8.5	2.3	4.1	2.6	2.0	1.6	11.4	18.6	8.6	2.2	1.3	2.1	0.7	1.6	1.4	6.5	2.9	2.9	1.7	7.5	8.9	0.8	1.9	11.1	1.3	7.2	26.6	3.3	7.3	6.5	16.8	1.9	2.7	20.8	4.1	2.8	3.0	3.5	11.3	6.5	7.1	4.6	1.6	0.1	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.5	9.0	1.4	0.5	0.7	0.0	0.2	0.0	9.8	0.0	6.8	1.8	0.5	0.4	4.2	39.8	0.0	0.0	0.1	0.0	0.2	0.2	10.4	0.3	0.4	5.7	3.5	0.3	0.2	5.4	0.1	8.4	0.1	0.1	2.2	0.0	0.0	0.2	0.4	1.2	15.8	0.0	0.0	0.3	0.0	0.1	2.2	0.7	7.3	0.5	11.5	0.2	3.6	6.5	7.6	4.6	4.7	1.4	2.2	2.7	3.8	2.1	3.0	2.6	3.2	11.3	7.1	3.1	3.5	0.8	1.6	5.2	5.4	23.7	2.8	4.1	2.6	8.6	2.2	6.5	6.5
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: "	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favourable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.5	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	10.6	2.5	0.9	3.4	2.7	2.4	4.4	1.0	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0
CCNF	"FBX1, FBXO1"	ENSG00000162063	"Cyclin F"	P41002	16	2429394-2458854	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060596, HPA070495, HPA071600"	Enhanced		Supported	Centrosome				Centrosome		"HPA060596: , HPA070495: AB_2686273, HPA071600: AB_2686424"	"unprognostic (3.87e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (7.46e-7)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-1)"	2.1	1.8	4.1	6.0	3.2	9.2	5.1	11.6	4.9	2.1	3.0	1.9	3.6	4.4	1.5	3.4	8.1	1.5	1.5	1.8	4.3	3.9	1.7	1.6	2.2	10.5	1.9	3.1	1.8	1.7	0.8	1.8	3.8	2.4	3.0	3.2	0.7	3.2	3.4	2.5	7.2	3.2	1.8	1.7	4.7	2.6	5.1	2.3	35.7	1.6	3.4	14.2	5.0	2.9	2.7	1.4	0.1	1.1	4.1	3.1	1.7	8.3	13.2	12.7	11.6	0.8	1.2	10.0	10.1	5.0	14.1	10.9	26.3	10.3	17.7	3.4	5.7	14.3	21.1	7.8	6.8	12.5	10.0	19.4	13.7	8.0	1.0	12.7	12.7	0.8	1.0	10.0	4.8	10.5	20.6	11.6	7.1	18.2	18.5	8.4	12.6	6.1	31.0	15.0	15.8	3.9	3.7	12.4	7.0	15.1	13.2	2.7	14.0	6.5	7.2	7.8	20.3	5.5	10.5	7.1	8.5	30.6	2.2	12.7	10.6	0.0	1.1	0.0	2.8	0.6	1.7	2.7	1.5	3.1	0.5	2.6	1.2	1.7	0.1	4.1	0.9	1.4	2.2	1.7	4.1	3.2	11.6	4.9	4.3	3.9	1.9	3.1	2.4	2.3
CCP110	"CP110, KIAA0419"	ENSG00000103540	"Centriolar coiled-coil protein 110"	O43303	16	19523811-19553408	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039402	Approved		Supported	Centrosome				Centrosome		"HPA039402: AB_10671041"	"unprognostic (2.83e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.37e-1)"	5.2	5.9	19.0	6.0	39.1	12.6	9.0	19.1	28.4	7.6	4.5	13.2	4.6	3.7	8.9	7.3	6.4	13.0	5.7	4.4	23.6	15.0	4.5	3.4	8.1	7.1	40.0	13.3	10.6	3.7	9.6	17.2	4.6	20.6	7.3	5.5	2.1	4.8	7.1	4.3	5.5	4.5	7.6	16.0	5.8	6.1	31.6	36.6	10.9	6.9	1.9	7.1	5.7	6.6	4.5	4.0	13.0	5.3	2.3	5.6	2.5	11.2	5.2	12.9	12.5	6.5	5.8	6.7	12.0	7.0	10.7	12.1	4.2	6.0	16.5	7.6	5.9	7.9	13.2	3.8	18.1	7.5	6.0	8.2	7.2	7.2	3.2	21.1	10.6	2.8	5.3	12.0	7.4	8.2	8.6	8.3	12.5	8.7	21.6	8.2	9.9	3.9	27.6	24.1	5.8	4.9	4.7	25.5	12.9	13.0	6.2	3.9	11.3	12.9	4.8	12.5	8.3	8.4	9.8	9.3	8.6	12.0	8.0	9.1	7.3	13.0	3.8	6.7	5.5	3.6	3.5	3.3	4.9	5.2	4.0	4.5	5.6	3.2	7.7	2.3	5.3	2.6	3.9	2.5	19.0	39.1	19.1	28.4	23.6	15.0	40.0	13.3	20.6	36.6
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"		170000	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	8.8	0.1	4.7	5.2	0.0	0.0	6.5	0.2	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.5	4.3	6.8	0.0	0.0	5.4	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510675-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA049352: "	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favourable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	17.7	14.2	36.8	6.9	41.6	5.1	8.2	36.4	54.6	13.6	9.5	16.3	2.7	30.0	13.4	4.4	8.0	10.9	9.5	25.0	33.8	37.1	23.7	13.2	9.6	8.2	34.2	38.9	18.7	22.9	10.4	19.3	8.5	26.3	13.2	4.1	7.8	10.8	14.7	34.0	9.1	24.2	8.7	20.7	12.0	9.2	10.1	15.7	13.0	10.6	6.7	6.9	7.8	6.3	8.7	9.2	19.3	19.2	14.3	15.9	7.2	3.8	1.6	5.4	1.6	0.4	0.0	0.1	5.9	0.9	5.8	5.0	9.3	1.5	0.2	6.0	4.8	0.1	4.9	20.8	1.0	13.1	9.3	17.6	6.2	24.1	3.9	8.5	11.0	5.7	10.8	5.2	0.8	4.6	0.3	4.8	6.5	0.4	6.6	11.1	12.0	4.6	25.0	4.8	48.1	1.2	0.1	16.3	7.0	11.8	0.5	7.3	2.1	4.7	0.2	3.0	8.9	2.0	0.2	12.9	11.9	17.8	0.1	8.6	2.0	3.2	7.9	19.3	15.9	12.5	8.6	8.7	5.7	8.9	7.6	8.3	11.4	9.7	6.2	14.3	19.2	9.2	9.1	7.2	36.8	41.6	36.4	50.3	33.8	37.1	34.2	38.9	26.3	15.7
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 105.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: "	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.5	8.9	19.6	10.9	4.0	5.2	36.2	20.6	10.8	25.6	24.0	18.7	15.9	15.7	15.5	7.6	10.6	14.9	9.0	26.1	18.5	14.6	18.1	14.8	7.1	1.3	14.3	13.1	2.7	2.3	17.3	6.0	12.9	17.2	14.3	17.8	12.7	29.6	12.1	7.8	13.3	29.0	18.9	11.8	7.4	16.2	8.1	10.5	23.5	8.6	105.5	18.6	10.5	7.2	17.7	17.2	13.6	15.0	8.2	9.4	19.6	10.0	10.5	15.2	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"				Centrosome	"Cell Junctions"	"CAB079753: , HPA035820: AB_10671939, HPA046529: "	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.8	23.3	14.0	10.1	14.9	12.5	12.3	9.5	14.0	13.1	13.2	12.6	17.8	5.7	12.0	21.0	18.4	14.1	13.5	14.2	7.4	15.2	30.8	23.3	9.5	18.7	10.2	26.8	9.4	12.4	16.4	12.1	14.0	15.5	18.3	21.5	20.0	12.0	21.6	12.7	19.7	27.9	8.4	10.0	7.6	15.3	17.6	21.4	11.8	14.2	27.6	12.9	8.1	12.2	13.3	14.2	13.9	11.3	15.7	20.0	12.7	12.0	25.5	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HEK 293: 3.7;HHSteC: 4.3;RPTEC TERT1: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.6	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.7	2.4	1.9	0.5	1.2	0.1	0.9	0.1	0.8	0.0	0.5	2.2	0.2	3.7	0.0	0.2	0.0	4.3	0.0	0.1	1.4	2.1	0.4	0.8	0.1	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	8.1	0.3	3.0	2.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1
CDR1	"CDR, CDR34, CDR62A"	ENSG00000184258	"Cerebellar degeneration related protein 1"	P51861	X	140782405-140784871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 56.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA073147			Approved	"Nucleoplasm,Golgi apparatus,Centrosome"				"Nucleoplasm, Golgi apparatus, Centrosome"		"HPA073147: "	"unprognostic (7.10e-2)"				"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"		"unprognostic (3.49e-2)"		"unprognostic (1.44e-1)"	"unprognostic (1.03e-2)"		"unprognostic (2.41e-3)"	"unprognostic (1.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.84e-1)"		3.2	1.3	9.1	0.5	26.3	0.0	0.0	56.2	28.7	0.0	0.1			0.2	0.4	0.0	0.6	0.2	1.5	1.5	9.2	2.8	0.1	0.0	0.6	0.1	3.7		0.1	3.9	0.0	7.1	0.4		0.1	0.0		0.6	0.0	0.2	9.4	0.1	0.0	3.6	0.9	0.5	0.1			0.7		0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CENPJ	"BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4"	ENSG00000151849	"Centromere protein J"	Q9HC77	13	24882284-24922889	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA060426			Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Plasma membrane, Centrosome"		"HPA060426: "	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-5)"	"unprognostic (7.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (7.36e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	5.0	3.5	6.6	6.7	11.9	10.2	6.2	18.4	6.4	10.3	7.6	5.0	7.2	7.5	8.8	4.8	6.6	6.0	3.3	4.2	5.4	4.4	3.9	2.9	4.9	8.5	9.7	3.8	8.1	3.2	2.1	4.6	7.6	7.2	6.3	8.8	2.4	4.6	12.0	3.6	7.6	9.0	9.1	11.6	7.4	4.6	24.3	10.1	14.6	20.8	5.7	7.8	7.9	7.8	4.3	2.4	3.8	1.3	2.2	2.1	0.7	5.2	5.1	17.6	16.3	2.5	3.6	9.9	12.4	5.6	7.7	7.2	6.7	9.4	9.7	3.7	4.5	12.9	13.2	7.0	11.9	8.8	6.6	34.9	12.2	5.6	1.2	16.0	11.5	2.1	2.0	6.8	3.8	5.8	9.8	18.0	8.0	5.1	10.9	21.8	9.9	3.9	12.2	12.2	4.9	3.0	6.0	8.9	8.3	6.3	6.8	5.0	3.4	10.9	5.5	9.1	6.2	12.6	8.1	5.0	9.1	10.4	4.2	11.7	14.1	1.9	0.8	3.8	2.1	1.3	0.9	4.3	1.4	1.6	0.9	4.1	1.8	0.9	0.4	2.2	0.9	2.4	1.5	0.7	6.6	11.9	18.4	6.4	5.4	4.4	9.7	3.8	7.2	10.1
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039408	Approved		Supported	Centrosome				Centrosome		"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	4.0	3.0	3.5	10.1	5.5	21.4	4.8	9.9	10.3	3.7	6.9	0.9	5.4	4.7	3.3	3.4	5.5	3.3	3.0	4.4	4.5	1.5	7.1	2.4	4.4	6.3	3.3	1.6	5.5	6.0	2.4	5.8	9.0	4.7	3.5	5.1	1.8	5.1	6.9	1.7	4.7	7.9	3.3	9.0	6.1	4.1	15.8	4.8	18.4	6.2	2.4	7.1	3.7	7.6	5.3	4.4	6.0	4.1	3.6	3.3	1.4	4.7	3.6	7.5	9.1	1.3	2.5	4.8	8.3	3.5	6.2	7.6	7.8	4.0	10.9	3.6	2.4	11.2	8.4	3.0	9.1	9.6	5.1	17.6	18.5	4.2	0.9	14.7	8.3	0.9	2.4	6.8	4.0	4.5	10.6	13.3	5.2	2.6	10.8	13.8	4.7	3.7	13.3	10.1	13.5	2.2	4.6	9.0	6.0	6.5	5.4	2.5	4.1	7.2	3.6	15.2	8.0	11.7	9.2	5.6	6.2	12.8	4.9	21.5	10.6	4.5	3.2	5.3	2.7	4.1	2.3	2.9	3.0	2.8	2.4	5.3	3.3	3.3	6.0	3.6	4.1	4.4	3.1	1.4	3.5	5.5	9.9	10.3	4.5	1.5	3.3	1.6	4.7	4.8
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606, HPA061504"	Uncertain		Enhanced	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA037605: AB_10672908, HPA037606: AB_10672498, HPA061504: "	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	8.8	12.4	9.1	18.2	9.2	15.8	2.9	17.7	9.9	12.7	12.5	15.3	14.5	17.6	12.8	10.9	11.8	10.1	10.4	10.9	17.4	8.4	5.3	12.2	4.8	13.6	7.6	11.9	10.9	8.9	19.3	18.8	16.4	14.4	11.6	9.9	7.7	7.0	6.9	6.5	13.5	9.4	10.9	6.9	5.6	7.7	10.7	15.5	14.0	8.6	10.1	11.8	8.9	17.7	15.2	9.5	14.6	16.1	4.1	5.0	10.5	7.4	8.7	10.0	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"				Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: , HPA045597: , HPA045787: "	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.1	11.1	8.2	15.9	2.8	16.1	9.5	12.1	11.4	3.1	5.9	4.5	9.8	13.6	3.0	11.3	6.9	17.2	10.0	6.5	4.6	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.5	16.9	28.1	11.3	4.7	15.3	1.3	5.0	4.3	16.5	14.5	9.0	9.4	1.5	2.5	1.0	19.0	25.7	8.2	0.7	7.7	2.8	11.1	31.1	22.6	6.7	12.1	18.4	4.6	5.9	9.0	12.0	7.5	51.8	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0
CEP170B	"Cep170R, FAM68C, KIAA0284"	ENSG00000099814	"Centrosomal protein 170B"	Q9Y4F5	14	104865280-104896770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000871, HPA059017"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA000871: , HPA059017: "	"unprognostic (1.09e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (4.41e-4)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-2)"	10.3	8.8	19.9	7.3	26.3	1.3	10.9	25.9	39.7	6.6	18.0	5.3	9.1	24.7	7.4	5.0	14.7	8.5	15.1	4.9	18.5	12.4	9.9	9.4	8.0	2.1	8.9	19.7	4.6	25.4	9.0	10.5	4.8	13.5	10.3	8.9	5.3	17.5	12.5	4.6	35.0	24.6	6.7	6.5	3.8	23.2	10.9	6.0	0.2	10.1	6.2	5.6	8.8	11.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	10.8	9.0	0.7	8.6	3.6	2.7	20.1	8.6	3.4	4.3	2.9	9.5	6.7	0.0	10.5	6.5	24.1	2.0	10.0	1.1	4.0	4.2	0.0	9.6	6.2	7.4	0.0	8.9	2.6	12.8	4.5	6.6	4.3	2.7	0.1	3.6	22.9	0.0	0.1	2.8	7.8	3.6	0.0	2.6	4.3	18.5	2.3	2.4	12.7	7.5	11.4	13.1	1.6	9.5	6.9	7.6	18.9	5.7	0.4	0.0	0.0	5.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	19.9	26.3	25.9	39.7	18.5	12.4	8.9	19.7	13.5	6.0
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712293	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome				Centrosome		"HPA047614: , HPA071138: "	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	3.2	5.2	10.2	5.7	11.7	2.4	2.4	7.3	10.8	3.6	2.3	3.0	2.6	2.0	3.3	6.2	3.2	8.0	3.8	2.4	8.4	9.0	5.2	2.3	3.2	5.0	6.5	6.0	3.8	1.4	6.1	9.2	3.9	8.3	3.5	2.2	2.5	2.3	4.4	1.3	3.3	2.0	3.0	4.4	6.1	1.7	17.5	4.4	8.3	5.1	0.4	6.3	4.0	2.6	1.4	3.4	45.3	1.3	2.3	3.5	1.2	5.1	3.6	5.0	3.1	11.6	9.0	1.5	4.2	8.0	4.6	6.0	1.8	3.5	3.9	12.2	2.1	2.3	3.3	1.1	5.5	5.3	3.4	5.9	1.8	0.5	4.7	2.7	7.6	4.1	5.0	6.0	1.6	1.9	3.2	4.8	4.7	2.7	6.6	4.8	2.6	6.1	7.9	3.1	2.7	4.9	0.5	5.0	3.6	5.8	0.8	6.5	4.5	5.2	1.5	5.4	1.2	8.2	2.8	14.8	14.1	8.0	7.6	6.9	5.2	12.9	1.3	17.5	1.8	0.9	2.0	1.1	2.6	2.3	0.8	1.4	3.5	2.2	45.3	2.3	1.0	3.4	1.4	1.2	10.2	11.7	7.3	10.8	8.4	9.0	6.5	6.0	8.3	4.4
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039392, HPA040503"	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	7.6	6.5	7.9	14.9	11.8	16.3	8.3	14.5	11.8	8.8	7.7	11.1	7.1	6.7	13.6	9.3	7.6	8.8	9.9	7.1	8.1	4.7	6.9	6.1	8.7	11.0	8.7	11.8	17.4	9.5	10.4	11.1	7.8	11.8	8.0	9.4	7.9	10.4	6.6	6.2	8.2	9.6	9.5	7.6	8.4	8.2	16.4	9.8	18.3	11.1	6.0	12.2	12.1	8.6	3.9	1.8	2.1	4.9	0.9	3.5	1.0	9.9	5.4	14.8	7.7	6.5	10.1	4.8	7.0	9.3	11.1	11.8	7.4	4.4	11.3	4.7	7.1	4.9	12.8	6.6	13.2	4.4	4.6	10.3	8.3	3.9	3.4	16.3	7.9	6.9	2.5	9.3	8.5	9.1	14.1	7.6	8.6	5.0	14.0	7.1	4.7	3.4	12.1	11.6	5.8	3.8	10.2	10.8	6.1	11.2	5.6	3.5	4.4	8.4	9.1	8.8	20.8	10.0	9.6	5.1	7.3	12.9	5.6	7.4	8.4	1.5	2.1	1.5	3.2	1.5	2.4	1.8	2.1	2.0	0.9	3.9	2.3	3.5	2.1	0.9	4.9	1.8	1.8	1.0	7.9	11.8	14.5	11.8	8.1	4.7	8.7	11.8	11.8	9.8
CEP250	"C-NAP1, CEP2"	ENSG00000126001	"Centrosomal protein 250"	Q9BV73	20	35455164-35519280	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"		"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064875			Supported	Centrosome				Centrosome		"HPA064875: "	"unprognostic (6.35e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (9.27e-6)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (1.30e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.57e-2)"	7.2	8.3	15.2	12.9	23.6	20.0	6.3	35.1	19.7	9.9	8.3	12.0	13.1	7.2	11.4	9.8	9.8	12.8	7.7	6.5	10.8	12.7	6.0	5.3	7.3	21.7	10.6	11.3	15.6	7.7	19.0	17.8	6.7	11.5	11.9	8.9	11.2	10.3	9.8	8.8	13.4	9.6	10.3	11.8	17.4	7.9	18.5	14.7	12.2	8.3	6.2	14.1	10.2	9.4	6.0	12.7	14.8	2.2	6.4	10.0	4.0	13.2	15.4	7.5	14.0	11.4	10.4	11.5	6.6	7.3	10.5	8.3	20.6	10.9	14.2	8.9	9.4	14.7	8.1	20.0	11.8	2.6	3.2	26.7	11.5	18.9	6.9	13.0	14.8	7.4	12.2	17.8	25.3	10.7	9.2	13.6	17.8	6.8	15.9	13.2	5.2	17.5	9.3	21.8	3.9	10.0	15.1	10.4	11.3	18.0	12.5	8.6	8.6	11.4	17.2	47.5	12.4	17.6	9.6	4.8	5.2	13.2	25.8	8.8	8.0	14.8	1.7	4.5	10.0	2.2	6.3	5.4	4.3	8.0	3.7	6.0	5.2	5.7	0.7	6.4	1.4	12.7	4.5	4.0	15.2	23.6	35.1	19.7	10.8	12.7	10.6	11.3	11.5	14.7
CEP290	"3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6"	ENSG00000198707	"Centrosomal protein 290"	O15078	12	88049014-88142216	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	Activator	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB029995, HPA043918, HPA064397"	Approved		Supported	Centrosome				Centrosome		"CAB029995: , HPA043918: , HPA064397: "	"unprognostic (7.42e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (3.21e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.84e-3)"	7.0	7.7	14.4	15.5	17.2	9.3	9.8	15.2	19.5	10.0	8.1	5.4	7.6	5.2	13.3	11.8	4.9	10.6	7.3	6.4	11.3	10.9	7.9	4.7	7.0	8.2	13.2	13.4	17.7	6.7	21.7	22.4	8.3	12.7	10.4	7.5	4.9	4.8	7.7	4.0	7.0	6.1	8.7	14.0	7.5	7.6	15.7	15.5	8.9	12.1	4.1	6.4	8.5	7.5	9.3	5.7	1.9	1.9	3.2	6.5	0.7	8.8	8.2	10.4	4.8	8.9	18.4	5.2	10.9	6.8	5.6	5.2	11.7	5.3	8.9	4.3	5.5	9.5	3.9	4.9	9.4	5.9	6.9	7.7	5.6	5.9	8.2	9.9	4.3	8.6	5.9	11.7	11.1	10.6	14.8	3.3	11.0	4.2	6.9	12.9	4.1	9.7	5.0	12.2	6.8	7.7	9.0	8.0	9.7	6.4	4.8	8.3	11.3	5.1	11.3	14.1	6.6	9.1	10.4	9.2	10.8	9.3	4.5	5.0	5.8	0.0	1.6	1.9	5.4	1.1	5.6	6.5	5.5	5.2	0.7	9.3	5.6	6.5	0.3	3.2	1.9	5.7	4.2	0.7	14.4	17.2	15.2	19.5	11.3	10.9	13.2	13.4	12.7	15.5
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954738-180114880	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome				Centrosome		"CAB079754: , HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: "	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	17.2	11.3	13.8	18.9	18.0	26.5	14.0	23.1	14.8	15.3	16.9	13.1	10.5	11.1	13.9	11.9	13.4	11.9	10.8	12.8	13.1	9.4	11.4	12.6	12.4	16.9	17.7	12.3	18.0	13.7	27.2	25.5	14.4	16.2	11.6	13.9	9.0	13.5	12.1	44.2	15.1	22.1	11.5	14.6	17.8	13.4	28.8	18.5	29.8	13.9	11.6	16.5	17.0	20.1	7.2	5.9	8.1	3.7	3.2	6.1	1.3	12.7	9.3	12.0	4.2	10.2	9.5	11.2	8.7	11.7	7.5	8.3	10.3	7.7	14.2	9.5	7.8	15.8	9.0	5.0	9.9	13.7	6.2	10.1	11.7	6.4	11.2	19.9	9.5	9.4	7.9	9.8	12.9	9.2	19.5	10.8	8.1	9.4	11.6	5.6	11.2	2.3	10.1	13.2	10.9	5.3	26.7	8.4	9.0	14.5	9.8	16.6	10.6	17.9	9.3	10.7	7.5	9.4	9.2	18.9	23.8	27.8	5.0	8.6	15.9	2.3	3.7	8.1	5.4	3.4	6.1	4.1	3.9	3.4	3.0	7.2	4.2	3.5	7.3	3.2	3.0	5.9	5.7	1.3	13.8	18.0	23.1	14.8	13.1	9.4	17.7	12.3	16.2	18.5
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4"	"Low region specificity"	"Detected in all"							"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favourable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavourable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	5.5	8.3	11.0	5.7	15.8	3.5	9.0	14.7	15.6	20.8	12.2	7.1	22.8	35.7	14.0	14.8	10.2	20.3	8.9	11.3	10.9	15.9	17.0	18.8	11.5	4.2	12.6	10.2	14.4	17.4	16.6	27.8	2.7	14.4	14.3	12.1	12.6	6.1	28.7	10.6	4.6	11.5	14.0	19.1	3.9	8.6	41.5	15.3	24.2	26.2	6.7	4.5	13.3	9.1	2.9	0.2	0.5	0.1	3.6	6.4	2.0	21.5	4.5	10.6	13.0	6.6	7.5	10.0	4.2	8.1	5.9	8.8	6.3	11.7	5.1	10.2	8.0	9.5	9.7	8.5	13.5	8.9	6.3	14.6	10.5	8.2	10.5	0.7	5.4	40.2	5.0	4.5	11.2	8.6	10.6	17.1	9.7	8.1	15.3	0.8	6.3	10.2	16.9	13.8	13.1	11.4	9.6	13.0	8.4	22.5	5.4	25.4	27.0	7.0	5.0	4.4	8.4	9.0	5.2	15.9	8.7	17.3	9.8	1.4	14.9	0.4	0.1	0.2	4.2	0.1	5.0	2.9	3.4	3.7	0.1	2.0	5.9	6.4	0.5	3.6	0.0	0.2	2.0	2.0	11.0	15.8	14.7	15.6	10.9	15.9	12.6	10.2	14.4	15.3
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612272-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.7;HeLa: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;NK-cells: 7.7;T-cells: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 15.8"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Supported	Centrosome				Centrosome		"HPA058235: , HPA074879: "	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	2.5	2.3	4.7	6.5	6.5	7.1	4.0	7.3	5.9	5.4	3.0	6.6	2.0	3.8	4.8	3.1	4.6	4.5	9.1	2.2	4.5	2.7	2.8	4.2	4.8	6.4	3.8	3.5	7.6	6.2	3.7	4.5	4.0	3.3	3.5	2.5	4.8	4.6	3.2	2.6	6.0	3.4	4.9	3.3	4.0	4.9	18.8	4.3	9.4	4.9	2.6	7.9	2.9	3.6	3.2	0.7	0.6	1.0	7.7	3.2	1.4	4.3	7.1	6.4	9.0	0.6	0.6	11.6	1.9	0.8	4.3	3.8	6.4	6.7	5.1	5.0	0.8	4.2	4.5	3.2	1.7	26.7	7.1	5.7	21.5	2.5	0.8	6.5	3.8	0.7	1.4	3.7	2.5	1.6	5.7	6.1	2.1	3.3	9.7	5.7	4.2	6.7	7.4	3.7	7.1	1.4	3.4	4.9	3.8	13.8	4.6	1.2	4.5	5.1	0.5	4.1	6.1	3.9	2.6	3.9	3.7	5.1	2.6	9.2	4.3	0.0	0.6	0.6	2.4	0.2	3.2	2.6	2.1	2.2	0.2	3.2	3.0	3.0	0.0	7.7	1.0	0.7	2.6	1.4	4.7	6.5	7.3	5.9	4.5	2.7	3.8	3.5	3.3	4.3
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Supported	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"				Nucleoli	"Golgi apparatus, Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.4	6.7	10.8	11.4	3.0	2.8	21.1	6.8	3.2	9.5	10.1	8.6	12.6	12.8	9.3	2.8	11.9	12.0	5.7	9.5	9.4	10.4	18.1	13.1	9.0	3.1	16.5	20.0	1.4	5.6	7.9	5.8	4.2	24.3	17.9	6.9	4.8	15.8	20.0	10.4	11.1	16.1	12.5	11.9	4.7	2.0	18.3	8.4	9.6	8.0	8.0	7.3	11.8	4.9	7.7	12.9	9.0	10.5	14.1	20.6	16.0	4.8	29.1	14.6	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5
CEP95	"CCDC45, DKFZp667E1824"	ENSG00000258890	"Centrosomal protein 95"	Q96GE4	17	64506588-64542461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023654, HPA052426, HPA052428, HPA061371"	Approved		Approved	"Nucleoplasm,Vesicles,Mitotic spindle,Centrosome"				Nucleoplasm	"Vesicles, Mitotic spindle, Centrosome"	"HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: "	"unprognostic (1.28e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (5.78e-4)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	13.0	8.6	10.9	17.1	13.1	37.9	15.5	27.9	15.6	16.7	14.2	16.2	11.6	11.9	26.5	16.6	10.7	17.1	12.3	10.6	11.5	7.8	14.1	11.7	13.0	20.7	13.6	7.9	27.3	15.5	11.8	20.4	8.5	13.0	15.2	13.5	15.6	13.8	19.8	14.6	21.7	14.2	15.0	17.4	13.2	13.3	16.9	13.9	26.4	21.0	8.6	14.7	14.3	14.0	5.9	3.7	2.2	3.6	2.1	10.8	2.4	10.0	6.4	13.1	11.3	3.5	9.0	13.1	5.1	5.2	6.4	9.7	7.7	5.8	16.1	3.4	7.2	12.8	11.2	9.9	13.2	4.2	8.6	14.3	12.4	14.8	11.6	15.5	7.7	10.2	10.4	7.1	15.9	5.4	16.4	11.8	7.0	11.8	19.6	9.9	8.1	8.0	14.1	23.7	11.9	7.4	16.1	8.3	15.0	7.0	10.3	13.3	11.4	10.4	8.0	14.6	11.4	6.7	6.9	12.0	9.6	17.1	6.3	11.9	8.9	2.2	3.6	2.2	4.5	2.9	10.8	4.5	5.2	4.5	3.4	5.9	8.0	5.4	1.4	2.1	3.4	3.7	4.2	2.4	10.9	13.1	27.9	15.6	11.5	7.8	13.6	7.9	13.0	13.9
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392261-90409786	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome				Centrosome		"HPA035608: AB_10601098, HPA063704: "	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	8.6	11.6	13.7	8.0	16.3	3.6	12.4	11.5	17.9	11.5	8.9	8.7	8.9	5.2	11.0	11.5	11.4	12.0	5.6	14.4	15.6	11.4	10.6	6.9	12.1	9.3	18.2	13.2	17.1	5.8	11.8	34.3	10.0	20.6	10.3	10.7	5.9	7.8	9.7	11.7	8.2	5.6	7.7	37.2	7.6	6.7	63.1	16.5	7.3	7.9	6.1	10.5	7.5	9.6	17.2	19.9	9.4	10.5	11.4	14.9	4.7	16.7	7.4	30.0	6.1	16.9	23.0	18.0	18.3	11.3	17.6	21.9	11.2	20.6	31.7	18.3	8.6	12.0	25.6	24.7	29.2	25.4	11.8	16.1	11.1	14.0	12.1	11.9	10.1	14.4	16.3	12.8	21.4	11.0	20.3	14.2	19.7	11.1	19.6	18.7	10.6	19.1	17.9	21.0	16.1	15.6	6.2	16.4	16.8	17.8	9.2	12.9	17.3	16.1	12.3	10.6	15.2	14.7	24.5	13.2	23.6	28.1	12.4	26.9	10.7	7.8	6.7	9.4	9.3	8.1	9.7	17.2	10.3	9.9	7.4	14.6	14.9	11.9	0.8	11.4	10.5	19.9	8.0	4.7	13.7	16.3	11.5	17.9	15.6	11.4	18.2	13.2	20.6	16.5
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.5	3.7	2.7	23.2	10.6	16.6	31.8	18.9	16.0	5.4	4.9	10.3	16.4	5.8	40.7	18.2	23.8	1.8	11.4	0.8	8.9	6.4	2.0	5.2	44.5	14.8	1.8	12.2	22.3	20.1	5.4	5.2	0.0	12.9	14.2	5.1	29.2	0.2	4.8	11.5	14.3	0.0	8.8	11.3	6.4	8.4	6.8	10.4	9.1	8.8	25.8	3.0	6.3	0.4	19.9	10.9	23.7	9.8	17.1	5.3	2.6	18.2	1.8	20.0	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.1;REH: 35.6;U-266/70: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol			560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavourable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.6	8.5	3.2	0.7	3.1	1.7	0.0	2.6	3.5	1.4	2.0	0.2	6.9	0.0	8.3	10.5	14.4	0.6	8.3	1.2	0.0	2.4	0.0	3.9	6.3	1.0	0.0	16.3	1.0	9.6	3.9	3.3	2.8	0.0	27.1	6.9	7.0	0.0	0.0	2.8	0.0	35.6	4.3	8.4	7.0	1.2	0.3	0.7	6.8	3.9	0.0	2.8	0.0	3.3	0.3	0.1	10.0	0.4	24.6	5.9	6.8	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Plasma membrane,Centrosome"			460000	"Plasma membrane, Centrosome"	Nucleoli	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	13.7	25.5	20.6	11.5	25.7	18.6	12.5	34.6	32.9	11.3	14.6	16.5	7.3	10.2	13.7	10.4	11.7	9.5	10.1	16.6	19.2	19.3	9.7	37.7	8.5	14.1	18.8	21.1	23.8	7.9	20.0	20.8	13.8	33.0	13.5	15.0	9.1	8.7	12.0	26.3	10.7	9.9	16.1	22.5	8.8	12.9	25.4	22.2	28.6	8.0	10.8	14.7	12.6	9.7	8.6	8.4	6.0	8.7	11.7	10.0	3.6	25.9	25.1	53.9	23.1	12.8	20.1	12.5	29.8	18.1	28.4	30.2	20.4	8.8	28.3	10.5	20.0	29.5	38.6	16.9	35.7	25.5	29.5	47.2	20.1	19.6	9.5	36.0	19.8	10.2	9.0	15.9	34.5	21.4	33.3	26.6	23.4	17.9	30.6	9.3	29.0	20.2	32.5	57.4	24.8	9.1	16.0	25.1	21.4	40.5	14.5	14.8	26.7	9.8	18.4	27.6	24.4	46.7	43.9	15.1	32.6	40.8	17.3	17.1	27.0	5.4	5.7	6.0	9.0	8.7	8.8	8.6	6.7	10.0	8.4	8.0	8.2	8.5	0.9	11.7	7.8	5.4	7.5	3.6	20.6	25.7	34.6	31.2	19.2	19.3	18.8	21.1	33.0	22.2
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723329-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.1"	"Group enriched"	"Detected in many"	4	"HEL: 44.4;HMC-1: 82.3;NB-4: 109.3;THP-1: 88.3;U-937: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.0;monocytes: 17.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"		45000	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	5.5	5.4	3.0	5.6	3.1	77.1	4.5	4.5	3.6	33.6	6.5	1.2	6.7	3.9	26.6	27.8	6.7	13.5	10.7	5.6	2.6	3.4	7.4	5.4	7.5	3.5	2.9	1.3	16.1	2.6	2.0	7.5	6.9	4.0	18.9	2.1	8.9	2.9	10.2	3.4	5.0	5.2	8.5	3.4	4.9	3.1	4.9	0.8	4.0	3.8	4.5	2.6	8.4	10.1	0.3	12.0	1.2	17.2	3.4	3.2	6.7	0.3	0.4	0.0	0.3	4.3	5.9	10.1	17.3	4.7	2.0	1.9	0.0	0.0	0.0	0.2	8.6	0.2	0.0	0.0	1.3	0.0	2.8	44.4	0.0	0.0	2.7	0.0	82.3	4.3	0.0	0.2	0.2	2.2	0.5	0.2	3.7	0.3	0.3	109.3	0.2	0.5	3.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	6.7	0.1	88.3	12.4	0.1	5.4	0.0	0.1	0.2	0.2	0.0	6.3	45.8	5.7	1.0	17.2	0.2	0.6	7.2	0.0	0.3	0.2	0.1	12.0	0.3	1.5	3.2	1.2	3.4	3.3	3.2	0.1	6.7	3.0	3.1	4.5	3.6	2.6	3.4	2.9	1.3	4.0	0.8
CLHC1	"C2orf63, FLJ31438"	ENSG00000162994	"Clathrin heavy chain linker domain containing 1"	Q8NHS4	2	55174791-55232563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045418, HPA053557"	Uncertain		Approved	"Nucleoli fibrillar center,Centrosome"				"Nucleoli fibrillar center, Centrosome"		"HPA045418: AB_10962144, HPA053557: "	"unprognostic (1.60e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-4)"	"unprognostic (6.36e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (2.15e-4)"	4.8	5.7	10.4	3.6	8.7	3.5	6.7	15.7	11.9	6.0	5.3	12.9	9.3	3.9	8.5	9.8	5.5	9.5	6.2	4.6	8.2	5.1	5.2	3.5	5.3	6.6	6.0	8.3	7.4	5.5	8.4	23.6	6.9	8.9	9.1	6.6	8.9	5.8	8.9	3.0	9.6	5.6	7.1	12.0	7.2	4.9	23.2	8.8	10.1	8.3	1.6	5.2	6.6	6.1	1.3	2.9	4.0	2.0	3.2	2.1	1.0	4.3	3.2	8.3	4.9	3.4	4.7	7.2	5.7	5.4	2.9	2.7	6.3	4.0	6.4	3.4	2.6	6.6	3.5	4.9	6.0	5.7	4.1	9.3	9.7	5.7	3.7	5.6	4.6	6.6	4.0	3.6	8.4	2.9	4.7	3.8	3.3	3.5	4.1	6.3	3.0	1.3	5.0	4.7	4.0	4.6	5.1	9.5	5.8	3.3	5.4	5.4	4.1	3.1	8.4	7.3	4.9	3.4	4.0	7.6	1.9	3.7	5.4	5.7	1.8	1.2	0.6	4.0	0.9	2.0	0.1	1.2	1.7	0.9	1.0	1.3	2.1	1.0	0.4	3.2	1.6	2.9	1.1	1.0	10.4	8.7	15.7	11.9	8.2	5.1	6.0	8.3	8.9	8.8
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: "	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	12.3	12.6	11.3	15.2	12.4	16.6	14.0	14.2	13.4	13.4	14.0	12.5	12.8	10.8	19.8	13.5	14.8	16.1	9.8	13.0	10.5	9.4	13.1	13.5	11.4	14.7	9.7	11.9	14.7	14.0	16.0	23.0	11.3	13.3	13.1	15.7	12.2	12.0	10.9	13.5	14.9	14.7	12.8	10.5	15.1	12.2	40.5	10.9	30.2	13.8	11.9	17.4	13.0	12.6	15.0	14.1	16.0	21.0	9.0	18.5	11.2	8.2	9.3	9.7	9.1	4.7	5.4	64.7	7.0	7.0	10.0	11.3	7.0	7.2	13.6	4.7	4.9	7.3	11.4	9.2	10.0	11.7	11.7	17.4	8.4	6.8	13.7	14.3	6.7	4.0	8.3	11.0	14.6	8.1	18.1	10.6	5.8	6.8	12.7	6.9	14.6	8.9	12.9	6.6	13.6	6.4	9.7	5.5	10.7	10.3	14.5	8.4	14.1	16.2	5.0	6.2	8.8	8.1	11.5	11.0	22.5	13.6	6.3	10.9	7.5	12.8	11.2	16.0	11.4	15.7	12.3	14.8	18.5	13.6	14.1	15.0	18.5	16.2	8.8	9.0	21.0	7.8	14.4	11.2	11.3	12.4	14.2	13.4	10.5	9.4	9.7	11.9	13.3	10.9
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.9"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: , HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	13.2	5.6	4.3	5.2	5.1	12.5	7.4	15.5	4.5	16.6	8.6	4.2	6.7	2.2	22.6	6.0	6.0	8.0	7.4	4.9	4.2	3.8	5.0	20.0	5.4	4.8	4.9	2.6	15.2	3.6	10.0	13.2	6.1	6.3	9.8	4.0	7.0	3.8	6.3	5.9	3.5	4.4	11.9	8.1	8.6	4.4	8.2	6.8	4.4	5.5	5.8	2.8	11.7	13.5	0.3	1.5	0.8	6.9	1.2	0.2	0.5	5.8	4.0	8.9	5.0	4.4	10.3	0.3	6.9	4.6	5.1	7.0	0.3	2.0	4.3	1.1	4.7	0.3	10.2	2.8	8.1	0.2	3.6	25.0	8.6	1.4	4.8	3.4	5.5	6.5	1.5	4.3	4.2	7.3	0.9	1.0	8.2	0.5	2.8	5.5	6.9	7.5	4.1	8.2	2.1	3.0	1.4	5.6	5.8	8.4	0.2	2.1	1.7	8.7	5.3	7.1	2.8	7.7	5.9	3.5	4.2	0.1	3.3	4.3	3.2	0.6	2.7	0.1	0.1	3.3	0.0	0.3	0.2	0.1	1.5	0.3	0.1	0.1	0.8	1.2	6.9	1.5	0.2	0.5	4.3	5.1	15.5	4.5	4.2	3.8	4.9	2.6	6.3	6.8
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA020468: , HPA020480: , HPA051583: "	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.3	3.6	10.0	7.2	1.5	2.3	1.7	3.7	2.8	2.9	2.5	2.1	5.9	24.6	1.4	2.7	11.3	3.3	2.2	4.8	14.9	2.6	12.8	6.5	2.5	2.1	34.8	15.6	1.4	1.7	3.1	7.5	6.4	8.3	14.1	2.8	3.4	13.6	11.9	3.4	2.9	12.9	15.1	7.0	1.4	2.5	3.8	5.7	12.7	2.3	2.9	4.9	16.7	4.7	3.1	5.4	4.8	6.8	9.8	10.7	16.7	2.6	14.4	7.1	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949918	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	9.0	7.4	7.5	9.2	10.1	18.4	9.3	11.2	12.7	13.0	10.9	9.8	9.9	6.8	21.3	12.6	11.0	10.4	9.0	7.1	9.5	8.0	9.2	8.7	15.0	8.4	9.3	9.9	11.4	11.0	16.5	9.6	9.9	9.9	9.9	12.5	10.3	9.6	8.6	6.8	16.9	9.1	16.3	7.0	9.9	8.4	51.2	6.4	16.0	10.4	6.2	11.2	9.3	10.0	2.1	7.6	9.4	3.4	3.4	3.5	2.6	22.1	14.5	21.8	12.0	9.2	12.7	7.1	19.3	18.1	27.1	20.8	12.3	8.3	22.8	10.3	16.9	17.9	16.8	13.5	30.3	22.4	13.2	15.1	23.8	9.7	13.6	14.0	23.4	11.6	10.0	19.0	19.2	16.7	10.9	11.2	18.7	7.2	21.2	13.5	4.8	11.4	22.6	14.9	8.5	12.5	6.8	7.1	12.8	15.6	8.0	6.2	10.9	8.9	13.6	15.1	12.8	20.5	26.6	17.2	11.5	15.8	13.0	17.9	21.5	9.4	2.5	1.0	2.9	3.4	2.6	2.1	2.2	3.5	1.7	1.5	1.4	2.4	0.4	3.4	1.4	7.6	2.9	2.6	7.5	10.1	11.2	12.7	9.5	8.0	9.3	9.9	9.9	6.4
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	20.2	1.1	0.0	0.0	0.1	0.3	0.0	16.2	30.8	16.6	4.1	0.1	1.7	0.0	3.2	6.9	1.2	0.0	8.9	17.2	0.1	0.0	0.0	6.5	0.4	0.4	0.0	0.0	0.2	14.5	1.5	2.1	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	2.4	0.0	16.7	0.0	7.8	0.8	0.0	0.0	10.7	5.1	0.1	0.1	0.0	12.4	4.0	34.2	1.3	1.6	0.0	0.0	0.0	61.4	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: "	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	9.0	1.7	7.2	0.8	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.2	3.4	0.7	0.8	0.0	13.2	0.0	3.7	49.9	0.5	0.0	0.0	17.6	3.7	0.0	0.0	0.0	0.0	0.3	1.8	2.5	0.0	0.4	5.7	2.0	0.0	0.0	0.1	0.1	0.5	70.2	23.2	103.0	12.9	0.0	7.7	0.3	0.0	2.8	7.2	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3
CPT1C	"CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.4;AN3-CA: 15.5;SH-SY5Y: 33.2;U-87 MG: 13.9"	"Cancer enhanced"	"Detected in many"		"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome				Centrosome		"HPA014529: AB_1847206, HPA063621: "	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	9.3	11.2	3.1	18.9	0.8	1.1	16.3	34.0	4.1	1.9	8.9	0.2	2.7	6.4	5.3	1.8	4.1	7.6	2.8	11.9	12.8	1.6	1.6	2.5	2.6	8.0	13.4	3.8	1.2	0.7	15.6	1.9	11.4	2.8	1.7	7.4	1.5	4.8	1.7	1.5	2.4	7.8	6.6	4.2	1.4	4.1	6.3	0.0	1.7	0.2	1.7	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	18.4	15.5	6.7	5.2	0.0	5.8	11.7	7.5	10.6	0.3	0.0	0.3	0.0	5.8	1.3	0.0	0.0	4.0	0.2	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.1	0.0	6.1	0.0	10.4	0.0	0.0	0.4	0.3	0.1	0.0	0.8	3.8	0.0	0.0	0.0	0.4	0.0	12.9	33.2	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.1	3.5	2.9	0.1	1.3	0.1	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.2	18.9	16.3	23.4	11.9	12.8	8.0	13.4	11.4	6.3
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 129.0;CAPAN-2: 71.9;HaCaT: 77.9;HDLM-2: 55.1;HeLa: 63.2;T-47d: 101.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	44.3	3.3	3.8	37.5	4.9	5.5	97.2	3.2	4.0	37.7	44.0	4.5	65.3	25.7	20.0	83.0	28.4	23.7	33.8	45.5	4.5	4.7	20.4	2.6	56.7	53.0	4.7	4.5	11.2	4.2	1.1	7.3	38.5	4.8	11.7	13.2	9.9	21.8	71.0	12.9	48.8	106.3	25.9	5.1	16.6	20.3	7.5	1.9	24.2	32.0	83.4	58.3	18.4	18.9	111.4	79.3	56.3	49.4	56.9	121.1	75.8	0.0	129.0	0.8	0.1	2.3	1.6	12.0	0.2	0.0	1.7	0.0	4.0	71.9	38.9	0.7	34.4	77.9	0.0	0.0	0.1	55.1	0.0	3.0	63.2	21.7	0.4	0.0	0.0	0.7	0.0	4.2	0.0	0.1	0.1	0.1	0.0	1.0	1.9	0.3	1.2	6.7	30.5	0.0	8.1	0.0	0.0	3.4	0.2	0.4	0.2	0.0	101.1	18.5	0.2	0.0	0.1	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.1	19.4	43.3	56.3	47.7	38.5	32.7	111.4	92.1	51.4	79.3	43.6	21.9	25.7	2.9	56.9	49.4	62.1	121.1	75.8	3.8	4.9	3.2	4.0	4.5	4.7	4.7	4.5	4.8	1.9
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.4	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	29.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.2	0.6	55.5	32.7	4.9	0.0	0.0	42.4	26.8	0.0	0.1	0.3	0.2	0.0	1.7	1.0	7.1	0.6	0.6	3.7	0.5	0.0	2.5	0.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"				"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favourable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	4.9	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.6	0.7	2.8	0.3	3.5	3.3	1.2	11.6	2.7	3.1	4.2	3.7	0.7	1.1	9.8	10.6	3.2	2.1	9.7	4.2	1.4	4.3	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.7	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	21.0	14.7	19.6	25.8	21.4	27.3	18.9	20.9	21.3	20.3	23.5	18.4	31.7	16.1	25.4	25.2	18.9	21.0	17.7	25.6	17.5	15.8	19.3	35.3	19.3	26.9	17.9	14.7	21.7	14.6	14.5	22.6	22.4	17.5	19.4	18.1	16.1	15.5	34.3	27.3	20.1	19.7	23.8	16.6	49.5	25.9	35.5	20.6	31.0	15.9	15.5	29.7	22.2	29.3	24.9	31.4	60.3	29.1	21.7	18.2	18.4	15.3	14.2	13.6	10.6	9.8	8.1	21.5	9.8	10.3	23.6	20.9	52.9	12.4	17.1	14.4	9.9	16.5	18.2	23.2	25.5	8.2	9.1	56.1	7.8	25.8	10.2	17.7	74.6	8.6	13.8	13.3	13.3	14.1	15.1	7.0	12.6	12.7	28.7	23.6	12.2	20.6	20.2	26.3	12.9	10.3	12.9	10.9	13.0	17.0	24.5	17.2	12.0	14.3	10.4	23.7	14.1	15.5	15.9	8.2	10.4	19.9	16.6	11.1	12.5	60.3	22.3	27.9	15.8	29.1	15.0	24.9	15.4	16.2	31.4	23.4	15.5	16.6	4.9	21.7	28.7	24.7	18.2	18.4	19.6	21.4	20.9	21.3	17.5	15.8	17.9	14.7	17.5	20.6
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955323	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 17.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	9.8	10.6	11.7	8.6	19.3	5.2	9.3	8.5	16.6	22.3	18.5	39.1	11.8	5.0	13.4	13.9	21.2	21.6	12.9	24.2	12.6	12.1	12.0	3.7	13.7	4.4	30.0	8.0	6.4	11.6	7.1	11.5	7.8	18.5	13.0	7.2	19.3	19.1	18.4	48.9	5.5	7.3	19.2	18.7	6.6	12.2	2.9	28.3	2.5	11.2	15.8	4.7	15.4	10.4	0.0	17.6	1.8	1.3	0.1	0.0	0.1	8.2	25.4	26.6	4.7	4.3	8.0	0.9	5.8	11.8	12.2	8.9	4.6	31.6	0.1	23.7	11.2	6.6	2.9	12.5	4.4	16.0	4.9	0.2	16.5	3.8	10.5	0.1	2.0	8.1	7.6	7.1	6.0	5.9	0.3	0.1	11.2	4.6	0.4	0.2	0.9	7.0	0.8	6.9	1.2	8.3	5.4	11.0	6.0	2.4	2.6	10.0	36.8	0.9	7.4	32.7	20.7	8.9	12.9	0.0	0.1	0.1	14.2	1.1	26.1	0.6	0.4	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	1.3	17.6	0.0	0.1	11.7	19.3	8.5	15.4	12.6	12.1	30.0	8.0	18.5	28.3
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565408	"Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: "	"prognostic unfavourable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	15.9	14.5	18.7	12.7	29.1	19.1	21.1	21.0	24.2	15.0	15.6	18.3	15.1	12.3	17.6	14.5	13.6	17.6	12.4	16.3	16.0	20.5	18.2	14.3	14.6	15.7	18.0	21.3	24.0	16.3	20.5	12.6	29.0	20.2	15.3	15.0	18.6	14.6	16.1	16.4	17.4	12.5	16.2	17.8	15.0	13.0	12.7	17.6	12.8	20.2	13.2	19.0	14.4	13.1	19.4	12.0	16.8	15.4	7.7	12.9	10.9	17.0	20.0	12.1	13.8	13.8	10.1	15.5	11.8	12.1	18.5	16.7	17.3	17.3	27.0	29.6	13.7	11.4	30.5	15.6	26.0	16.2	23.0	9.6	18.2	11.6	11.0	26.6	15.5	11.1	13.5	22.6	19.4	12.9	21.6	17.3	9.0	29.9	16.7	14.0	18.1	20.8	16.3	12.5	20.3	11.1	13.4	8.3	14.6	22.8	12.7	15.8	10.5	11.6	12.4	11.2	7.8	20.6	24.8	15.0	26.5	27.5	10.1	26.1	14.2	5.7	12.8	16.8	12.4	15.4	11.4	13.5	10.8	12.9	12.0	19.4	11.1	10.5	6.5	7.7	14.1	11.3	12.4	10.9	18.7	29.1	21.0	24.2	16.0	20.5	18.0	21.3	20.2	17.6
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042299	Approved		Approved	"Nuclear membrane,Nucleoli,Centrosome"	"Secreted - unknown location"			"Nuclear membrane"	"Nucleoli, Centrosome"	"HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favourable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favourable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.8	10.5	6.1	6.4	39.3	11.6	2.5	7.6	16.4	5.5	5.7	3.1	5.2	2.5	6.9	8.8	11.1	2.5	3.5	2.2	8.3	12.6	2.4	6.6	5.2	7.1	1.0	4.8	15.1	8.4	3.0	6.0	10.0	2.5	15.5	4.2	9.6	3.6	1.6	2.2	5.7	4.4	5.4	6.2	12.8	4.1	4.9	4.1	8.5	5.0	11.2	13.2	1.5	13.5	8.1	2.1	7.5	3.9	3.0	2.2	1.9	10.0	2.2	3.1	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 94.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 38.7;HUVEC TERT2: 21.9;RPTEC TERT1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	55	"dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome				Centrosome		"CAB037302: AB_1078622, HPA040472: , HPA048436: "	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11.0	8.1	4.8	16.4	15.0	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0.0	18.2	8.8	6.1	0.2	0.1	14.0	1.2	1.7	7.2	8.1	2.6	0.1	0.1	1.8	0.3	17.0	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.8	0.0	38.7	0.5	2.9	1.3	0.5	21.9	6.6	3.7	6.0	0.5	2.6	0.0	9.9	0.0	0.7	7.8	0.0	20.0	18.2	4.0	4.5	0.0	1.8	7.7	0.0	5.8	0.1	0.0	0.1	0.0	0.0	14.6	3.0	0.0	0.1	2.4	1.2	1.3	5.3	6.9	0.0	11.9	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	1.6	0.1	11.7	5.3	0.0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavourable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	27.5	24.8	23.2	23.6	16.9	19.6	17.4	20.6	15.8	19.6	20.1	24.4	27.0	38.4	35.3	21.5	20.8	31.4	26.3	38.0	36.6	22.3	53.1	14.9	27.7	19.3	21.7	22.9	15.9	18.2	28.8	48.0	27.2	35.6	16.9	29.8	22.5	41.1	22.8	35.5	38.8	26.8	28.2	39.6	28.5	23.1	29.6	28.1	12.9	20.2	23.3	31.1	14.9	17.8	20.0	32.1	25.7	27.5	18.7	32.5	54.3	26.9	47.5	25.5	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0
DCTN2	"DCTN-50, RBP50"	ENSG00000175203	"Dynactin subunit 2"	Q13561	12	57530102-57547331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039715, HPA040040"	Enhanced		Supported	Centrosome			3200000	Centrosome		"HPA039715: AB_10795154, HPA040040: AB_10794870"	"unprognostic (1.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (1.38e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.41e-3)"	24.3	32.6	40.9	18.5	44.3	19.6	25.8	93.4	72.9	28.7	31.5	26.8	23.1	21.4	29.7	34.0	38.5	28.7	21.9	37.4	38.3	48.6	24.8	19.6	21.1	20.7	49.7	44.8	31.0	34.7	31.4	24.6	23.1	41.8	24.7	33.9	15.2	32.7	31.5	40.0	29.7	22.9	42.2	40.2	17.3	28.7	28.7	25.9	18.1	24.8	28.7	29.4	22.5	27.1	24.3	34.7	31.0	36.2	24.9	32.9	38.2	24.3	29.2	32.5	23.9	51.8	54.4	18.8	27.7	48.1	52.4	39.9	21.1	21.4	25.5	32.6	43.7	18.7	26.8	33.2	41.4	29.3	30.2	22.8	18.4	23.7	36.1	15.5	16.9	48.3	55.8	32.6	56.3	52.7	34.7	36.8	49.3	28.4	26.1	19.7	15.8	32.6	19.1	26.9	22.5	40.5	28.6	49.7	33.6	26.7	22.1	24.1	37.1	14.2	42.5	31.8	24.8	19.3	17.9	24.3	23.9	25.5	29.6	18.9	31.1	25.1	31.7	31.0	28.2	36.2	29.9	24.3	28.9	30.5	34.7	22.1	21.6	26.5	18.9	24.9	35.8	26.2	32.9	38.2	40.9	44.3	93.4	72.9	38.3	48.6	49.7	44.8	41.8	25.9
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: "	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.1	27.9	27.9	13.3	27.3	41.0	25.7	30.3	36.5	19.8	15.9	32.4	17.7	15.9	20.6	27.6	20.0	18.4	16.5	20.6	27.3	29.0	20.0	22.0	17.8	13.3	30.8	24.0	26.3	32.5	23.9	27.7	25.9	33.2	24.1	18.6	21.3	15.7	22.4	42.0	19.0	15.4	21.3	34.7	13.9	18.0	22.9	25.4	18.8	24.8	15.3	14.5	23.3	16.2	5.0	10.9	16.4	10.7	3.0	6.9	5.2	9.4	11.3	20.5	34.2	25.1	24.3	16.9	16.7	16.8	20.2	20.4	21.1	11.9	9.2	23.4	19.8	11.5	25.2	19.6	24.8	18.5	19.8	11.9	13.1	13.2	22.9	14.3	17.0	24.5	17.5	18.1	31.8	14.3	18.1	11.9	26.1	9.9	8.8	7.7	10.3	17.8	7.8	12.4	10.2	15.0	16.2	46.6	19.6	17.7	24.2	24.8	23.4	19.2	15.9	22.6	12.7	14.7	17.6	10.6	13.5	5.5	26.0	19.3	18.4	3.2	10.7	10.5	5.5	7.8	5.6	5.0	6.2	5.4	10.9	4.4	5.9	6.9	16.4	3.0	6.4	5.1	4.3	5.2	27.9	27.3	30.3	33.3	27.3	29.0	30.8	24.0	33.2	25.4
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073845-31104791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				Nucleoplasm	"Nucleoli fibrillar center, Centrosome"	"HPA065197: "	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	6.3	5.3	6.4	8.0	8.7	21.0	5.9	18.1	10.5	7.6	6.1	6.0	8.8	7.1	11.0	3.7	7.6	7.5	5.1	4.0	7.0	2.7	6.5	7.0	4.9	14.9	8.4	4.6	9.6	19.0	7.7	9.3	5.6	7.1	8.0	8.6	5.0	11.3	7.1	8.8	14.2	12.1	8.0	6.7	10.9	8.0	8.2	9.4	33.2	7.2	6.4	11.1	5.8	7.8	5.8	4.9	1.3	7.3	4.3	5.5	1.9	12.4	12.2	14.1	12.6	2.2	4.7	20.8	7.7	3.9	9.1	9.7	14.4	21.2	16.3	10.8	4.1	12.3	11.1	10.6	7.3	14.9	22.8	19.4	20.2	8.9	0.8	13.6	12.6	4.5	4.7	11.5	9.0	4.4	9.5	36.5	6.5	10.3	23.3	20.4	29.7	6.5	18.8	22.1	22.7	4.8	14.2	10.2	7.5	7.9	12.2	3.9	10.3	8.7	3.6	7.9	15.6	15.3	14.0	14.8	11.4	39.0	9.4	10.9	7.2	0.0	2.3	1.3	4.2	2.5	3.3	5.2	4.0	3.1	3.1	5.8	4.1	5.5	1.1	4.3	7.3	4.9	3.4	1.9	6.4	8.7	18.1	10.5	7.0	2.7	8.4	4.6	7.1	9.4
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HEL: 8.6;HMC-1: 26.9;MOLT-4: 8.3;THP-1: 7.9;U-937: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (8.95e-4)"	"prognostic favourable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favourable (5.62e-4)"	2.1	1.3	1.5	22.0	2.5	14.1	2.0	0.5	1.6	1.0	2.8	2.5	0.0	3.4	1.0	1.5	1.7	1.7	3.4	1.0	1.3	1.3	2.2	2.0	5.2	30.1	3.1	0.6	0.8	1.0	0.0	1.1	1.3	2.2	1.7	0.8	1.4	5.4	0.8	0.6	1.0	12.1	0.8	2.7	31.3	3.5	0.5	2.7	32.9	1.8	1.2	25.2	3.0	1.5	16.3	12.2	19.0	20.6	14.1	26.7	20.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	12.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	8.6	0.0	0.8	0.0	4.2	26.9	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	8.3	6.5	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.0	0.0	17.9	0.0	10.4	11.6	19.0	26.7	20.6	23.4	16.3	19.1	22.9	12.2	13.7	24.8	21.6	17.6	14.1	20.0	7.1	21.9	20.2	1.5	2.5	0.5	1.6	1.3	1.3	3.1	0.6	2.2	2.7
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299833	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000599	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655"	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.18e-5)"	"prognostic favourable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	6.5	8.9	3.0	6.1	5.0	3.3	7.4	6.3	6.0	8.6	12.0	9.8	8.4	16.1	6.7	8.9	35.7	5.4	10.2	3.7	2.7	3.1	8.5	47.1	6.7	4.8	3.6	5.3	4.2	10.7	11.5	5.2	4.1	6.0	5.5	5.4	7.1	14.0	15.6	1.8	20.8	25.7	4.8	4.4	6.3	6.1	2.8	3.7	5.6	6.6	25.6	16.5	6.0	13.0	10.4	10.7	17.3	9.5	4.2	11.7	4.7	11.0	2.6	2.9	1.1	6.7	7.1	0.7	3.9	8.7	9.4	10.2	1.0	10.7	5.2	1.7	6.1	9.0	2.1	18.3	4.5	3.5	2.3	1.5	6.4	17.4	3.1	3.1	1.2	6.4	10.7	2.3	1.7	7.0	3.2	4.9	7.6	4.4	1.1	1.1	0.5	4.0	3.9	2.0	7.1	7.2	4.1	2.5	1.8	5.6	7.6	1.9	3.9	0.9	2.7	0.7	1.8	1.1	1.3	2.8	2.2	2.5	3.3	2.7	0.9	10.0	8.7	17.3	6.9	9.5	7.5	10.4	7.5	6.3	10.7	7.0	7.6	4.2	5.7	4.2	5.9	6.4	11.7	4.7	3.0	5.0	6.3	6.0	2.7	3.1	3.6	5.3	6.0	3.7
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"				"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: , HPA062700: "	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	10.4	7.3	9.7	6.9	14.6	13.9	9.8	9.7	14.3	12.2	23.2	14.8	10.7	9.9	19.7	13.9	13.9	12.5	9.2	16.9	9.0	5.8	10.4	7.5	8.7	12.6	8.2	6.7	13.9	6.5	12.1	13.5	8.4	10.9	13.3	14.3	12.4	10.4	12.6	12.5	11.1	12.4	14.7	9.9	8.4	13.4	12.5	9.4	12.1	8.5	7.6	11.2	15.9	11.8	4.6	6.7	2.0	4.9	5.8	8.2	4.4	7.3	4.4	11.9	4.9	4.6	6.0	8.4	4.4	7.8	10.1	7.8	21.0	7.2	8.4	7.8	8.4	11.7	8.2	12.9	10.1	2.1	4.0	11.2	10.0	11.9	5.5	13.0	5.9	7.0	8.3	8.9	8.4	4.5	11.3	4.8	5.4	6.0	21.3	10.0	6.8	9.9	10.4	17.4	6.8	3.7	8.4	10.5	8.2	12.1	7.3	11.1	9.9	10.8	4.4	14.6	8.0	5.7	9.1	4.8	6.4	8.8	8.6	5.9	7.6	0.0	4.9	2.0	5.3	4.5	5.2	4.6	4.5	5.6	6.7	4.3	8.2	4.3	1.0	5.8	3.8	2.4	2.8	4.4	9.7	14.6	9.7	14.3	9.0	5.8	8.2	6.7	10.9	9.4
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	13.7	15.4	18.7	14.7	16.6	11.8	14.5	15.7	16.4	13.7	11.8	20.7	19.1	9.0	14.7	15.5	10.6	15.5	10.0	20.1	17.3	17.0	14.2	15.2	10.8	14.0	19.4	10.8	16.2	24.4	24.9	18.9	9.0	17.7	14.7	10.3	15.4	14.4	16.3	29.4	9.4	9.0	15.2	19.6	11.1	10.5	15.4	14.0	19.3	18.0	9.4	12.8	12.5	9.7	9.1	10.5	7.8	13.1	14.1	13.2	8.0	8.4	19.2	5.8	7.7	7.3	9.9	8.2	6.3	6.9	9.3	7.8	9.4	5.7	30.0	6.9	7.5	14.4	14.3	5.0	6.9	7.9	13.2	17.6	12.5	10.7	5.5	17.1	6.2	4.0	5.7	2.5	8.3	7.2	10.2	7.3	8.3	6.2	7.6	10.0	9.2	10.6	11.5	25.0	17.5	3.1	9.6	9.9	9.7	12.8	4.2	7.0	6.3	11.4	9.3	10.8	10.2	4.5	10.8	6.4	19.9	14.5	3.7	22.6	4.3	7.8	5.9	5.1	9.9	7.1	12.8	8.5	9.5	13.2	10.5	9.1	11.6	9.6	0.7	14.1	13.1	7.5	8.8	8.0	18.7	16.6	15.7	16.4	17.3	17.0	19.4	10.8	17.7	14.0
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 32.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"K-562: 25.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.5"	"Low lineage specificity"	"Detected in single"											"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome				Centrosome		"HPA027718: AB_10601210, HPA028545: , HPA031379: "	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.6	5.2	6.3	2.7	2.5	2.5	5.2	0.9	3.4	3.1	2.9	0.2	3.8	1.7	3.3	6.5	2.0	2.6	5.3	3.7	7.0	5.5	4.2	6.8	5.4	0.6	2.9	4.6	5.5	11.2	3.4	32.4	2.6	7.2	4.3	3.7	3.6	3.4	7.8	0.6	1.0	1.1	4.6	8.5	1.0	3.8	29.9	0.8	3.2	7.1	0.9	0.4	2.5	1.9	0.6	0.2	0.4	0.2	3.5	0.9	0.0	10.2	5.3	4.9	5.3	1.9	4.0	11.7	2.1	2.0	4.0	3.5	8.3	11.4	0.0	5.4	2.1	0.1	7.5	2.0	6.7	0.0	12.5	4.9	3.6	1.8	2.4	10.2	1.7	3.9	4.6	5.4	3.8	1.3	25.2	0.0	6.7	2.7	1.8	10.6	13.7	6.5	0.0	18.5	9.4	3.6	4.8	8.2	9.3	8.3	6.3	16.7	11.5	8.9	0.2	0.0	7.9	0.2	0.0	11.5	7.1	0.1	0.0	0.0	7.4	0.0	0.1	0.3	0.1	0.2	0.0	0.6	0.3	0.7	0.2	0.3	0.4	0.5	0.4	3.5	0.1	0.0	0.9	0.0	6.3	2.5	0.9	3.4	7.0	5.5	2.9	4.6	7.2	0.8
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	8.2	11.4	24.1	9.6	21.9	3.9	13.7	8.6	19.8	17.8	10.1	8.5	19.7	7.3	9.8	15.0	12.3	33.5	12.7	9.9	17.7	15.2	16.0	7.1	12.8	7.5	9.5	15.7	15.8	14.9	19.2	19.3	11.9	7.9	13.2	9.2	13.1	16.4	16.3	4.4	11.4	8.0	7.7	6.4	7.5	11.1	36.5	9.7	13.2	26.1	6.6	8.6	8.4	9.1	12.6	14.8	17.5	11.2	15.7	16.6	8.1	8.8	4.5	9.1	8.1	11.6	11.7	0.0	3.7	7.3	5.8	6.4	2.8	10.5	2.2	8.2	5.5	4.3	5.7	10.1	4.1	5.5	7.4	1.2	1.3	3.1	18.5	7.1	1.9	9.4	33.0	7.8	14.1	8.4	2.6	4.5	7.2	11.0	6.6	7.0	3.5	3.6	6.4	3.9	2.9	12.3	5.3	12.8	6.9	7.8	6.0	15.3	10.9	6.8	5.1	5.3	5.4	8.1	3.8	2.8	0.8	1.0	16.0	2.4	5.1	15.6	9.6	12.8	13.5	9.5	16.6	8.7	11.2	12.1	9.8	12.6	13.3	11.0	17.5	15.7	11.2	14.8	10.2	8.1	24.1	21.9	8.6	19.8	17.7	15.2	9.5	15.7	7.9	9.7
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.0;HL-60: 16.8;MOLT-4: 15.7;NB-4: 26.6;REH: 19.8;RT4: 17.5;THP-1: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003218	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol				Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695"	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favourable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favourable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.4	17.0	1.2	0.0	0.7	0.2	0.1	0.0	5.8	0.6	0.0	0.0	0.0	0.0	16.8	2.3	0.0	3.1	0.0	0.0	0.0	3.7	8.6	0.0	1.0	15.7	26.6	0.0	0.2	19.8	0.0	6.5	0.0	17.5	0.0	0.0	0.0	0.2	1.1	0.4	50.6	3.3	0.0	0.1	0.2	0.0	3.4	0.0	0.0	0.0	10.6	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155388-184173610	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"				"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: "	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (4.77e-5)"	"prognostic unfavourable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	22.8	18.5	18.0	16.8	19.4	15.3	25.1	18.3	23.2	22.6	27.6	24.7	23.9	16.2	32.1	16.4	20.0	22.2	22.2	27.9	19.9	12.3	16.8	13.1	20.6	12.1	21.4	16.0	30.0	22.7	17.2	17.8	56.0	17.4	19.7	15.8	31.1	18.7	26.2	26.3	27.6	19.1	30.3	16.4	17.8	19.4	15.6	20.1	7.3	20.9	13.3	14.6	24.5	26.3	2.5	2.7	4.1	4.0	1.5	3.1	1.2	19.8	6.5	15.8	17.9	16.4	16.4	40.7	11.8	12.1	14.3	11.9	19.1	8.0	13.9	31.7	15.4	17.0	12.9	9.4	10.0	21.9	13.5	15.5	9.8	11.5	24.6	8.6	12.1	16.5	16.9	10.4	11.9	10.4	15.5	19.3	15.0	19.0	12.7	10.2	13.9	9.4	20.3	18.3	12.1	13.3	16.4	17.1	21.7	14.7	17.0	28.8	42.5	11.0	10.2	13.0	12.7	13.6	18.3	20.7	15.3	15.5	12.9	9.2	10.0	0.2	2.4	4.1	2.3	4.0	3.1	2.5	1.5	2.4	2.3	2.0	2.0	1.3	3.6	1.5	2.8	2.7	1.1	1.2	18.0	19.4	18.3	23.2	19.9	12.3	21.4	16.0	17.4	20.1
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964510-102056443	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol			120000	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavourable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	23.3	17.2	24.3	13.9	42.9	21.1	12.7	43.9	53.4	16.9	18.4	35.0	10.2	13.9	18.6	12.5	18.3	15.5	16.1	26.6	26.1	26.6	11.2	9.4	14.6	14.0	29.1	23.4	24.7	15.4	28.1	16.4	14.8	51.5	16.7	11.9	15.5	18.0	18.6	44.5	42.0	13.8	17.7	30.3	15.4	15.5	17.2	12.6	15.1	18.1	11.1	12.9	19.1	12.8	2.7	6.3	4.5	6.0	7.8	4.7	3.3	23.8	35.7	19.7	15.1	44.1	28.8	12.0	20.7	19.3	24.4	21.5	15.2	12.1	13.7	17.0	28.2	21.8	19.2	23.1	8.9	11.8	11.6	9.8	23.3	24.6	20.1	14.4	10.2	18.7	12.2	57.6	43.0	26.7	8.4	15.7	27.7	23.4	9.4	3.6	11.9	44.2	8.9	20.7	7.8	19.7	38.0	22.4	18.1	27.3	13.9	18.0	11.5	6.1	58.6	29.0	12.4	40.0	28.2	10.8	10.9	9.2	39.9	8.6	17.8	3.6	3.4	2.5	4.6	6.0	4.7	2.2	3.0	4.0	6.3	2.7	3.6	4.2	4.5	7.8	3.9	3.3	3.0	3.3	24.3	42.9	43.9	53.4	26.1	26.6	29.1	23.4	51.5	12.6
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525971-32570874	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	16.1	11.6	15.8	14.8	18.6	27.5	18.9	24.5	28.0	13.4	13.8	12.7	9.2	11.6	17.0	11.6	13.9	14.7	14.1	40.1	16.3	23.4	18.4	15.9	16.3	15.8	18.3	16.4	15.2	18.6	16.8	18.9	14.9	26.5	18.6	14.2	14.1	12.0	12.9	41.1	32.1	13.0	19.7	16.6	18.1	13.8	34.0	11.7	19.3	12.8	16.6	17.2	15.5	13.5	6.2	15.3	29.8	25.1	7.5	6.1	10.7	13.1	14.2	22.1	13.8	12.7	15.0	61.0	20.3	28.0	36.7	30.2	15.0	11.3	16.4	13.8	20.5	6.8	22.1	15.9	35.1	15.5	15.3	21.7	10.4	13.4	15.6	24.6	12.8	12.1	12.7	25.8	20.3	23.6	25.1	15.2	19.6	10.5	18.8	10.9	22.8	19.1	16.6	11.8	17.1	14.9	12.0	9.5	14.0	14.3	17.7	15.3	14.7	14.4	17.5	20.2	17.0	17.5	20.3	11.0	27.7	26.6	11.3	21.3	15.7	11.3	13.3	11.7	5.2	16.8	5.4	6.1	5.6	5.7	15.3	6.2	3.9	5.0	29.8	7.5	25.1	8.4	6.1	10.7	15.8	18.6	24.5	28.0	16.3	23.4	18.3	16.4	26.5	11.7
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751798	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057201			Approved	Centrosome,Cytosol				Centrosome	Cytosol	"HPA057201: "	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	26.5	21.4	63.8	16.8	63.5	16.7	19.0	28.8	43.3	23.0	24.4	61.2	17.6	19.5	23.9	19.5	23.7	17.9	22.5	26.6	68.3	48.3	20.3	13.0	20.8	11.0	75.0	28.9	22.1	20.2	44.7	19.3	21.1	51.1	25.3	28.7	13.6	20.8	24.5	17.2	23.1	19.8	30.1	89.5	15.5	22.6	14.9	55.0	6.7	28.8	7.9	12.6	20.4	20.0	9.0	12.1	16.3	17.1	8.2	14.9	7.9	15.0	15.8	23.5	21.0	30.4	30.2	21.4	24.6	19.7	20.2	26.3	21.4	14.8	6.3	19.6	24.1	21.8	18.0	17.6	29.6	4.2	13.0	7.7	18.3	20.2	16.9	8.1	11.5	19.7	24.2	23.2	16.1	28.3	12.5	8.3	26.1	10.7	5.1	10.7	14.1	27.5	11.2	49.7	7.5	20.1	21.2	23.6	16.5	44.4	9.6	28.5	11.7	8.2	35.9	26.2	13.1	12.8	16.7	10.6	7.7	12.5	22.5	7.9	16.4	10.1	17.1	16.1	13.4	9.8	14.9	5.2	11.3	10.7	12.1	9.0	9.6	9.1	16.3	8.2	13.1	7.6	10.9	7.9	63.8	63.5	28.8	43.3	68.3	48.3	75.0	28.9	51.1	55.0
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	9.2	6.7	6.3	16.6	9.7	27.9	9.0	20.3	10.0	10.5	8.1	7.7	6.8	7.1	12.2	8.3	7.5	9.8	6.4	7.5	7.4	5.4	5.9	5.0	7.2	12.5	8.8	7.3	13.4	14.0	6.3	18.1	8.2	8.0	10.0	7.3	5.2	19.7	12.7	12.7	8.3	9.0	9.5	7.8	9.3	8.4	21.2	9.0	20.2	7.7	4.5	10.7	10.1	8.7	9.6	9.9	9.1	7.0	6.9	9.7	3.5	8.9	8.7	10.9	11.9	5.1	8.5	5.7	11.2	11.0	13.0	14.8	11.0	7.6	12.0	5.6	7.1	11.3	17.2	2.7	14.8	7.9	13.7	8.4	7.4	6.4	8.6	12.6	8.7	5.2	4.3	12.4	5.6	6.1	7.9	9.2	7.3	3.6	12.5	8.7	16.1	7.9	10.0	10.5	7.8	4.5	4.1	5.9	11.6	8.3	4.2	7.6	7.7	4.8	3.9	6.9	7.1	9.0	12.7	12.0	8.0	18.9	7.4	6.2	3.8	9.1	7.0	6.5	7.8	5.8	9.7	9.6	6.9	7.1	6.8	8.1	7.3	7.5	8.4	6.9	4.2	9.9	7.4	3.5	6.3	9.7	20.3	10.0	7.4	5.4	8.8	7.3	8.0	9.0
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"salivary gland: 39.7"	"Cell line enriched"	"Detected in many"	7	"RH-30: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA043020: , HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	9.3	6.1	3.1	3.8	3.0	1.6	10.1	3.7	3.8	8.9	5.4	2.5	8.7	2.8	10.1	8.1	6.4	7.2	8.3	3.9	2.5	1.6	10.8	6.1	7.2	5.5	2.1	2.7	10.7	34.4	6.0	3.6	4.5	3.5	7.7	3.7	6.1	39.7	14.6	2.8	6.2	3.3	7.0	2.9	3.8	6.0	4.3	1.4	1.5	8.4	5.1	6.2	7.7	6.9	0.7	3.9	1.2	5.4	1.8	10.6	2.6	1.9	3.4	1.8	2.1	5.2	4.9	1.5	2.1	4.3	3.6	3.6	2.0	3.2	1.1	2.4	2.9	1.9	1.3	1.3	3.6	1.1	2.0	5.5	1.9	3.5	4.6	1.3	2.4	5.2	3.4	3.7	3.9	3.8	3.3	8.7	2.1	1.4	1.6	3.9	1.3	3.2	3.2	58.0	3.7	2.4	2.2	1.7	2.3	3.8	2.8	2.3	4.6	3.6	3.6	5.4	3.0	2.2	2.2	1.9	0.8	1.4	4.1	5.8	3.6	0.5	3.9	0.1	2.5	1.5	10.6	0.7	4.9	2.9	3.9	0.7	2.5	1.9	1.2	1.8	5.4	2.0	3.0	2.6	3.1	3.0	3.7	3.8	2.5	1.6	2.1	2.7	3.5	1.4
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513761	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: "	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favourable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	10.8	25.9	15.6	16.3	18.5	8.8	15.3	23.2	24.6	12.8	13.3	22.7	19.0	13.3	17.5	22.1	14.2	16.0	13.3	17.0	16.3	15.7	16.4	18.7	11.6	17.5	16.7	21.8	20.8	18.8	16.6	18.8	12.9	19.9	18.1	13.0	18.5	14.8	17.5	23.6	14.7	11.7	16.4	18.6	14.9	13.9	24.9	13.6	23.7	17.8	13.7	17.8	15.5	11.9	20.4	19.5	10.4	12.0	18.4	21.3	14.2	16.7	15.9	21.3	21.5	17.1	15.8	12.1	20.3	14.1	26.0	23.6	15.5	17.8	31.6	12.7	17.5	10.4	20.6	29.6	15.9	17.6	16.0	28.6	24.6	17.2	18.8	21.6	17.8	17.1	16.0	29.6	18.9	22.3	29.9	9.9	25.8	18.5	25.8	24.5	25.5	27.3	12.9	10.3	19.3	18.2	14.9	19.0	18.5	17.3	14.0	10.5	19.1	17.5	14.5	26.6	19.0	13.8	25.3	20.9	27.4	29.0	13.8	26.4	27.1	10.4	12.0	8.4	19.5	11.0	15.1	18.7	18.3	19.5	15.0	20.4	17.3	17.4	1.7	18.4	7.6	19.5	21.3	14.2	15.6	18.5	23.2	24.6	16.3	15.7	16.7	21.8	19.9	13.6
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA062681: "	"unprognostic (2.21e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavourable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	30.6	30.2	13.2	13.8	9.5	7.7	25.5	22.0	10.8	18.1	16.7	18.2	11.5	19.3	32.1	10.2	29.6	15.3	15.5	13.1	18.6	57.1	14.0	21.2	25.3	13.8	9.7	14.4	9.6	17.7	16.6	11.7	13.7	17.5	14.0	13.2	18.6	19.8	28.6	19.0	34.1	18.5	12.3	18.3	25.3	8.7	10.9	19.8	18.1	14.2	23.4	16.5	10.5	15.0	15.2	18.9	22.9	32.2	13.7	15.1	12.7	23.8	12.7	18.2	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favourable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.6	3.4	6.2	3.6	1.5	6.5	3.4	1.7	2.8	2.0	5.1	4.9	0.0	4.2	3.5	6.7	5.4	3.7	1.6	2.7	7.2	4.0	9.8	3.0	2.7	4.6	7.7	4.0	5.2	2.4	2.7	2.9	5.8	2.8	1.8	3.8	0.4	4.4	1.5	8.7	8.5	11.6	2.9	1.5	12.7	2.8	5.7	5.5	25.5	2.5	9.0	4.4	3.8	5.5	4.1	4.8	3.4	6.8	1.2	1.9	2.3	8.5	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0
ENKD1	"C16orf48, DKFZP434A1319"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favourable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	8.5	7.7	4.9	5.9	7.0	3.8	6.6	5.0	6.9	10.4	11.7	6.1	18.6	4.7	11.2	14.2	8.2	14.5	11.0	6.1	5.4	5.2	10.9	4.7	8.9	2.9	4.5	4.4	10.9	38.8	23.7	12.0	4.8	8.3	12.7	3.6	7.9	11.7	12.6	6.0	7.2	5.1	12.9	4.3	6.1	7.3	19.6	6.4	7.1	20.4	5.2	4.9	12.9	6.4	0.6	4.2	3.0	1.3	0.7	1.5	0.5	6.9	4.8	11.3	5.2	3.8	3.9	5.6	5.5	3.3	4.3	5.4	3.4	10.7	2.6	9.4	3.4	8.1	2.9	6.5	5.4	4.0	6.6	2.5	14.4	8.1	6.0	4.6	3.6	3.4	4.7	6.0	5.4	3.5	4.2	1.6	2.2	3.5	5.0	19.2	5.3	1.9	17.8	1.2	19.1	4.6	0.7	11.4	12.4	11.6	1.1	5.9	10.2	6.5	9.2	5.4	7.5	10.0	0.0	12.5	5.6	2.7	8.1	6.8	1.6	0.0	1.3	0.0	0.3	0.5	1.5	0.6	1.2	0.7	0.5	0.0	0.8	1.1	3.0	0.7	0.7	4.2	0.0	0.5	4.9	7.0	5.0	6.9	5.4	5.2	4.5	4.4	8.3	6.4
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: "	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	10.9	9.6	8.9	5.6	0.6	1.1	4.9	11.8	5.4	10.4	10.9	7.8	6.9	17.8	4.5	4.2	9.1	16.6	8.8	18.5	10.1	12.1	6.1	3.3	4.6	0.0	11.9	8.6	0.1	0.5	14.4	2.7	5.7	8.0	4.4	10.5	8.6	11.3	7.0	16.1	14.9	9.5	15.9	3.1	2.6	6.8	7.3	5.2	8.7	5.9	2.2	4.5	2.6	3.5	7.0	11.3	13.2	7.7	3.4	5.3	15.3	4.9	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202635188-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: "	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	5.8	12.5	10.1	11.1	10.3	4.3	10.0	20.8	18.1	5.5	7.9	3.2	7.1	7.0	5.0	7.5	9.6	6.6	6.2	4.3	8.6	10.8	8.3	3.6	6.2	13.0	5.9	9.1	8.8	11.6	24.7	7.5	11.0	4.7	8.6	7.9	3.7	8.6	9.3	5.8	9.0	6.0	7.3	5.7	8.2	6.6	12.6	5.8	22.4	5.5	4.8	11.7	7.2	12.7	9.0	4.8	2.3	8.9	4.5	9.9	3.3	1.5	2.0	8.8	6.0	3.0	1.7	8.5	0.5	0.8	0.5	1.0	2.5	3.4	6.6	5.4	0.9	1.5	7.5	3.8	1.4	0.1	6.0	5.5	3.8	9.3	2.4	4.7	2.5	2.3	5.3	1.1	1.6	2.3	7.9	1.3	0.5	3.2	12.6	9.8	8.9	3.8	10.0	1.8	7.8	4.7	4.2	14.9	12.9	6.6	4.4	3.1	1.8	6.5	1.4	1.1	2.0	1.5	0.9	4.9	2.8	8.8	2.0	3.6	1.1	0.3	4.5	1.6	1.6	8.9	4.0	9.0	3.6	3.1	4.8	8.5	9.9	6.8	2.3	4.5	8.8	1.7	1.3	3.3	10.1	10.3	20.8	18.1	8.6	10.8	5.9	9.1	4.7	5.8
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107866735	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;pituitary gland: 10.3"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA039453, HPA058768"	Enhanced		Approved	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles"	Centrosome	"HPA039453: AB_10795290, HPA058768: "	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.9	2.7	10.7	0.6	4.3	0.4	0.6	6.9	19.0	1.5	0.7	0.6	0.0	0.5	1.7	4.0	0.7	0.7	1.3	0.7	8.8	10.8	0.7	0.4	1.2	0.5	6.4	4.9	0.7	0.5	0.4	10.3	1.2	2.0	2.7	0.7	0.7	0.3	3.8	0.4	0.5	0.7	1.2	2.7	0.6	0.7	2.3	0.5	0.0	1.3	0.0	0.9	1.4	0.2	0.2	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	2.4	0.1	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.2	0.0	11.6	1.9	7.1	16.1	0.0	0.0	0.0	4.1	0.0	0.2	5.0	2.0	1.7	0.2	0.0	0.0	0.0	10.2	0.0	3.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.8	0.0	0.0	0.0	0.0	10.7	4.3	6.9	12.3	8.8	10.8	6.4	4.9	2.0	0.5
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630251-69633599	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 20.5;PC-3: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavourable (8.64e-4)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (9.72e-4)"	1.4	3.3	13.1	2.0	13.5	1.1	5.3	34.5	23.9	1.3	3.0	3.2	0.6	3.0	2.7	13.0	4.0	4.8	2.1	6.9	15.0	17.8	4.7	2.3	4.1	2.7	10.8	14.4	2.0	7.9	5.6	5.3	1.3	8.3	7.8	2.6	5.1	5.6	5.6	1.6	2.4	2.2	4.5	4.6	0.8	4.2	11.4	2.4	0.7	6.0	0.1	2.4	2.6	1.6	0.3	0.0	0.5	0.0	0.2	14.2	2.8	13.3	14.6	1.8	15.0	0.0	0.0	6.5	1.3	0.3	2.4	2.6	10.5	11.1	0.0	20.5	0.3	5.5	7.8	4.5	3.4	13.3	10.7	0.0	3.2	4.0	4.0	0.0	4.8	0.0	4.4	0.1	2.3	0.0	4.9	0.0	0.2	17.9	0.1	0.0	9.0	26.9	0.0	0.0	0.1	5.1	7.6	7.6	10.4	5.5	14.0	8.5	9.6	2.4	0.6	0.4	9.3	0.0	3.9	2.4	6.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	8.9	0.1	8.5	5.6	0.0	0.3	14.2	4.9	0.5	0.2	0.0	0.0	5.3	2.8	13.1	13.5	34.5	23.9	15.0	17.8	10.8	14.4	8.3	2.4
FAM45A		ENSG00000119979	"Family with sequence similarity 45 member A"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	12.2	13.2	16.2	8.5	20.0	17.0	9.5	10.2	17.6	11.6	12.5	10.2	6.5	7.6	9.4	10.7	16.0	9.0	8.5	10.8	13.5	10.4	16.6	18.9	8.6	6.8	10.6	17.6	17.3	8.8	11.6	5.4	10.8	18.4	8.9	11.0	7.7	10.7	8.3	14.0	12.0	9.7	9.8	13.5	8.4	9.7	7.1	11.5	10.1	14.8	10.8	9.9	13.1	14.7	2.3	9.9	30.2	19.2	3.8	10.0	6.0	8.3	9.8	12.5	14.4	21.4	21.4	5.5	11.9	29.8	10.7	10.3	9.5	11.2	5.9	4.5	14.6	12.6	10.6	10.4	9.3	10.0	6.0	1.3	3.4	8.3	24.4	3.5	2.8	22.2	8.9	7.8	11.0	14.4	2.8	6.7	13.4	6.7	4.4	6.0	7.5	4.0	4.8	15.7	4.3	10.3	8.9	2.1	8.3	8.5	8.9	17.4	8.6	12.3	14.6	7.6	3.9	7.8	6.0	7.3	2.7	6.5	12.3	15.3	3.4	23.0	15.1	30.2	4.2	18.3	3.4	2.3	6.3	5.5	9.9	1.9	3.1	4.1	20.1	3.8	19.2	2.5	10.0	6.0	16.2	20.0	10.2	17.6	13.5	10.4	10.6	17.6	18.4	11.5
FBF1	"ALB, FBF-1, FLJ00103, KIAA1863"	ENSG00000188878	"Fas binding factor 1"	Q8TES7	17	75909574-75941140	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023677			Supported	Centrosome				Centrosome		"HPA023677: AB_1848440"	"unprognostic (7.40e-3)"	"unprognostic (9.90e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.14e-3)"	"unprognostic (7.88e-4)"	"unprognostic (5.76e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.31e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.08e-9)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.77e-1)"	4.5	5.5	9.0	4.8	14.9	6.5	3.8	6.1	11.8	3.6	3.1	9.1	8.4	4.0	5.8	11.8	6.4	8.3	5.9	2.7	11.1	6.0	3.9	1.9	4.5	5.5	10.0	8.6	4.9	5.3	5.3	9.8	3.2	10.3	6.4	3.2	5.6	6.0	7.0	2.5	18.0	5.1	3.0	9.4	6.6	3.6	40.4	11.1	5.2	14.0	2.1	5.5	3.6	6.1	0.8	1.9	0.5	1.4	1.1	2.2	0.7	9.5	12.7	3.8	7.1	3.6	2.5	10.6	5.5	1.0	3.9	2.8	3.2	5.6	4.7	3.6	2.6	6.1	2.2	3.9	2.9	2.7	4.2	4.2	7.7	2.4	1.8	1.4	6.6	2.5	4.8	6.4	4.3	2.9	7.7	5.4	2.6	10.7	11.8	4.7	3.2	5.5	9.5	6.2	4.1	1.9	1.6	4.4	4.0	7.8	6.0	3.1	16.6	3.4	1.7	8.5	6.7	4.3	5.0	9.4	2.4	1.9	5.3	3.1	8.1	0.5	0.4	0.4	1.9	1.4	0.5	0.8	1.3	2.0	0.1	0.0	1.5	1.8	0.2	1.1	0.8	1.9	2.2	0.7	9.0	14.9	6.1	11.8	11.1	6.0	10.0	8.6	10.3	11.1
FBXO9	"FBX9, NY-REN-57"	ENSG00000112146	"F-box protein 9"	Q9UK97	6	53051991-53100873	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064246			Approved	Centrosome				Centrosome		"HPA064246: "	"unprognostic (6.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.89e-3)"	"prognostic favourable (1.51e-4)"	"prognostic favourable (1.82e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.64e-3)"	22.6	77.8	19.0	25.2	22.3	47.2	22.8	33.5	42.6	19.4	22.3	15.2	37.2	17.4	21.3	26.6	25.1	20.6	22.6	28.7	20.0	23.8	27.3	38.0	40.5	28.9	22.7	30.5	20.6	32.9	32.7	22.5	28.9	30.4	21.3	18.0	21.8	35.3	43.7	32.0	20.9	19.9	26.9	13.8	22.2	27.0	18.2	17.1	13.8	24.8	29.9	18.3	20.7	18.6	16.0	15.6	14.6	24.2	14.8	14.6	8.4	27.6	11.3	10.6	31.6	21.9	17.8	24.6	26.8	27.3	24.8	24.8	22.1	12.0	14.2	18.4	26.4	17.0	23.1	21.5	31.9	17.5	23.0	34.0	20.9	31.2	18.3	32.2	21.5	23.0	23.7	17.1	17.6	21.0	33.6	22.2	26.0	18.2	13.9	21.1	9.3	16.5	16.2	28.7	17.2	27.2	20.8	38.3	14.6	26.9	19.7	35.4	30.4	31.5	16.9	35.7	24.5	38.8	30.5	23.5	29.6	22.0	17.1	22.3	19.5	14.6	24.2	13.4	12.8	12.6	14.4	14.4	13.1	12.6	15.6	16.0	14.6	11.1	14.4	14.8	12.2	12.3	13.5	8.4	19.0	22.3	33.5	42.6	20.0	23.8	22.7	30.5	30.4	17.1
FCHO2		ENSG00000157107	"FCH domain only 2"	Q0JRZ9	5	72955981-73090522	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 15.9;monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037685, HPA037686, HPA077850"	Enhanced		Approved	Vesicles,Centrosome,Cytosol				Centrosome	"Vesicles, Cytosol"	"HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: "	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.21e-1)"	"prognostic favourable (7.00e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-1)"	32.2	9.6	10.7	10.0	12.2	8.3	18.0	23.1	18.3	16.2	18.3	8.9	15.3	15.5	23.7	13.0	30.2	14.6	15.7	12.5	11.2	7.0	18.6	16.0	22.8	18.5	10.8	9.5	16.1	11.1	17.5	11.4	19.2	10.9	12.6	16.1	9.9	17.1	12.6	17.7	15.2	20.8	16.6	11.9	18.9	12.2	10.5	12.4	3.2	22.4	11.7	11.8	14.6	22.5	0.7	1.1	15.9	4.5	0.7	1.3	0.5	9.0	7.4	7.1	6.2	10.0	13.3	20.9	8.0	11.9	6.1	9.6	3.7	15.9	2.2	11.3	11.1	6.9	6.0	14.1	8.3	2.3	7.0	4.4	6.1	4.6	5.0	0.9	4.6	8.9	7.3	8.2	13.1	13.8	5.0	3.9	12.5	4.2	0.0	4.4	2.2	3.7	2.0	6.9	2.6	14.8	12.9	2.8	4.5	11.0	7.8	5.0	9.5	6.3	14.3	8.0	3.8	8.8	5.6	1.4	2.5	0.4	5.2	0.6	9.8	11.5	2.6	6.4	1.3	3.5	0.8	0.3	0.4	0.5	1.1	0.7	0.2	0.4	15.9	0.7	4.5	0.4	0.3	0.5	10.7	12.2	23.1	18.3	11.2	7.0	10.8	9.5	10.9	12.4
FGF11	"FHF3, FLJ16061, MGC102953, MGC45269"	ENSG00000161958	"Fibroblast growth factor 11"	Q92914	17	7438273-7444937	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5"	"Cell line enhanced"	"Detected in many"		"A-431: 9.3;HaCaT: 16.9;LHCN-M2: 11.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066605, HPA075188"	Enhanced		Approved	Centrosome				Centrosome		"HPA066605: , HPA075188: "	"unprognostic (7.35e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-4)"	"unprognostic (9.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.00e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.90e-3)"	"unprognostic (4.97e-3)"	3.3	23.5	10.5	3.0	13.8	2.1	2.9	4.5	11.6	6.4	1.6	4.6	0.1	1.8	3.1	1.9	13.0	1.7	3.2	11.6	11.7	4.6	3.4	1.1	1.3	6.2	8.1	5.2	1.6	1.3	1.5	1.0	2.0	10.6	1.4	1.4	6.8	3.7	1.7	8.8	19.7	1.3	2.9	4.1	2.4	1.6	2.8	9.9	2.5	7.2	7.1	9.0	2.9	8.7	0.0	0.0	1.6	0.6	0.0	0.3	0.0	9.3	0.6	5.2	0.0	3.0	0.1	2.6	0.2	3.2	0.3	0.6	0.2	1.0	2.8	0.7	0.1	16.9	1.9	5.3	1.2	5.8	4.1	5.1	0.5	1.3	0.5	0.2	5.7	0.6	1.5	0.4	0.2	0.2	2.0	0.2	11.2	2.1	1.6	2.2	1.9	0.2	4.4	4.7	1.1	0.7	0.8	1.1	5.3	0.6	0.6	0.4	0.3	0.4	0.1	0.3	5.6	0.0	0.2	0.4	1.3	0.9	1.3	3.1	0.6	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0	10.5	13.8	4.5	11.6	11.7	4.6	8.1	5.2	10.6	9.9
FGFR1OP	FOP	ENSG00000213066	"FGFR1 oncogene partner"	O95684	6	166999182-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876			Supported	Centrosome				Centrosome		"HPA071876: "	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.2	12.2	11.2	12.9	12.5	9.8	10.2	11.9	13.0	10.1	9.5	6.9	11.8	10.8	13.6	14.1	8.8	19.1	7.9	6.4	10.8	9.1	12.2	24.9	6.7	9.4	6.4	11.5	11.8	10.2	8.2	17.2	6.6	9.4	7.4	12.1	8.9	8.1	11.6	5.8	7.9	13.0	7.4	7.4	9.4	7.8	50.3	8.0	14.5	12.5	6.2	11.8	7.0	8.2	6.8	10.0	24.1	4.1	3.5	6.8	3.0	12.0	6.7	17.0	11.6	10.0	7.5	20.7	15.6	10.5	12.8	12.4	24.9	10.3	14.4	8.9	9.5	11.4	14.9	11.0	24.1	9.0	12.9	9.9	12.1	27.0	5.4	17.6	10.5	4.1	8.2	26.2	12.3	8.8	32.3	12.4	16.3	11.1	14.1	25.8	14.5	5.2	16.3	11.6	11.9	13.3	6.5	12.7	12.8	12.7	13.7	5.4	11.2	21.8	5.7	12.8	21.3	15.2	19.5	10.6	14.5	14.6	14.4	16.5	15.6	0.2	4.1	13.5	3.3	3.6	4.9	6.8	3.9	3.1	6.5	5.0	2.3	3.7	24.1	3.5	3.6	10.0	6.8	3.0	11.2	12.5	11.9	13.0	10.8	9.1	6.4	11.5	9.4	8.0
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;Karpas-707: 42.0;RPMI-8226: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome				Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.1	2.8	0.5	0.7	12.6	19.1	1.0	16.6	23.9	18.4	21.8	10.7	12.0	32.4	0.5	27.2	8.9	5.8	7.3	9.6	6.8	1.2	1.2	3.0	0.1	46.2	0.6	0.9	21.3	14.2	14.1	26.3	10.4	0.4	42.0	6.7	6.0	4.8	1.1	1.4	5.3	13.3	0.8	42.0	2.3	0.4	6.9	2.0	5.5	8.3	3.7	0.5	1.0	8.3	3.6	0.7	0.3	0.3	24.6	20.3	16.4	2.2	0.7	5.9	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9
FNTB	FPTB	ENSG00000257365	"Farnesyltransferase, CAAX box, beta"	P49356	14	64986720-65062652	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 75.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062743	Uncertain		Approved	Centrosome				Centrosome		"HPA062743: "	"unprognostic (2.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (6.21e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-3)"	7.4	9.0	6.3	4.9	21.9	2.3	7.8	11.4	13.7	8.0	6.3	24.3	6.2	5.6	6.4	6.6	13.5	9.0	5.1	12.0	8.1	7.9	8.0	5.6	7.0	5.1	34.0	7.2	7.4	5.9	13.6	7.9	8.2	25.4	8.9	7.9	4.4	8.0	9.6	14.3	10.3	5.1	11.6	75.0	4.6	5.7	9.0	22.2	4.7	5.6	5.8	7.3	7.4	7.8	2.4	6.4	12.3	10.3	2.8	8.8	5.3	18.3	13.4	10.4	5.9	6.7	5.9	7.6	10.6	7.8	12.0	12.4	7.1	7.6	3.1	6.1	11.2	12.2	25.0	8.3	9.9	4.4	7.0	12.4	3.6	10.3	4.4	4.2	17.2	5.0	7.2	5.2	2.8	10.0	6.7	4.5	7.0	12.1	6.4	7.0	4.5	13.6	6.3	9.7	3.9	8.3	6.8	6.6	6.6	6.6	13.0	14.4	12.0	7.4	7.9	8.7	18.0	3.9	6.8	2.3	2.6	3.2	10.1	5.5	20.1	12.3	10.3	9.2	3.6	8.6	8.8	2.4	5.5	4.3	6.4	1.9	4.5	3.3	2.7	2.8	4.3	4.9	5.1	5.3	6.3	21.9	11.4	13.7	8.1	7.9	34.0	7.2	25.4	22.2
FOPNL	"C16orf63, DKFZp686N1651, FLJ31153, FOR20, PHSECRG2"	ENSG00000133393	"FGFR1OP N-terminal like"	Q96NB1	16	15865720-15888625	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040599	Supported		Supported	Centrosome				Centrosome		"HPA040599: AB_10794036"	"unprognostic (1.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.78e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.45e-3)"	12.0	21.6	15.6	13.4	17.3	13.2	21.4	13.1	19.5	14.2	16.0	14.5	9.5	13.7	11.7	9.3	21.3	12.8	15.4	15.4	14.0	14.7	19.4	18.3	11.3	23.8	16.5	11.3	16.8	14.3	15.5	16.4	14.7	17.9	14.3	15.3	14.5	11.4	13.2	32.7	18.3	12.5	13.1	12.9	13.9	11.4	21.7	13.0	25.7	36.0	22.1	16.4	20.5	13.0	13.9	14.9	23.7	12.9	16.0	15.3	13.6	15.2	16.4	5.9	0.9	13.5	16.8	0.7	8.5	9.9	8.8	10.4	8.8	1.5	11.1	11.1	2.1	12.4	14.6	1.1	18.6	11.7	10.8	1.6	3.9	3.3	11.4	3.1	12.3	1.5	20.0	1.9	13.6	14.8	29.8	1.4	2.3	11.6	9.6	11.8	14.6	0.9	2.1	13.9	1.1	1.1	4.7	5.3	0.4	0.8	11.1	18.3	1.3	1.3	5.0	1.2	1.1	17.3	29.9	4.0	12.8	18.4	16.0	25.9	12.9	23.7	12.9	6.0	11.7	12.7	15.2	13.9	14.4	13.8	13.4	13.7	15.3	14.1	3.7	16.0	10.5	14.9	13.6	13.6	15.6	17.3	13.1	19.5	14.0	14.7	16.5	11.3	17.9	13.0
FP565260.6		ENSG00000280071			21	5079294-5128425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"			Mitochondria	Centrosome	"HPA018517: "	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	3.9	6.7	2.8	2.0	6.6	1.3	3.4	8.2	7.0	3.0	5.7	5.2	2.5	5.7	2.2	5.0	3.9	3.3	2.8	15.5	3.2		12.9	14.4	4.8	10.5	6.7	4.7	5.6	2.7	4.0	0.9	6.4	4.2	3.0	4.7	4.4	4.9	2.3	17.1	1.3	3.6	2.4	3.0	2.6	2.2	1.4	3.9	1.1	4.2	11.1	2.4	3.9	2.0	47.1	43.8	19.9	46.4	37.1	41.4	46.1	13.1	12.4	13.8	24.2	13.2	12.6	6.7	0.0	2.6	0.8	1.2	2.0	13.5	1.2	15.3	16.2	9.5	19.9	10.4	1.2	9.0	8.9	51.0	13.2	12.6	12.0	21.9	9.7	20.1	17.4	8.0	14.6	16.0	20.0	15.2	9.5	27.5	21.9	24.0	26.9	20.3	44.9	10.4	47.8	18.1	12.2	13.9	23.5	18.3	34.4	12.8	35.3	30.8	5.7	7.9	9.8	0.8	8.0	20.5	20.9	8.6	16.3	45.4	6.6	19.9	33.6	16.9	31.6	36.0	31.6	43.9	41.4	32.9	43.8	47.1	39.7	30.2	6.8	37.1	46.4	28.9	40.0	46.1										
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.0;HEL: 7.7;U-2 OS: 8.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"HPA050483: , HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavourable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	14.0	7.4	33.6	7.0	47.2	8.2	4.2	29.1	53.8	6.9	5.6	17.3	3.0	2.3	18.1	1.9	2.9	7.9	4.1	4.6	24.8	21.4	2.9	2.0	6.9	6.6	15.6	33.7	7.8	5.1	1.8	5.8	5.0	22.3	12.8	3.2	4.4	13.0	13.3	8.5	18.3	6.1	5.5	14.9	24.2	6.1	4.3	15.4	0.0	3.9	0.1	5.2	4.0	5.9	1.8	1.7	0.0	0.5	0.0	0.4	0.3	2.9	0.0	1.9	8.0	0.9	2.1	2.1	2.0	0.8	1.8	0.5	2.3	0.1	1.4	2.0	0.0	2.4	0.9	0.0	0.0	7.2	3.4	7.7	3.4	0.0	1.2	0.3	4.0	0.0	0.0	1.6	0.0	1.0	6.6	0.0	0.3	1.9	0.7	0.1	0.6	1.1	3.5	0.7	0.1	0.3	0.0	0.5	1.3	0.5	0.0	3.3	1.5	1.1	4.5	3.2	8.3	0.3	3.7	7.0	0.7	0.0	1.8	3.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	33.6	47.2	29.1	53.8	24.8	21.4	15.6	33.7	22.3	15.4
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell line enhanced"	"Detected in many"		"A549: 16.2"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA042666: "	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.4	16.2	4.5	6.8	0.0	0.0	3.8	1.3	0.0	0.0	0.0	9.8	7.4	7.4	2.1	0.0	5.4	0.0	0.0	0.0	7.2	7.9	4.9	10.3	5.0	0.1	4.4	5.9	0.0	0.0	0.0	0.0	0.0	11.8	4.4	0.0	13.8	1.7	2.1	6.1	2.2	5.2	3.2	5.7	0.0	4.4	8.1	3.7	1.6	4.1	4.8	3.4	1.9	1.5	5.2	5.8	1.3	1.8	12.1	3.2	4.3	2.8	8.0	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529206-41545046	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	2.0	3.0	2.3	6.2	4.7	9.0	2.7	1.6	3.7	2.7	3.4	6.8	0.0	2.5	2.4	3.0	6.0	1.6	2.4	5.7	3.7	1.8	2.2	2.2	2.5	7.9	5.9	3.3	2.6	1.3	1.6	1.2	4.8	2.8	1.8	5.1	1.9	2.6	0.8	3.7	3.4	3.7	2.4	4.7	5.0	2.1	8.6	5.6	14.0	2.1	5.7	9.6	2.1	3.0	5.8	5.2	3.9	1.4	2.7	6.7	1.7	9.5	13.8	19.6	8.7	1.2	1.5	8.1	13.7	8.3	14.2	16.7	12.7	8.4	13.3	5.6	6.9	7.3	15.7	11.3	21.0	4.9	8.7	19.3	10.2	8.6	0.3	4.2	10.0	0.8	0.5	23.5	5.3	7.0	9.5	4.5	9.9	6.6	17.4	4.8	10.8	7.6	16.3	18.2	5.6	5.1	9.1	6.0	4.7	9.7	4.3	3.9	11.2	4.7	4.8	9.7	14.7	17.8	13.7	5.3	7.7	15.9	6.9	9.9	23.4	2.4	1.4	0.5	3.0	1.3	1.7	2.4	4.8	2.0	0.7	5.8	3.1	2.0	3.9	2.7	0.7	5.2	6.7	1.7	2.3	4.7	1.6	3.7	3.7	1.8	5.9	3.3	2.8	5.6
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome			9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: "	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.5	18.8	0.1	23.4	15.0	8.6	12.5	15.1	11.1	13.7	0.0	3.2	0.1	4.0	13.4	3.0	10.4	12.8	14.7	0.1	9.6	17.6	18.1	1.2	23.7	2.2	3.8	16.1	32.4	5.9	17.1	7.4	1.4	0.0	20.7	0.5	0.1	0.1	5.4	7.4	8.2	7.2	8.8	33.1	9.9	13.8	9.5	13.4	0.2	10.6	2.5	0.4	13.1	24.8	17.5	5.7	4.7	0.1	0.0	0.1	6.5	1.3	11.0	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome			8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: "	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavourable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	13.9	4.9	9.5	5.6	9.1	10.9	7.8	10.6	8.5	10.8	10.8	7.5	4.9	7.5	7.1	11.3	7.4	8.9	10.8	15.1	8.4	5.5	6.5	8.5	6.4	7.8	10.2	6.0	8.1	9.2	12.4	8.6	12.9	8.5	7.4	10.7	9.5	7.8	8.3	9.5	5.8	5.6	22.4	4.8	12.0	10.7	6.1	10.7	7.4	8.4	11.6	6.5	9.0	11.7	9.1	12.5	13.6	12.0	7.9	8.9	8.7	15.1	10.1	14.1	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115105-52191369	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"			11000	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: "	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favourable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favourable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	6.2	11.2	17.7	8.2	25.6	3.7	8.9	42.5	30.7	15.2	9.2	4.0	9.6	4.6	21.2	13.4	9.0	20.4	15.4	17.3	13.0	18.6	26.9	10.3	5.8	14.7	13.6	21.9	38.1	13.7	35.5	14.7	4.4	21.3	12.9	4.5	20.4	6.5	20.3	1.7	4.8	7.0	13.3	5.9	8.3	7.5	11.7	9.2	7.0	16.2	1.9	14.1	14.6	14.0	21.6	9.9	3.6	1.9	10.8	19.7	9.3	8.0	20.8	5.8	10.2	9.9	12.4	5.6	15.8	15.4	14.1	15.4	5.8	6.1	14.1	5.0	12.9	11.9	10.2	15.0	10.7	10.9	7.7	9.4	28.1	6.7	11.8	4.7	34.1	11.4	12.7	11.3	4.2	8.8	0.7	13.3	15.4	14.4	7.4	13.4	5.3	9.2	10.0	20.1	17.1	10.0	24.7	9.3	8.1	15.1	1.4	12.3	4.9	14.7	21.6	12.7	13.9	14.4	15.9	8.5	16.3	15.4	26.7	11.5	20.4	3.6	1.9	0.2	10.7	1.7	8.9	21.0	14.0	12.8	4.8	21.6	13.2	11.3	1.0	10.8	1.4	9.9	19.7	9.3	17.7	25.6	42.5	30.7	13.0	18.6	13.6	21.9	21.3	9.2
GRAP		ENSG00000154016	"GRB2-related adaptor protein"	Q13588	17	19020673-19047637	"Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.3;lymphoid tissue: 20.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.7;HUVEC TERT2: 13.1;REH: 16.6;TIME: 25.7;U-698: 22.3"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 28.2;T-cells: 37.3"									"HPA046595, HPA066654"	Uncertain		Approved	Centrosome				Centrosome		"HPA046595: AB_10966385, HPA066654: "	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	2.8	1.4	0.7	5.7	0.9	2.4	2.8	0.1	0.4	1.4	0.6			0.3	1.4	0.0	0.5	1.9	2.1	0.6	0.8	0.6	2.2	2.7	3.5	15.8	1.0		0.6	0.1	0.0	0.7	2.5		1.0	0.4		0.4	1.6	0.3	0.8	7.7	1.1	1.0	20.9	0.5	2.5			2.7		14.2	1.7	0.8	28.2	2.7	5.6	2.5	4.9	37.3	13.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	6.5	0.5	0.3	0.0	16.6	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	25.7	0.0	0.0	3.1	0.0	0.0	0.0	22.3	0.0	0.0	0.1	5.6	2.5	0.3	5.9	1.3	5.9	28.2	18.5	7.7	2.7	22.8	37.3	17.9	0.7	4.9	0.1	2.0	15.4	13.0										
GRAPL		ENSG00000189152	"GRB2 related adaptor protein like"	Q8TC17	17	19127469-19159176	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	7	"Daudi: 21.7;HUVEC TERT2: 9.0;TIME: 24.0;U-698: 20.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 10.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.8"									"HPA051796, HPA066654"	Uncertain		Approved	Centrosome				Centrosome		"HPA051796: , HPA066654: "	"unprognostic (2.85e-1)"		"unprognostic (3.37e-1)"		"unprognostic (5.09e-4)"	"unprognostic (4.49e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	4.6	1.6	0.7	9.5	1.7	1.0	1.7	0.4	2.0	1.5	1.3	0.1	2.9	0.7	3.6	1.9	2.5	1.6	2.2	3.4	1.7	0.8	2.8	1.8	4.6	15.6	1.1	1.2	1.1	0.4	0.0	1.0	1.7	1.0	1.4	1.3	1.0	1.4	1.3	2.3	0.7	9.7	1.9	0.9	20.6	0.8	1.1	0.5	7.7	2.7	1.7	17.0	1.7	2.3	10.8	0.1	0.0	0.0	0.0	2.2	0.7	0.0	1.2	1.5	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.3	21.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	2.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	24.0	0.0	0.2	1.1	0.0	0.0	0.0	20.1	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	10.8	1.4	0.3	0.1	4.1	2.2	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.7	0.4	2.0	1.7	0.8	1.1	1.2	1.0	0.5
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"				Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.90e-10)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.5	10.2	20.2	15.9	0.4	1.2	9.7	18.7	8.8	27.4	22.6	10.7	8.2	20.4	5.0	7.2	11.3	18.1	4.7	17.6	12.2	19.5	13.6	14.4	8.2	0.0	24.4	16.7	0.2	0.3	11.7	6.0	11.8	10.4	25.7	16.3	12.0	21.8	12.0	14.1	11.6	21.7	22.7	13.4	4.5	3.9	10.5	14.3	17.9	11.7	8.2	9.9	9.4	9.3	15.6	29.6	12.7	19.6	14.7	7.0	20.7	9.9	11.8	22.7	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3
GVQW3		ENSG00000179240	"GVQW motif containing 3"	Q3ZCU0	11	76381313-76414619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"		"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA057405	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Centrosome"				"Nucleoplasm, Centrosome"	"Endoplasmic reticulum"	"HPA057405: "	"unprognostic (8.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.56e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.05e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.13e-1)"	3.3	5.8	7.0	4.7	11.8	3.5	5.8	13.9	14.3	5.0	3.2	5.0	2.2	4.5	6.7	4.0	1.8	7.1	2.5	3.2	6.2	5.2	5.1	2.5	2.9	6.0	4.0	7.2	8.4	16.0	3.2	15.9	3.0	8.7	3.5	4.9	7.6	9.1	3.3	2.9	4.5	3.6	3.5	4.2	5.0	4.2	9.6	4.6	5.5	5.5	0.4	5.7	2.8	4.0	3.1	1.7	5.1	1.2	3.8	4.1	1.2	1.7	2.2	9.4	5.0	2.3	4.7	2.5	1.2	1.0	2.2	2.1	6.5	4.0	7.4	3.3	1.2	5.3	5.1	1.3	3.0	5.2	3.0	3.8	8.4	2.1	1.2	3.4	2.0	1.1	1.5	3.4	1.3	1.4	2.4	4.5	0.7	2.1	4.7	5.6	1.5	3.4	7.0	5.5	4.7	0.7	1.8	12.3	4.3	2.9	1.3	0.8	3.8	1.0	0.8	3.9	3.9	6.1	1.4	4.8	2.3	6.9	1.2	3.0	2.2	3.5	1.2	1.2	3.7	0.7	2.5	3.1	3.8	1.7	1.7	3.1	4.1	4.1	5.1	3.8	0.8	1.2	3.3	1.2	7.0	11.8	13.9	14.3	6.2	5.2	4.0	7.2	8.7	4.6
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104332-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favourable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	15.2	11.8	10.3	14.6	13.1	23.1	14.5	15.8	12.2	14.3	13.4	6.2	13.1	9.9	15.5	28.4	15.9	13.8	11.6	9.3	10.3	8.0	14.4	12.1	10.9	22.9	13.6	6.8	20.4	12.0	6.5	18.1	13.0	12.0	14.8	16.3	7.3	11.4	14.4	7.1	8.6	13.4	12.2	14.4	17.9	12.2	11.8	15.4	38.4	14.3	14.4	26.1	13.9	12.3	28.1	23.4	13.0	18.2	19.3	34.9	19.3	18.4	11.2	42.5	22.9	10.9	16.9	11.4	18.1	18.1	28.9	28.8	10.9	10.5	35.3	10.9	12.9	19.7	25.4	15.3	31.9	19.8	17.0	25.9	12.0	20.6	9.2	47.2	15.9	8.2	6.1	17.8	9.2	31.5	18.4	10.1	25.8	10.8	37.4	22.6	27.1	6.6	37.5	30.5	25.2	22.8	13.0	20.0	20.8	16.8	5.8	13.6	8.5	23.0	17.8	17.0	11.5	7.3	18.8	11.8	17.9	32.7	10.8	40.1	19.4	4.4	18.2	13.0	16.0	16.4	17.7	28.1	21.6	18.9	21.6	23.7	15.4	18.1	2.0	19.3	12.7	23.4	34.9	19.3	10.3	13.1	15.8	12.2	10.3	8.0	13.6	6.8	12.0	15.4
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548810-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	18.7	11.3	13.1	12.1	11.5	49.9	18.6	13.3	15.4	9.9	11.9	11.1	5.6	8.9	14.0	10.4	12.8	9.7	9.3	10.8	14.1	13.6	10.3	11.0	16.8	16.6	14.6	13.9	12.1	12.1	8.4	9.9	11.6	13.1	8.8	10.8	8.5	10.5	8.5	13.5	11.8	9.5	12.3	18.7	11.2	9.7	13.7	11.7	18.4	10.1	11.8	13.0	10.8	14.0	10.3	7.2	7.5	13.5	4.4	8.7	4.3	11.3	6.0	11.0	7.0	5.6	6.3	10.7	11.5	6.9	10.9	9.1	12.2	7.2	7.3	5.7	6.3	19.0	11.7	7.4	10.9	9.4	6.8	10.0	10.6	9.5	8.0	17.5	9.1	5.5	5.6	8.6	8.9	10.9	17.3	9.0	10.5	7.1	12.8	14.1	9.6	7.9	14.4	13.4	9.4	6.9	8.1	9.0	7.4	11.5	11.1	6.8	11.1	13.0	8.6	16.7	12.2	25.8	21.3	13.7	38.3	21.9	10.4	19.2	12.7	7.3	7.7	7.5	8.4	9.0	8.3	10.3	8.3	6.0	6.5	8.9	6.1	8.3	3.8	4.4	13.5	7.2	8.7	4.3	13.1	11.5	13.3	15.4	14.1	13.6	14.6	13.9	13.1	11.7
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favourable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.7	22.2	9.8	19.1	3.5	4.8	13.7	9.5	5.4	11.0	19.7	16.1	7.7	13.2	30.7	6.5	11.7	14.1	9.6	8.6	15.8	23.2	9.6	20.6	12.0	3.1	15.8	13.9	7.3	2.5	9.8	6.2	7.8	12.0	6.8	6.5	26.5	14.8	19.1	6.1	22.2	13.9	16.2	19.9	3.5	8.7	10.9	8.3	5.2	11.3	3.9	4.5	7.6	5.0	9.5	19.0	22.2	17.4	9.9	26.2	51.5	5.1	28.4	13.1	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.1	6.6	9.2	7.0	10.8	5.7	6.2	5.6	6.8	8.0	7.7	7.6	3.1	10.9	7.7	8.9	5.5	11.8	6.6	11.6	7.9	6.0	15.9	8.3	8.0	9.0	12.7	19.7	6.1	9.6	10.2	10.5	11.8	10.8	11.8	11.5	61.5	16.6	7.2	9.4	5.9	10.1	27.0	3.8	7.2	7.0	4.1	5.4	10.2	11.0	7.2	6.4	18.3	11.5	7.9	10.7	12.8	8.5	7.4	5.8	9.5	8.8	10.3	17.9	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol				Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: "	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (5.52e-4)"	"prognostic unfavourable (1.93e-7)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.1	14.5	1.4	2.6	20.2	20.1	9.8	25.2	22.9	27.0	40.8	35.1	19.2	6.2	24.4	31.3	19.0	43.0	31.8	9.7	21.0	9.5	13.1	0.4	18.6	19.4	0.7	1.1	23.6	18.5	14.3	19.8	28.8	26.2	7.7	19.6	10.6	23.4	14.5	21.4	36.3	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	27.6	14.9	9.3	18.1	15.3	14.4	26.9	15.5	25.9	28.3	11.9	28.8	17.3	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 61.3;HSkMC: 25.1;RT4: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol			64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: , HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.6	18.9	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.9	4.6	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.1	61.3	7.9	0.0	0.2	25.1	0.0	6.2	0.0	4.4	0.2	0.3	13.2	1.0	0.0	0.2	7.8	1.6	0.1	0.5	0.0	18.9	31.8	0.1	0.4	6.0	7.7	0.0	0.2	14.4	1.3	1.3	3.4	1.8	4.4	0.1	0.0	0.2	6.0	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 23.0;HEK 293: 11.1;HMC-1: 14.1;K-562: 11.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	61	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA057432: "	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.8	3.8	1.8	0.0	0.0	0.2	0.1	2.1	1.9	3.1	23.0	1.4	0.1	4.0	0.0	0.0	7.9	11.1	7.5	0.6	0.0	4.9	0.0	14.1	3.7	0.0	5.6	0.0	6.4	11.2	0.2	5.5	0.0	1.8	0.0	0.0	0.0	0.0	4.3	1.5	4.5	1.9	0.0	0.0	0.6	0.0	2.8	0.4	1.4	2.5	0.3	0.2	0.8	0.2	1.9	3.9	0.7	1.5	0.0	2.1	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1										
HPS4	"BLOC3S2, KIAA1667, LE"	ENSG00000100099	"HPS4, biogenesis of lysosomal organelles complex 3 subunit 2"	Q9NQG7	22	26443423-26483837	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033106, HPA050189"	Approved		Approved	Centrosome				Centrosome		"CAB033106: AB_2264349, HPA050189: "	"unprognostic (1.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.46e-2)"	7.9	9.6	10.7	7.4	16.3	11.3	8.4	43.1	16.4	11.9	8.0	14.1	9.5	6.6	11.2	10.1	10.5	11.8	7.4	5.0	9.4	11.8	10.7	7.9	8.0	10.8	10.7	11.9	15.8	15.5	14.5	18.7	6.7	12.0	8.9	6.9	15.7	10.8	10.2	5.0	17.1	7.4	8.9	10.5	9.0	8.8	18.2	8.3	18.0	12.3	4.0	12.7	8.0	8.8	7.8	7.3	12.6	4.0	9.2	6.9	5.7	7.4	3.5	7.4	7.5	5.6	6.6	3.9	4.5	8.8	10.2	9.2	3.7	3.7	7.1	3.6	5.5	6.2	7.0	9.8	9.3	5.2	7.3	7.2	3.1	6.0	10.0	8.4	8.1	6.5	8.1	9.3	16.6	6.6	7.8	9.0	7.4	3.1	14.0	2.9	4.4	3.8	39.4	8.7	9.2	4.7	4.7	8.4	6.2	4.3	5.1	22.0	5.4	6.4	4.1	12.0	22.5	5.9	5.6	13.5	10.4	23.3	7.8	5.4	7.7	12.6	4.0	4.0	6.6	3.0	6.2	7.8	5.4	5.6	5.6	6.7	6.4	6.9	1.4	9.2	2.6	7.3	3.6	5.7	10.7	16.3	43.1	16.4	9.4	11.8	10.7	11.9	12.0	8.3
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: , HPA061446: "	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favourable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	8.9	11.8	6.4	10.1	4.4	4.5	7.4	4.1	1.7	4.0	4.4	8.6	4.1	0.0	7.5	1.1	2.1	37.3	14.7	5.5	16.7	11.1	4.8	16.2	10.4	1.6	18.5	8.2	4.1	13.7	2.6	9.4	5.1	8.5	5.5	4.9	6.5	5.8	1.6	1.5	9.8	0.0	0.7	0.9	13.5	4.1	11.8	4.3	7.4	12.9	0.6	9.8	3.1	1.4	1.4	0.0	1.7	9.8	10.8	12.4	2.8	5.4	12.6	4.2	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2
HSPBP1	"FES1, HspBP1"	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262231-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol				Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: "	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	14.1	13.9	24.5	15.8	42.9	16.4	13.8	13.3	32.5	11.3	17.3	9.1	13.0	18.8	14.8	12.4	14.5	30.3	13.3	19.1	25.3	20.1	15.4	18.0	18.2	17.6	16.2	20.0	17.4	21.1	13.0	10.2	9.8	15.2	12.0	8.3	7.6	19.3	13.6	35.4	15.4	17.2	16.8	15.0	11.6	15.3	21.1	9.3	11.7	12.0	24.4	8.9	10.5	10.5	24.0	23.0	3.0	19.0	18.4	20.5	11.5	22.0	39.7	7.0	10.3	4.2	3.5	21.6	11.6	4.7	11.6	9.9	22.4	15.4	14.6	11.3	6.2	15.4	8.3	11.2	3.1	12.4	68.3	19.5	12.6	20.6	9.1	18.2	10.3	4.9	10.1	11.6	5.5	5.8	15.5	8.3	4.0	20.9	16.4	16.9	25.2	33.4	16.0	11.1	31.5	7.8	14.5	19.4	29.0	14.3	14.8	11.1	11.3	14.2	8.0	14.0	15.2	7.9	21.1	13.3	30.6	15.2	15.6	15.8	14.8	0.8	11.5	3.0	18.0	19.0	18.7	21.0	19.8	20.5	23.0	24.0	19.9	19.3	0.8	18.4	16.0	13.1	17.8	11.5	24.5	42.9	13.3	32.5	25.3	20.1	16.2	20.0	15.2	9.3
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684453	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 274.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 107.5;HEK 293: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 110.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"				"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favourable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	34.2	37.4	24.9	19.1	20.6	69.8	31.5	11.3	57.3	21.9	34.0	22.9	13.2	20.7	18.6	11.6	12.1	28.1	33.5	46.1	20.0	14.6	31.2	117.5	25.4	22.4	19.0	35.3	59.7	15.0	274.1	17.2	14.8	20.0	27.2	26.4	13.3	24.5	72.7	8.8	16.6	20.4	19.2	15.8	21.3	16.2	7.1	14.2	19.0	46.8	15.1	10.2	31.8	38.0	0.3	25.0	110.4	26.0	90.9	42.4	18.0	0.2	19.9	8.2	10.1	13.2	2.1	31.4	22.7	2.7	10.2	4.3	39.8	1.0	0.5	27.0	38.8	17.1	5.3	0.1	3.0	107.5	69.6	14.3	12.2	48.6	3.9	10.6	40.3	3.6	0.4	4.6	0.2	0.2	0.8	17.0	15.7	6.7	1.1	1.2	14.9	15.7	1.4	5.7	10.7	10.2	8.9	15.5	22.0	1.2	17.3	1.7	2.8	6.3	4.1	12.6	2.2	18.6	1.3	1.3	1.0	12.4	15.9	32.8	6.8	9.0	8.2	110.4	42.4	24.2	25.3	0.3	13.1	29.5	25.0	0.2	16.4	31.4	11.2	90.9	26.0	1.1	1.0	18.0	24.9	20.6	11.3	57.3	20.0	14.6	19.0	35.3	20.0	14.2
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218797	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.3	9.6	8.9	4.6	13.2	1.7	9.2	14.4	11.9	12.6	11.5	6.6	18.8	3.0	14.9	19.6	6.4	18.8	8.9	7.3	8.9	8.5	10.0	4.4	8.5	3.0	5.9	8.4	14.7	5.1	21.8	30.4	5.2	10.7	13.7	6.2	11.8	8.9	15.5	6.4	5.9	4.6	17.7	8.5	4.0	7.4	29.8	8.4	6.2	14.3	5.4	3.1	13.5	10.4	1.8	3.5	3.0	1.3	2.1	1.9	1.3	7.3	13.9	28.7	12.1	5.3	10.9	2.1	4.7	7.2	10.1	8.7	2.6	4.1	2.4	2.6	8.9	6.5	10.5	5.5	13.2	3.0	5.7	5.0	8.2	4.3	4.5	3.1	2.4	7.8	6.2	9.5	2.4	6.3	6.1	1.3	9.3	1.5	6.3	5.2	14.1	4.6	7.4	7.5	3.2	12.6	4.9	17.8	19.8	12.7	2.7	19.0	14.4	4.7	4.2	5.7	3.0	4.7	4.3	4.2	4.1	3.3	13.8	3.9	6.4	0.3	1.3	0.6	0.7	0.8	1.9	1.6	1.7	0.8	3.5	1.8	1.5	0.7	3.0	2.1	1.0	3.5	0.7	1.3	8.9	13.2	14.4	11.9	8.9	8.5	5.9	8.4	10.7	8.4
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	421933		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.5;SK-MEL-30: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome				Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.1	3.8	2.5	1.2	1.9	1.2	0.5	11.1	13.0	2.8	5.4	1.0	51.5	0.2	3.1	9.9	14.0	0.0	12.9	6.7	0.0	0.3	2.2	1.4	0.0	0.6	0.4	1.7	2.1	1.8	2.0	6.8	1.6	0.0	0.5	6.1	16.3	0.3	0.0	0.1	2.8	0.1	8.6	0.4	3.9	17.0	0.2	0.2	1.2	3.9	22.9	11.8	1.6	1.0	6.6	8.1	9.7	0.1	0.1	0.0	0.0	1.5	10.0	17.0	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.1;U-937: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"				Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: , HPA013335: AB_1847553, HPA030747: "	"unprognostic (2.03e-1)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favourable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.1	7.1	1.8	2.1	0.0	1.5	3.2	1.8	5.5	0.5	2.6	6.1	5.2	1.3	4.5	6.8	2.0	1.3	4.5	2.5	5.0	0.5	0.0	1.6	5.2	0.4	2.7	2.0	2.1	2.0	2.3	3.2	9.6	1.3	4.4	5.1	16.1	2.8	2.5	4.2	2.1	4.9	1.4	2.5	1.0	2.2	2.0	2.1	0.2	2.2	9.8	1.2	4.7	2.7	0.0	1.7	11.1	8.7	9.0	1.5	15.0	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099666-160200313	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 62.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 36.6;RPTEC TERT1: 73.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"				"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.3	0.3	0.3	3.1	0.3	0.0	8.7	0.3	0.3	4.1	8.3	0.1	4.5	3.5	2.1	2.5	18.7	1.2	12.0	0.7	0.3	0.3	62.1	0.3	28.8	0.1	0.3	0.1	1.5	3.8	7.0	2.2	18.7	0.2	7.5	3.0	0.1	3.8	4.8	31.5	1.9	11.7	2.0	0.3	0.3	7.9	0.6	0.1	0.1	4.9	6.8	5.9	12.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.2	0.0	7.5	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	73.2	12.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1
ITPRIPL2	"FLJ22994, LOC162073, MGC126798, MGC126800"	ENSG00000205730	"ITPRIP like 2"	Q3MIP1	16	19113932-19121629	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042011			Approved	Centrosome				Centrosome		"HPA042011: "	"unprognostic (1.07e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	32.6	10.7	6.2	8.3	6.0	0.9	25.8	1.2	4.1	16.0	11.4	4.3	8.2	6.1	12.7	10.6	16.4	10.2	12.7	9.9	3.8	2.8	6.4	9.5	16.7	5.1	5.6	2.1	11.6	15.0	8.5	4.7	26.5	5.7	19.1	5.9	9.5	8.5	8.9	7.3	19.7	9.1	11.3	4.0	7.8	9.9	4.9	5.7	2.0	12.0	12.8	8.0	14.2	25.7	0.5	1.9	1.3	6.6	0.2	0.6	0.6	9.0	5.3	2.1	7.0	18.2	27.8	14.0	14.4	10.2	4.2	3.9	2.2	16.3	0.0	14.9	11.4	10.3	2.9	4.4	5.6	0.0	3.0	0.7	10.7	3.8	11.8	0.0	0.0	18.4	12.3	8.2	9.4	5.5	1.3	0.0	10.0	6.1	0.0	0.2	2.1	7.1	0.0	0.3	0.0	6.4	15.2	0.2	2.7	11.8	1.2	7.0	7.0	1.4	10.9	14.8	6.4	7.5	5.4	0.1	0.0	0.0	8.6	0.3	7.4	1.3	2.8	0.3	0.6	3.4	0.3	0.5	0.3	0.5	1.9	0.3	0.2	0.5	1.0	0.2	6.6	1.2	0.1	0.6	6.2	6.0	1.2	4.1	3.8	2.8	5.6	2.1	5.7	5.7
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"			8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: "	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526"	Supported		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB004526: AB_2128417, HPA002470: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	3.9	2.2	3.6	9.0	8.4	5.1	5.0	7.4	5.3	7.8	1.1	2.6	13.4	2.1	9.4	1.1	5.4	1.6	4.5	12.2	5.1	11.8	6.2	0.4	4.2	1.8	15.3	3.6	2.9	4.6	3.0	5.0	7.5	19.0	7.5	1.8	3.8	3.5	0.9	3.9	5.1	4.1	2.8	7.2	8.0	1.1	2.4	2.8	4.5	17.0	4.7	8.0	4.8	9.0	3.6	3.3	5.7	7.3	15.1	3.2	8.2	7.8	18.9	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1
KCNH5	"eag2, H-EAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699454-63102037	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 9.2;retina: 5.7"	"Group enriched"	"Detected in some"	5	"HeLa: 9.9;RT4: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0.0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3.0	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0.0	0.0	0.3	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.2	9.2	1.3	3.0	1.2	4.2	6.5	0.0
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.6	12.1	15.8	11.0	6.0	10.4	6.0	8.5	8.0	12.1	10.6	8.9	3.6	5.6	5.7	7.8	14.6	14.9	7.7	19.4	5.6	11.9	3.2	10.5	6.3	8.9	5.5	7.2	6.8	10.9	12.1	10.0	8.8	7.9	0.8	9.4	5.5	6.0	4.8	9.6	6.4	8.8	5.3	1.8	10.8	10.2	5.9	10.6	11.2	2.9	6.5	5.0	3.6	8.1	11.4	5.2	5.9	12.5	1.3	1.9	2.4	8.0	3.2	7.6	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favourable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.7	5.5	12.8	8.4	21.4	27.9	6.7	7.6	14.3	7.9	8.7	4.0	8.9	8.8	4.4	18.0	6.3	7.9	9.4	12.8	6.6	5.0	9.7	10.0	7.6	11.1	9.1	5.4	16.0	11.3	9.4	13.0	16.7	6.3	10.7	16.1	5.6	7.8	7.1	4.2	6.1	4.5	17.8	2.2	13.8	12.7	7.5	6.7	4.8	5.5	10.7	6.0	7.5	22.3	9.8	9.7	8.0	7.7	10.4	6.7	6.4	10.4	8.0	7.1	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2
KIAA1211L	"C2orf55, MGC42367"	ENSG00000196872	"KIAA1211 like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;epididymis: 27.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.9;HDLM-2: 31.3;Karpas-707: 9.2;SiHa: 8.9;SK-BR-3: 11.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"							"Group enriched"	"Detected in many"	15	"amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"				"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: , HPA061678: "	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favourable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (2.22e-2)"	2.7	0.8	19.0	1.3	23.7	0.5	3.5	2.4	27.4	4.6	5.0	0.8	3.5	6.7	1.5	27.7	9.1	19.3	2.5	1.4	12.9	1.9	2.5	0.4	3.9	0.6	2.7	18.3	1.4	3.7	9.6	4.3	4.0	0.1	1.6	4.0	0.0	9.0	4.3	1.3	4.3	6.1	2.1	1.2	1.0	6.8	3.6	3.6	0.0	4.3	3.3	2.5	2.4	3.2	0.0	0.7	1.4	0.3	0.2	0.9	0.0	4.2	0.2	0.1	1.7	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.2	2.5	0.0	5.5	0.0	3.8	0.1	0.2	0.0	31.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.6	1.3	0.0	9.2	0.0	8.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	1.7	3.4	3.1	0.5	8.9	11.9	0.0	4.6	0.7	5.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.7	0.0	0.0	19.0	23.7	2.4	27.4	12.9	1.9	2.7	18.3	0.1	3.6
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;fallopian tube: 25.2"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.5"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: "	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.6	0.9	9.3	1.6	29.5	1.1	1.1	25.8	14.1	2.1	3.1	17.4	0.0	6.6	1.1	1.1	1.1	25.2	1.6	1.1	11.9	6.6	0.9	1.6	3.1	1.0	25.0	4.2	1.1	3.0	0.9	0.3	0.8	6.5	0.9	2.1	0.8	2.5	1.3	1.0	0.8	5.2	1.6	6.2	11.6	2.2	1.2	29.9	0.0	2.3	0.0	1.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	9.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.9	1.6	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	9.3	29.5	25.8	14.1	11.9	6.6	25.0	4.2	6.5	29.9
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome			2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: , HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (5.45e-4)"	"prognostic unfavourable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.2	17.3	28.9	25.6	10.9	15.4	23.6	18.5	15.3	20.2	25.6	18.6	18.9	42.8	20.4	16.3	11.0	21.9	14.9	27.0	42.9	15.3	43.0	16.2	10.1	12.9	23.4	16.4	12.7	9.8	19.6	17.8	18.4	30.4	26.1	16.8	13.0	39.1	11.6	16.8	10.9	28.9	22.9	23.6	9.0	21.0	25.9	21.5	25.1	10.6	13.0	13.8	13.2	15.9	12.0	19.9	13.9	18.4	24.7	35.6	45.2	13.9	28.2	14.7	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006219			Supported	Nucleoplasm,Midbody,Centrosome				"Nucleoplasm, Centrosome"	Midbody	"HPA006219: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	28.7	11.2	25.0	20.0	1.3	2.9	16.8	21.6	15.4	44.2	38.6	18.9	20.8	33.1	10.4	10.6	13.7	25.4	14.5	40.5	21.4	10.9	39.2	19.8	15.7	0.1	28.9	18.2	0.7	1.4	31.5	15.4	14.2	30.9	28.4	27.9	11.2	30.4	17.5	24.4	14.1	24.4	37.8	20.8	7.4	10.4	17.2	12.3	28.7	20.5	18.1	11.8	22.0	8.4	16.1	31.9	17.4	37.8	15.1	15.3	47.8	10.3	28.2	30.9	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725405	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 10.4;SCLC-21H: 14.6;SK-MEL-30: 5.9;U-2197: 3.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA038811, HPA058624"	Enhanced		Approved	Centrosome				Centrosome		"HPA038811: AB_10795140, HPA058624: "	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	1.3	1.4	5.1	0.7	9.1	0.9	1.9	2.2	11.4	1.4	1.0	18.8	0.1	1.7	1.0	2.6	1.3	9.9	1.6	1.3	7.3	7.1	1.4	1.3	2.4	1.2	11.8	3.2	1.8	1.6	1.2	5.6	1.2	8.6	1.1	0.9	1.7	1.0	0.9	1.6	1.2	1.1	0.8	10.6	0.9	0.9	12.6	7.8	0.0	2.0	0.0	0.9	0.7	0.4	1.2	2.7	2.5	0.6	1.3	0.7	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	1.2	0.3	0.7	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.3	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	10.4	0.3	0.1	14.6	0.2	0.0	0.1	5.9	0.1	0.1	0.2	0.1	0.2	3.4	0.8	0.2	0.0	0.0	0.8	0.1	1.8	1.9	0.6	0.4	0.5	0.3	0.5	0.7	0.5	0.4	0.2	1.2	0.6	0.7	2.5	1.3	0.4	2.7	0.3	0.1	5.1	9.1	2.2	5.4	7.3	7.1	11.8	3.2	8.6	7.8
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome				Centrosome		"HPA055997: , HPA062674: "	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.6	1.8	10.2	10.7	0.2	0.4	6.2	7.7	1.9	6.1	5.2	3.7	4.7	7.0	3.0	1.6	5.8	2.6	3.6	6.7	4.1	5.8	5.7	8.6	5.4	0.0	4.6	6.3	0.0	0.9	5.1	1.5	0.5	1.7	17.4	4.6	2.7	2.7	9.3	4.7	2.2	7.0	5.7	2.4	0.9	2.4	9.3	4.1	2.8	5.9	1.4	6.2	4.8	1.4	3.2	10.0	5.4	11.4	5.7	10.9	6.8	0.0	6.9	5.7	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2
KLHL21	KIAA0469	ENSG00000162413	"Kelch like family member 21"	Q9UJP4	1	6590724-6614607	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 9.7;neutrophil: 31.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051364, HPA059307"	Uncertain		Supported	Centrosome				Centrosome		"HPA051364: , HPA059307: "	"unprognostic (6.13e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.33e-3)"	"prognostic favourable (1.71e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.19e-2)"	18.1	11.3	8.7	7.8	16.1	13.6	20.0	7.3	12.7	11.9	14.6	19.1	12.0	4.6	13.7	6.0	17.3	8.5	14.8	20.5	8.6	7.3	11.7	9.1	8.7	7.5	31.2	5.4	18.0	21.0	8.7	11.2	4.4	14.0	15.7	3.5	17.1	20.4	19.4	58.7	15.1	5.4	22.9	9.9	6.5	10.1	6.6	22.4	4.5	10.1	13.8	7.4	19.4	19.5	2.2	1.8	31.2	3.0	1.4	3.8	2.5	9.8	5.9	3.0	9.7	17.0	10.6	7.8	13.9	11.2	9.2	5.5	17.2	6.4	0.4	12.4	8.5	16.3	6.5	15.3	5.2	21.0	10.6	11.4	10.6	15.4	14.1	6.7	7.0	11.8	5.2	20.9	7.1	3.9	12.5	9.2	7.5	3.4	6.9	5.9	5.5	22.0	10.7	12.5	12.3	5.4	3.0	12.2	3.0	10.9	8.8	24.5	5.7	8.1	13.0	30.1	3.7	27.6	33.2	10.5	13.0	6.9	29.2	12.8	11.2	3.6	3.0	9.7	3.6	1.2	3.3	2.2	3.4	3.6	1.8	1.4	2.9	2.7	31.2	1.4	1.1	1.7	3.8	2.5	8.7	16.1	7.3	12.7	8.6	7.3	31.2	5.4	14.0	22.4
KLHL35	FLJ33790	ENSG00000149243	"Kelch like family member 35"	Q6PF15	11	75422394-75430629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;testis: 11.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.9;HMC-1: 9.3;PC-3: 8.0;SiHa: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.4;T-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039864, HPA070736"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				"Nucleoplasm, Centrosome"	"Nucleoli fibrillar center"	"HPA039864: AB_10794204, HPA070736: "	"unprognostic (3.53e-2)"	"prognostic favourable (4.63e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.28e-1)"	1.1	3.4	4.5	0.7	14.1	0.7	3.5	1.8	8.2	3.2	1.0	3.0	0.2	0.7	0.5	1.0	1.0	2.0	1.1	1.1	3.7	6.2	0.6	0.6	2.7	0.7	3.1	3.3	0.5	4.5	0.5	0.8	0.8	6.2	0.7	0.6	0.7	1.3	1.0	0.9	1.2	0.5	1.1	4.3	1.0	2.3	11.2	2.4	0.0	1.4	0.0	0.7	0.7	0.2	0.2	0.8	5.4	0.3	0.0	2.1	1.2	0.0	0.3	0.1	0.0	0.2	1.2	0.0	0.8	0.0	0.8	0.1	13.9	1.2	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.7	3.5	9.3	0.2	0.2	0.0	0.0	0.3	0.0	0.0	1.0	0.6	0.3	0.1	0.1	8.0	0.0	0.0	0.8	0.6	0.1	1.0	0.9	16.4	3.1	0.0	3.1	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	2.1	0.0	0.5	0.0	1.2	0.7	0.8	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.0	1.2	4.5	14.1	1.8	7.1	3.7	6.2	3.1	3.3	6.2	2.4
KXD1	"BORCS4, C19orf50, FLJ25480, KXDL, MGC2749"	ENSG00000105700	"KxDL motif containing 1"	Q9BQD3	19	18557762-18569387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041507, HPA041599"	Approved		Approved	"Nucleoli fibrillar center,Centrosome,Cytosol"				"Nucleoli fibrillar center, Centrosome, Cytosol"		"HPA041507: AB_10795698, HPA041599: AB_10795502"	"unprognostic (8.48e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (7.36e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (7.71e-10)"	"unprognostic (7.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-1)"	52.9	42.2	47.2	48.7	44.9	49.1	42.8	28.4	60.9	37.2	44.5	56.7	34.3	43.7	48.9	43.2	45.9	45.6	44.1	43.2	43.3	41.8	39.6	73.3	42.2	56.1	46.7	34.2	52.3	58.9	33.6	48.2	53.7	43.7	46.6	43.2	40.0	60.4	45.4	58.3	46.8	39.9	49.3	56.2	48.3	44.5	75.4	38.9	42.1	47.0	45.5	53.2	57.2	54.0	26.9	37.1	41.3	46.4	29.7	37.6	30.6	32.8	33.2	27.3	31.0	28.3	32.8	44.7	36.5	29.3	27.3	31.7	27.2	39.4	22.7	42.9	32.4	25.1	41.9	44.6	24.6	27.5	59.2	24.9	26.0	24.5	32.7	38.8	27.4	34.8	31.8	40.9	49.0	38.6	38.6	35.9	28.4	38.2	34.9	28.6	34.4	50.9	33.6	21.4	33.0	27.8	30.1	25.4	32.7	23.8	21.4	30.6	18.2	26.8	31.3	24.6	21.7	78.6	47.2	42.8	31.9	33.9	42.5	45.6	35.5	15.0	41.0	35.0	29.8	46.4	27.7	26.9	27.6	29.5	37.1	26.4	22.2	24.2	41.3	29.7	43.4	22.1	37.6	30.6	47.2	44.9	28.4	60.9	43.3	41.8	46.7	34.2	43.7	38.9
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971806	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.7	15.2	15.0	15.3	27.9	8.3	17.0	42.6	24.4	13.4	17.8	14.1	9.7	13.9	12.6	11.2	24.4	9.7	14.2	10.6	14.0	14.0	21.4	27.8	10.2	17.2	14.8	14.9	10.6	10.3	25.2	22.4	12.7	22.7	13.8	21.0	9.1	21.2	12.5	13.5	21.8	19.8	12.6	15.3	14.3	13.9	9.8	18.5	23.4	12.0	9.4	18.2	16.9	15.7	12.3	15.3	9.6	15.3	18.9	19.7	10.0	9.5	22.3	14.4	11.6	14.9	12.9	10.3	15.6	12.9	13.4	12.3	15.4	6.3	19.4	9.1	15.9	18.7	19.1	13.9	13.0	12.8	8.6	30.5	18.2	27.0	11.8	27.4	42.6	13.9	10.9	10.4	13.6	13.0	18.4	10.7	15.9	40.6	14.5	20.9	6.2	9.6	16.3	25.0	20.3	11.8	26.8	10.2	15.6	11.9	18.3	12.1	15.2	25.0	15.5	13.3	9.2	12.2	18.5	8.4	26.1	17.8	11.7	39.3	14.1	5.4	9.4	9.6	18.7	14.6	17.5	12.3	18.7	15.2	15.3	10.1	19.5	17.5	2.3	18.9	15.3	11.5	19.7	10.0	15.0	27.9	42.6	24.4	14.0	14.0	14.8	14.9	22.7	18.5
LEPROT	"FLJ90360, OB-RGRP, OBRGRP, VPS55"	ENSG00000213625	"Leptin receptor overlapping transcript"	O15243	1	65420587-65436007	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069444			Approved	Centrosome				Centrosome		"HPA069444: "	"unprognostic (3.64e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	37.3	30.0	13.9	12.6	14.0	17.1	37.8	9.2	13.3	25.4	20.5	18.0	16.1	12.5	42.6	18.4	25.5	20.7	20.8	22.1	11.4	11.0	50.7	31.1	26.3	24.5	16.5	10.1	28.7	30.8	22.5	21.7	44.3	18.9	25.4	16.9	30.4	21.4	20.5	13.6	16.2	23.5	26.2	20.0	24.3	18.1	17.4	11.7	6.5	34.2	14.0	14.7	28.5	19.5	2.2	8.1	15.3	18.0	4.1	4.9	8.4	10.5	4.4	4.6	2.0	41.1	27.8	14.8	16.4	23.0	13.3	13.5	3.8	6.7	2.5	9.5	16.4	6.6	2.5	6.8	17.0	11.3	2.6	12.2	5.7	6.8	11.4	2.3	6.5	38.0	17.3	10.7	8.4	15.2	7.2	6.0	23.9	2.6	0.9	2.8	7.4	4.9	0.5	10.3	3.8	59.8	7.9	4.7	6.3	10.0	8.9	9.5	6.8	4.5	17.7	13.6	10.0	10.3	6.1	7.4	6.6	1.1	10.9	6.2	8.5	15.3	12.7	10.7	4.1	12.7	4.9	2.2	3.9	3.7	8.1	1.5	3.9	3.8	11.8	4.1	18.0	6.7	3.0	8.4	13.9	14.0	9.2	13.3	11.4	11.0	16.5	10.1	18.9	11.7
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell line enhanced"	"Detected in some"		"AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Approved	Centrosome	"Secreted to blood"			Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.9	10.2	0.4	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9
LINC02203		ENSG00000280709	"Long intergenic non-protein coding RNA 2203"		15	21552795-21653276	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	15	"testis: 11.7"	"Cell line enriched"	"Detected in single"	21	"U-2 OS: 11.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Approved	Centrosome				Centrosome		"HPA057442: "																		0.0	0.0		0.0		0.0	0.0		0.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	11.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74491712-74493733	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040249	Approved		Approved	Vesicles,Centrosome				Vesicles	Centrosome	"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	2.0	4.1	2.6	2.6	3.0	2.1	5.8	2.3	4.3	3.1	4.0	3.4	6.5	5.8	3.4	6.5	3.6	5.8	8.8	2.9	3.3	2.6	8.1	5.3	4.0	8.4	3.5	1.0	6.2	10.8	6.2	4.3	8.3	2.9	4.6	3.6	3.8	5.9	6.9	11.3	2.4	6.3	3.1	2.9	4.2	5.6	19.0	0.8	8.7	6.4	5.5	4.3	4.6	3.8	11.2	7.2	6.6	4.9	8.1	14.8	5.4	2.5	3.2	7.0	3.3	2.9	0.6	9.9	0.9	1.6	4.4	2.8	10.5	3.5	15.5	6.0	0.6	3.7	3.2	2.4	1.7	3.6	3.2	4.5	2.8	2.8	3.3	5.2	6.2	1.6	2.6	2.2	2.9	0.3	3.5	4.4	1.3	4.0	6.9	7.9	6.2	4.2	5.6	7.7	4.3	2.9	8.7	7.1	4.5	6.5	2.0	9.4	6.3	3.9	1.2	1.0	2.6	1.5	2.3	7.3	6.5	10.5	0.8	3.0	3.4	0.0	4.9	6.6	5.9	3.0	8.8	11.2	7.9	7.2	5.3	11.0	14.8	11.2	1.1	8.1	3.7	7.2	3.7	5.4	2.6	3.0	2.3	4.3	3.3	2.6	3.5	1.0	2.9	0.8
LMF2	"TMEM112B, TMEM153"	ENSG00000100258	"Lipase maturation factor 2"	Q9BU23	22	50502949-50507691	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062626	Approved		Approved	Centrosome				Centrosome		"HPA062626: "	"unprognostic (2.69e-1)"	"prognostic favourable (3.47e-4)"	"unprognostic (8.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.75e-2)"	18.2	13.7	7.7	14.3	10.1	20.9	16.9	14.6	16.6	16.9	20.0	16.1	11.0	18.7	14.7	19.3	17.5	13.0	19.0	11.2	8.1	8.7	18.5	34.7	14.2	15.3	10.7	10.1	18.0	122.0	8.7	20.8	14.2	11.3	15.8	5.3	16.9	27.3	16.4	10.8	17.8	21.3	11.3	7.8	19.0	12.9	12.0	7.8	12.8	20.4	13.9	19.9	13.3	14.1	10.8	25.3	16.1	17.7	12.1	21.0	12.6	17.9	13.5	7.7	14.7	11.2	9.7	18.1	32.2	17.1	20.8	23.3	13.3	9.4	8.0	8.7	16.9	21.6	2.6	10.2	2.9	6.2	28.3	4.4	24.8	14.0	14.1	8.2	17.4	14.2	9.5	14.1	3.5	11.5	5.2	26.9	9.0	12.9	5.8	9.7	4.6	16.9	13.2	12.4	21.6	8.4	9.8	6.9	10.2	21.9	19.1	14.7	10.9	5.8	16.6	29.4	16.7	21.0	1.6	10.4	3.3	4.8	21.3	5.0	23.9	10.3	13.2	16.1	21.0	17.7	15.9	10.8	17.5	19.4	14.0	7.3	10.4	10.9	12.4	12.1	14.5	25.3	15.9	12.6	7.7	10.1	14.6	16.6	8.1	8.7	10.7	10.1	11.3	7.8
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA038640: "				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.5	2.3	3.1	5.4	1.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.9	0.1	0.9	0.8	1.9	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.6	0.5	0.4	0.2	0.2	0.2	6.6	0.1	6.7	0.2	0.4	3.8	0.3	1.5	0.3	0.2	0.9	23.5	0.2	0.8	1.3	1.6	0.3	1.5	2.5	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721894-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.5	7.6	7.6	4.9	9.9	4.9	10.4	9.9	8.4	14.0	8.1	6.3	8.8	2.2	11.1	13.0	12.9	11.2	9.4	6.5	8.9	5.3	6.3	9.3	8.1	8.7	6.9	6.9	20.4	10.3	12.6	4.9	9.6	5.5	12.8	4.2	13.9	7.9	10.9	18.4	29.7	5.3	10.0	6.1	9.2	6.9	16.1	4.5	6.2	8.6	7.3	7.3	10.6	19.0	1.1	0.9	2.4	2.1	0.1	1.6	0.2	0.6	1.6	8.4	2.6	8.9	4.3	5.6	2.1	3.5	2.3	3.2	0.5	2.1	12.9	0.5	3.6	1.0	6.6	2.5	2.6	2.0	3.7	4.2	0.3	3.4	8.3	1.1	1.6	4.0	4.6	1.4	5.1	3.6	0.6	31.8	1.5	2.3	5.5	3.7	8.6	0.5	3.1	5.7	2.3	2.0	5.6	17.7	2.1	1.2	2.8	16.4	0.6	5.7	1.6	1.2	2.1	5.0	1.6	2.4	10.7	6.8	6.8	3.9	3.8	0.0	0.5	2.4	0.5	1.8	1.6	1.0	1.0	0.6	0.4	1.1	0.0	0.0	1.9	0.1	2.1	0.9	0.0	0.2	7.6	9.9	9.9	8.4	8.9	5.3	6.9	6.9	5.5	4.5
LRRC45	MGC20806	ENSG00000169683	"Leucine rich repeat containing 45"	Q96CN5	17	82023302-82031151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023372, HPA023382, HPA024768"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Centrosome, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348"	"unprognostic (6.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.78e-3)"	"unprognostic (6.17e-3)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-1)"	5.1	4.9	7.1	7.0	9.3	12.0	4.5	20.3	10.8	4.6	7.0	5.7	9.5	11.1	4.4	5.0	8.0	10.5	5.8	3.1	7.7	3.9	5.9	12.9	5.6	6.5	8.3	4.7	3.7	15.5	4.5	4.8	4.9	6.5	6.6	3.6	4.9	13.6	5.0	4.3	10.2	9.4	5.2	3.3	7.6	10.4	3.1	9.9	7.1	9.8	6.8	6.5	5.0	5.1	2.3	3.3	5.0	3.2	2.8	4.6	3.1	9.7	11.1	3.4	6.9	1.4	1.9	13.2	6.8	2.8	4.1	3.5	9.9	6.7	7.3	6.2	1.3	11.4	3.2	4.1	0.9	4.4	20.9	4.6	20.2	13.3	1.1	5.4	11.6	1.8	1.7	2.4	0.6	6.0	3.2	3.2	1.0	16.5	12.1	18.1	3.5	14.9	10.0	6.6	4.0	2.6	9.0	10.5	10.2	3.1	16.3	5.7	13.3	6.3	3.5	7.2	9.1	11.4	11.5	6.3	1.6	1.1	3.9	4.7	7.5	5.0	3.2	3.6	3.9	2.4	4.0	1.5	4.5	4.6	2.2	2.3	2.4	3.1	0.2	2.8	1.0	3.3	3.8	3.1	7.1	9.3	20.3	10.8	7.7	3.9	8.3	4.7	6.5	9.9
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.3;HEL: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	10.3	0.2	0.0	0.0	0.0	0.5	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6
LRRCC1	"CLERC, KIAA1764, VFL1"	ENSG00000133739	"Leucine rich repeat and coiled-coil centrosomal protein 1"	Q9C099	8	85107147-85146076	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012893, HPA075880"	Uncertain		Supported	Centrosome				Centrosome		"HPA012893: AB_1852434, HPA075880: "	"unprognostic (1.01e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.52e-1)"	5.2	5.6	10.8	9.8	10.7	7.0	7.3	2.3	7.2	7.0	10.8	5.6	5.1	7.3	7.1	7.3	6.1	5.2	4.8	5.3	10.4	9.0	9.7	4.4	6.1	4.9	12.7	6.0	9.4	4.8	6.0	2.7	2.5	8.8	8.9	10.1	3.4	3.6	6.8	2.0	6.5	10.0	11.7	15.0	5.3	6.5	33.1	9.9	11.4	10.1	3.4	3.9	8.0	22.1	1.3	2.9	0.1	1.2	2.5	3.6	0.6	4.3	0.9	8.2	1.9	4.0	3.5	6.5	4.7	2.9	1.0	1.8	2.2	6.3	3.2	0.7	2.8	6.0	9.7	2.7	1.6	25.3	0.8	12.7	2.5	3.2	1.2	4.8	3.4	2.0	0.7	2.8	0.6	1.1	14.3	3.0	5.2	1.6	14.5	3.8	2.8	2.1	10.7	5.2	2.2	2.8	3.3	1.1	2.8	2.2	4.3	1.6	9.8	10.5	1.4	4.0	5.4	4.2	6.1	4.1	4.0	6.4	3.3	12.6	7.7	0.0	0.8	0.0	1.8	1.2	0.9	1.3	1.4	1.9	2.9	1.2	1.6	2.8	0.1	2.5	0.9	1.9	3.6	0.6	10.8	10.7	2.3	7.2	10.4	9.0	12.7	6.0	8.8	9.9
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;lymphoid tissue: 81.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 19.4;HDLM-2: 10.9;NB-4: 12.6;REH: 11.9;U-698: 14.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048884	Approved		Approved	Centrosome				Centrosome		"HPA048884: "	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favourable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favourable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	1.0	0.2	0.2	35.9	0.2	3.4	0.5	0.1	0.1	0.2	1.5	0.0	0.0	1.3	0.2	0.3	2.7	0.4	0.7	1.9	0.2	0.1	4.2	1.3	4.2	27.8	0.2	0.0	0.5	0.8	0.0	0.2	0.3	0.1	0.7	0.6	0.5	6.1	0.3	0.1	0.6	18.0	0.3	0.3	69.7	2.0	0.2	0.0	81.5	1.1	0.8	41.6	1.6	0.5	44.1	15.6	17.8	3.6	5.2	39.3	10.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	19.4	0.2	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.6	0.0	0.0	11.9	0.0	2.7	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	2.5	0.4	17.8	3.7	2.0	26.8	42.5	39.3	17.3	0.6	44.1	33.5	14.2	14.5	5.2	3.6	15.6	22.2	10.7	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.0
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982013-20999038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: , HPA071248: "	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	21.2	16.9	17.3	15.6	17.4	10.3	17.9	20.7	24.7	18.5	18.3	25.3	20.6	18.9	24.9	14.0	16.5	18.3	21.2	15.8	15.4	10.9	17.2	13.1	16.2	12.8	19.6	16.5	21.7	16.2	24.9	26.0	18.8	19.0	16.9	12.9	18.9	17.5	18.0	17.2	15.0	15.7	21.9	14.0	19.3	14.5	10.8	19.2	10.8	19.6	12.6	12.5	18.5	16.4	1.6	2.2	0.2	3.4	1.8	3.0	1.5	6.2	5.1	7.6	9.2	17.6	12.2	6.2	12.8	9.0	7.3	10.0	3.0	2.6	6.6	4.8	14.2	8.4	5.7	10.5	2.9	12.3	13.3	7.1	6.7	4.4	9.4	3.8	9.4	11.2	5.3	9.2	6.7	14.1	29.4	11.5	8.2	3.8	6.8	3.6	2.4	5.6	8.0	11.1	2.6	5.7	8.4	7.5	11.2	6.9	12.1	7.5	5.6	7.1	12.6	17.0	8.7	7.7	6.9	5.0	4.4	2.0	7.7	3.7	8.2	0.0	2.5	0.2	3.0	3.1	1.6	1.6	1.5	2.8	2.2	1.0	2.1	1.5	0.1	1.8	3.4	1.2	0.5	1.5	17.3	17.4	20.7	24.7	15.4	10.9	19.6	16.5	19.0	19.2
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	44	"testis: 9.0"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 36.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA055743: , HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAL		ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"esophagus: 447.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 44.8;MOLT-4: 62.7;RPTEC TERT1: 227.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1"	"Lineage enriched"	"Detected in many"	44	"T-cells: 57.9"	"Low region specificity"	"Detected in all"							HPA065691			Approved	"Golgi apparatus,Centrosome"				"Golgi apparatus"	Centrosome	"HPA065691: "	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favourable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	2.3	2.0	14.3	3.5	21.8	3.7	2.0	1.8	20.6	35.8	3.7	43.2	0.4	2.0	1.8	3.4	447.4	3.4	2.2	3.3	18.2	8.3	53.1	1.7	4.3	5.9	27.4	13.2	2.0	1.9	1.6	0.2	2.2	11.8	2.5	2.9	2.8	42.5	3.9	2.0	3.7	2.4	2.1	27.6	3.2	9.3	1.7	27.2	35.0	5.8	56.1	90.1	2.6	64.8	0.6	0.2	0.4	0.1	1.3	57.9	13.7	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	0.0	22.2	227.3	5.7	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.6	42.0	7.5	0.0	0.5	57.9	26.4	0.4	1.3	0.0	0.2	40.1	13.7	14.3	21.8	1.8	20.6	18.2	8.3	27.4	13.2	11.8	27.2
MAP7D3	FLJ12649	ENSG00000129680	"MAP7 domain containing 3"	Q8IWC1	X	136213220-136256482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035598, HPA058101"	Approved		Enhanced	Centrosome				Centrosome		"HPA035598: AB_10671108, HPA058101: "	"unprognostic (2.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavourable (9.00e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (4.16e-5)"	"unprognostic (5.35e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (7.91e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.38e-5)"	26.1	4.8	2.9	9.3	3.8	4.5	21.2	0.9	2.2	14.3	9.0	1.7	6.8	2.2	11.4	12.3	10.6	13.7	6.7	17.7	2.7	1.9	9.9	6.5	6.9	6.4	4.1	1.1	23.6	2.8	8.3	14.1	32.6	5.5	9.4	3.5	4.6	3.8	8.6	27.9	5.3	6.2	15.3	6.5	11.8	6.5	16.0	3.1	9.5	9.6	10.2	4.9	13.9	14.6	9.8	6.2	5.9	9.2	8.4	9.3	3.9	15.4	5.5	4.2	7.2	9.5	10.0	5.8	15.0	8.3	12.3	17.0	5.5	7.8	8.0	24.3	13.1	7.5	12.2	8.0	16.9	7.3	12.2	4.8	8.8	0.0	10.5	11.8	5.0	20.3	4.6	12.6	15.7	9.6	4.1	12.7	9.1	9.8	13.9	4.5	5.9	0.1	13.8	11.4	4.0	0.4	2.4	3.0	6.3	8.7	3.3	5.4	0.0	5.4	28.5	13.2	7.6	16.7	19.0	8.6	10.3	9.2	9.0	19.8	6.2	5.9	4.8	1.4	7.5	5.5	9.3	9.8	7.1	8.2	5.8	8.5	7.6	6.0	1.0	8.4	9.2	6.2	5.0	3.9	2.9	3.8	0.9	2.2	2.7	1.9	4.1	1.1	5.5	3.1
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: , HPA063708: , HPA064435: "	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	20.9	8.3	11.5	12.9	34.0	20.0	14.3	14.6	33.1	22.3	21.1	15.8	10.2	10.1	10.2	29.4	15.9	8.6	15.5	16.1	11.7	6.5	16.9	10.3	10.2	26.3	24.9	56.6	27.5	19.9	21.4	23.7	18.2	19.4	45.9	18.0	26.0	10.0	18.0	13.3	11.6	25.8	24.1	3.2	16.8	12.8	9.2	11.9	17.2	29.1	20.2	14.1	24.2	17.3	20.1	17.0	23.3	19.8	59.8	53.1	8.2	22.8	15.2	6.6	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol			63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: "	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.0	36.1	48.8	31.9	69.4	51.4	50.6	34.7	51.3	52.9	53.7	42.7	39.1	55.5	20.6	45.4	38.8	54.9	64.3	75.9	33.6	42.4	52.1	33.8	67.8	38.1	59.9	41.3	50.9	43.9	49.5	29.3	40.3	28.8	40.4	69.5	26.5	52.4	60.5	28.6	45.0	41.9	57.5	54.4	87.5	41.8	45.3	27.0	29.1	46.9	66.5	34.2	62.5	23.4	40.6	39.8	33.7	43.6	50.4	44.2	67.9	50.1	54.2	33.5	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA040411, HPA041594"	Uncertain		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favourable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	7.0	6.7	11.5	11.9	11.4	15.4	10.0	8.2	12.7	11.9	28.7	9.6	12.4	5.1	15.2	12.7	5.4	20.3	6.5	6.7	12.3	10.0	8.8	4.9	6.8	12.8	11.4	10.5	10.9	11.3	8.8	22.8	6.0	14.9	12.3	11.1	9.0	6.8	15.9	3.8	4.2	9.0	18.8	11.4	9.5	9.8	20.7	12.4	14.6	11.0	5.3	13.4	17.0	8.9	7.1	4.0	13.3	17.2	6.0	8.1	5.4	4.9	4.1	8.0	7.7	4.0	5.4	6.1	6.6	3.7	10.6	9.8	4.9	2.3	11.4	4.4	3.0	5.1	5.4	3.5	12.1	14.9	5.2	25.0	5.3	3.4	6.1	13.8	9.9	2.4	4.6	7.1	6.9	5.9	4.7	12.8	6.1	3.6	19.5	9.8	4.2	5.1	19.2	7.1	3.3	5.0	4.3	7.3	3.9	6.4	3.8	6.5	9.2	10.0	3.1	8.5	3.7	5.3	6.0	6.7	19.5	7.7	4.5	9.0	5.4	6.0	4.7	13.3	5.0	11.1	8.1	6.8	6.4	5.2	4.0	7.1	7.7	6.2	3.1	6.0	17.2	2.3	5.9	5.4	11.5	11.4	8.2	12.7	12.3	10.0	11.4	10.5	14.9	12.4
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	11.8	22.1	12.4	12.1	14.2	7.0	14.2	17.0	15.4	15.3	14.0	16.4	17.4	13.1	16.1	17.8	17.0	13.2	9.9	15.3	12.7	9.5	17.5	14.7	10.4	11.4	14.8	9.3	12.8	17.6	14.5	23.5	17.4	13.8	16.3	15.4	13.2	15.3	14.0	23.0	12.1	15.4	15.3	9.6	13.3	12.9	14.6	11.5	20.9	15.5	13.1	16.4	16.0	12.9	15.0	20.0	13.6	22.1	11.6	10.8	11.5	14.8	12.6	13.6	16.2	12.9	14.2	16.8	9.5	9.1	13.5	10.8	16.0	10.2	20.2	18.8	11.1	11.3	23.2	12.7	17.1	11.6	7.4	18.1	9.7	14.1	12.3	15.4	11.5	11.1	20.0	12.9	19.3	16.7	24.5	9.7	16.1	13.3	17.1	11.0	17.7	10.2	23.8	16.4	7.3	19.3	9.6	12.6	10.0	13.5	6.4	12.7	12.9	16.1	16.3	9.6	20.8	5.8	11.7	10.1	13.5	42.7	5.3	17.1	13.5	13.0	19.6	13.6	8.7	22.1	10.8	14.2	5.8	9.8	20.0	15.0	7.9	9.3	7.3	11.6	14.8	17.8	10.2	11.5	12.4	14.2	17.0	15.4	12.7	9.5	14.8	9.3	13.8	11.5
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824802	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	23.7	32.9	23.8	25.4	25.0	12.5	24.3	35.5	29.2	22.5	19.5	17.7	20.0	15.9	25.2	27.2	28.0	21.2	16.8	21.9	24.6	21.2	28.1	20.0	16.8	26.7	21.5	30.9	29.2	20.0	38.5	33.0	25.2	24.0	26.3	20.7	15.5	21.9	21.8	33.3	24.4	19.3	21.5	26.7	23.9	21.0	21.7	27.3	33.9	28.2	19.2	34.1	24.1	28.2	21.2	20.3	34.3	21.5	29.6	26.0	15.1	15.2	15.9	27.7	18.2	23.6	14.9	17.1	24.7	17.2	20.1	23.5	24.7	10.0	16.4	23.6	15.2	27.8	24.6	20.1	23.8	27.7	14.8	39.8	28.7	18.5	18.5	23.6	21.3	13.8	22.1	19.1	17.4	19.6	35.9	14.1	23.9	11.4	19.2	17.9	19.5	13.9	28.2	27.8	10.5	20.8	22.9	17.6	17.3	21.7	18.6	10.0	28.0	15.2	18.5	20.4	14.5	22.4	19.9	17.4	41.9	35.9	17.2	22.6	14.9	21.4	15.8	34.3	23.4	21.5	22.9	21.2	23.4	22.0	20.3	18.6	24.1	23.5	14.4	29.6	17.1	16.7	26.0	15.1	23.8	25.0	35.5	29.2	24.6	21.2	21.5	30.9	24.0	27.3
MKKS	BBS6	ENSG00000125863	"McKusick-Kaufman syndrome"	Q9NPJ1	20	10401009-10434222	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Chaperone	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041071, HPA044233"	Enhanced		Supported	Centrosome				Centrosome		"HPA041071: AB_10960408, HPA044233: AB_10962986"	"unprognostic (9.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (9.84e-5)"	"unprognostic (5.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.79e-9)"	"unprognostic (3.69e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.01e-1)"	13.1	15.9	24.3	11.0	26.8	3.1	15.7	31.0	31.6	18.3	19.6	9.9	18.7	21.8	13.9	18.1	15.0	16.1	16.0	25.3	23.7	22.4	33.2	30.6	12.1	11.9	22.4	21.5	17.5	15.2	27.6	16.1	11.7	21.8	16.3	23.0	11.5	18.7	23.8	29.5	11.3	22.0	17.0	16.8	12.1	13.5	20.6	11.6	8.3	20.1	24.0	12.9	13.2	12.9	15.1	22.6	22.6	22.0	13.5	20.9	20.0	12.0	15.1	12.7	18.9	14.4	11.8	4.7	8.6	8.6	9.8	8.3	5.0	6.7	9.2	3.7	7.3	15.3	15.1	15.8	11.9	1.6	6.6	20.7	4.2	16.2	11.1	13.4	4.8	11.4	26.7	9.8	21.2	8.3	11.6	7.1	12.0	5.4	12.5	11.8	9.5	10.2	8.3	13.2	9.5	15.5	5.9	18.4	12.3	7.3	35.4	18.7	10.0	9.7	4.0	8.7	8.4	10.7	14.5	5.7	20.8	4.7	7.8	14.6	9.3	22.6	22.0	18.8	15.9	19.9	18.6	15.1	18.0	14.2	22.6	10.7	20.9	19.5	10.9	13.5	19.5	17.7	13.5	20.0	24.3	26.8	31.0	31.6	23.7	22.4	22.4	21.5	21.8	11.6
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 4.7;Hep G2: 15.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"											HPA011940	Approved		Approved	Centrosome				Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.1	0.4	0.6	0.0	0.0	0.0	4.7	1.1	0.3	0.6	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.6	0.6	15.8	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.3	0.3	0.5	0.2	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome				Centrosome		"HPA002977: , HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	12.9	8.3	9.0	7.3	2.1	2.4	12.1	11.5	14.9	11.8	16.7	8.0	10.3	28.4	17.1	9.3	11.8	18.1	16.8	18.4	11.5	10.9	1.8	13.0	3.4	6.2	8.3	6.2	6.7	11.7	12.9	0.2	7.1	5.4	7.3	8.4	11.1	12.1	2.1	4.1	12.6	6.5	14.3	12.5	9.2	14.9	13.4	8.4	4.4	9.9	3.7	12.6	4.7	8.9	7.8	6.2	1.0	17.1	9.4	9.6	43.2	1.5	5.4	5.9	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 4.2;monocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030351	Approved		Approved	Centrosome				Centrosome		"HPA030351: AB_10602185"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.2	12.0	4.9	15.0	8.4	0.0	5.4	1.5	3.9	9.5	36.8	2.7	5.8	15.9	10.0	6.2	4.4	7.2	17.0	3.1	2.6	2.8	9.7	1.8	3.4	1.5	2.0	2.8	14.5	2.2	5.8	6.3	9.6	5.2	5.5	20.8	4.5	2.1	6.5	1.1	7.4	49.9	11.4	5.0	1.8	4.0	4.9	2.5	0.0	1.6	4.0	1.5	5.8	6.8	0.0	4.2	0.0	3.2	0.0	0.0	0.5	2.6	6.4	2.8	2.3	8.4	9.5	5.2	2.7	9.2	3.6	4.5	0.1	11.6	0.0	6.3	9.4	3.7	0.3	4.6	2.0	0.2	0.0	0.0	1.9	0.8	2.1	0.0	0.0	5.8	1.5	3.6	6.0	4.3	0.1	0.1	7.0	8.6	0.0	0.1	0.6	2.3	0.0	1.0	0.1	5.4	0.8	0.1	0.2	1.6	2.5	0.9	2.8	0.0	2.9	3.9	4.9	3.3	2.1	0.3	1.1	0.0	3.7	0.0	0.3	0.0	1.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	4.9	8.4	1.5	3.9	2.6	2.8	2.0	2.8	5.2	2.5
MTMR9	"C8orf9, DKFZp434K171, LIP-STYX, MTMR8"	ENSG00000104643	"Myotubularin related protein 9"	Q96QG7	8	11284416-11328146	"Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070944			Approved	"Actin filaments,Centrosome"				Centrosome	"Actin filaments"	"HPA070944: "	"unprognostic (1.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.43e-2)"	8.2	7.0	11.5	7.5	14.0	8.0	9.2	18.2	26.2	6.6	9.9	10.3	2.7	4.4	8.3	5.7	6.4	5.6	5.9	12.9	11.6	14.4	8.2	5.7	6.6	6.9	11.7	12.2	6.9	7.2	9.4	8.4	7.8	13.1	9.3	6.3	6.4	4.8	7.6	9.1	6.9	5.2	11.1	10.8	6.6	5.3	16.8	7.4	8.2	7.1	3.7	7.4	6.4	5.6	4.5	4.1	3.6	3.9	2.3	3.7	1.2	2.6	7.3	6.6	5.2	8.1	6.9	5.1	8.2	5.4	6.6	6.1	6.5	2.0	6.7	2.2	9.8	3.7	7.2	7.2	7.6	1.4	4.4	8.9	5.8	3.3	8.8	2.3	5.2	6.8	5.8	9.5	12.0	10.3	6.0	5.4	10.7	2.0	4.0	2.4	11.7	4.4	2.9	10.7	2.1	7.2	6.7	2.5	10.0	5.5	2.4	5.8	3.0	4.7	12.8	7.9	5.8	4.4	4.3	1.5	3.0	3.8	6.5	5.1	7.6	1.5	3.2	3.6	3.2	3.9	2.8	3.5	2.7	2.7	2.8	4.5	3.2	3.7	3.1	2.3	3.2	4.1	2.0	1.2	11.5	14.0	18.2	23.2	11.6	14.4	11.7	12.2	13.1	7.4
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.9	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.1	0.0	0.0	10.9	23.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.9"	"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"prognostic favourable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	17.7	17.1	34.7	22.1	22.6	31.3	17.1	9.6	25.1	17.5	20.3	7.6	23.0	30.0	11.9	22.3	23.5	14.0	17.5	57.5	28.0	20.7	14.4	15.9	7.5	15.6	18.9	16.4	20.8	55.4	5.6	7.2	5.3	8.8	16.4	3.4	9.3	48.5	19.7	40.7	12.6	22.8	17.3	12.0	15.5	24.0	11.1	5.5	28.3	17.8	23.8	17.0	16.2	12.8	11.9	5.4	31.9	1.0	2.6	9.3	2.2	35.6	19.2	0.4	7.4	0.5	1.3	7.7	12.1	2.8	4.7	4.6	47.2	12.3	23.1	15.7	0.5	16.1	1.2	8.1	0.1	9.1	58.8	9.5	21.6	55.8	2.9	16.6	3.6	3.7	4.4	3.0	1.4	3.8	18.7	24.4	1.1	32.2	23.0	70.0	12.5	44.1	19.6	6.7	51.7	2.9	16.5	28.0	3.5	12.3	8.4	22.0	13.1	30.0	10.6	12.3	29.8	5.2	11.8	22.8	16.9	18.6	17.2	10.8	7.3	6.9	1.0	31.9	3.8	0.6	4.2	11.9	8.5	4.9	3.4	6.2	9.3	4.5	0.4	2.6	0.3	5.4	8.4	2.2	34.7	22.6	9.6	23.1	28.0	20.7	18.9	16.4	8.8	5.5
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	28.9	39.1	50.8	23.9	33.5	63.4	23.8	19.5	35.1	24.3	31.3	14.4	27.7	34.2	24.7	24.0	30.6	19.4	26.7	56.6	33.7	29.3	22.5	31.1	14.4	27.8	32.8	33.3	31.0	104.2	10.9	17.1	16.2	19.7	28.4	11.6	18.6	63.6	24.9	87.5	20.9	32.1	31.8	21.7	26.8	33.8	26.1	15.4	35.3	36.0	27.1	22.2	24.4	34.9	15.3	21.7	31.7	9.3	12.1	13.3	4.9	40.8	17.3	4.4	21.0	1.7	6.4	20.4	19.6	7.3	7.6	5.5	35.3	21.3	22.5	30.6	4.4	23.2	2.3	6.4	1.2	33.3	53.5	12.1	25.3	38.5	7.5	16.0	12.1	6.9	9.1	5.1	2.5	8.3	16.0	33.7	5.4	47.4	35.8	93.1	14.0	31.7	41.8	11.0	70.6	4.5	13.5	30.5	37.2	11.8	21.4	31.8	25.3	47.3	14.8	21.9	35.5	17.5	18.5	41.1	25.6	27.7	33.0	23.7	15.8	0.1	9.3	31.7	7.7	9.1	6.2	15.3	11.3	10.7	11.2	14.8	13.3	10.7	4.6	12.1	8.4	21.7	8.7	4.9	50.8	33.5	19.5	35.1	33.7	29.3	32.8	33.3	19.7	15.4
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;MCF7: 10.6;RH-30: 10.7;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	7.9	0.0	0.0	0.0	0.0	1.6	0.5	0.7	1.0	0.0	2.4	0.2	0.0	0.0	1.2	0.4	2.0	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	6.3	1.3	0.5	0.0	10.6	0.1	0.1	5.9	0.0	5.9	10.7	2.7	0.6	1.2	0.9	0.4	0.3	37.9	2.5	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.1	6.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3
N6AMT1	"C21orf127, HEMK2, MTQ2, N6AMT, PRED28"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: "	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	5.4	10.9	10.1	6.0	18.6	2.0	10.5	7.4	14.8	9.9	7.0	17.0	6.0	6.7	13.8	13.7	5.6	9.3	6.2	10.8	10.8	9.2	9.0	6.3	5.5	6.7	21.3	8.4	18.3	6.6	14.6	15.6	13.1	14.1	10.1	7.4	8.4	6.5	9.0	11.3	8.0	6.2	7.8	14.5	7.9	6.7	7.6	19.3	3.9	12.1	4.0	6.9	8.7	9.2	2.2	2.0	1.6	2.1	4.1	4.8	1.8	3.4	3.0	7.7	10.7	6.4	7.1	5.9	7.4	3.0	4.3	2.6	3.8	6.1	3.8	3.7	4.0	4.0	6.6	3.7	5.4	4.8	5.0	8.0	4.7	4.7	5.8	4.8	3.1	3.6	8.0	4.4	3.0	3.2	9.8	6.7	8.9	3.4	2.2	3.8	9.7	4.3	3.4	7.3	2.8	8.0	5.0	5.9	8.3	6.7	2.4	2.7	3.3	4.2	7.4	3.7	6.5	6.6	4.4	4.1	4.6	2.1	5.7	12.5	6.8	1.1	1.5	1.6	1.8	2.1	2.0	2.2	3.4	2.3	2.0	2.2	4.8	3.4	0.5	4.1	1.6	1.7	1.4	1.8	10.1	18.6	7.4	14.8	10.8	9.2	21.3	8.4	14.1	19.3
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-266/70: 26.0;U-266/84: 8.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	26.0	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome			53000	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (9.44e-5)"	"unprognostic (1.97e-1)"	23.6	27.4	25.3	20.2	31.8	27.2	27.3	36.7	41.7	26.0	25.8	24.4	23.7	26.2	27.9	31.0	27.5	23.9	20.2	23.6	25.4	29.0	24.3	25.9	18.3	27.0	27.7	31.9	31.0	26.6	38.8	42.2	26.4	34.9	24.9	30.0	22.1	24.3	23.5	33.2	26.9	27.6	25.4	25.3	18.4	22.2	36.9	25.9	28.9	27.9	28.0	24.9	24.7	22.4	9.4	6.4	6.7	3.2	8.6	19.4	9.4	22.6	17.5	31.2	30.7	12.5	17.8	25.9	17.3	17.6	25.7	31.2	21.2	17.6	25.1	19.9	13.0	23.0	23.4	20.8	36.5	9.2	26.7	17.8	12.1	32.9	14.4	33.1	22.4	14.4	15.5	20.4	18.0	17.9	42.1	8.9	19.7	7.9	34.6	37.9	43.2	31.6	37.2	37.2	33.5	19.8	20.0	33.6	24.7	51.8	11.1	19.9	11.9	22.4	13.9	18.0	18.0	18.7	20.0	16.8	25.9	90.5	16.2	22.0	21.7	1.3	3.1	6.7	15.4	3.0	19.4	9.4	16.4	16.6	4.2	7.9	17.8	17.7	1.4	8.6	3.2	6.4	14.0	9.4	25.3	31.8	36.7	41.7	25.4	29.0	27.7	31.9	34.9	25.9
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA066330: "	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.5	4.9	24.5	10.8	1.3	2.9	12.6	25.4	13.6	33.3	28.4	13.4	12.3	23.6	11.5	9.8	13.4	27.3	11.0	35.3	8.8	6.9	18.6	14.0	10.3	0.4	35.6	15.7	1.5	1.0	19.1	13.6	15.1	15.1	30.1	29.0	9.7	17.3	15.5	12.6	7.2	19.2	25.0	18.9	8.7	10.5	19.8	8.9	23.2	6.1	9.2	10.3	14.2	9.2	21.7	48.4	17.1	33.4	13.2	20.8	31.7	9.6	16.5	18.3	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"Neural precursor cell expressed, developmentally down-regulated 1"	Q8NHV4	12	96907223-96953777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Centrosome"	"Plasma membrane"	"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (1.94e-4)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	10.7	6.2	5.7	10.0	6.6	9.8	9.8	2.5	7.1	10.8	9.3	7.1	1.7	4.9	13.5	8.3	11.6	10.0	5.5	8.3	6.0	4.4	12.6	5.4	9.4	10.3	7.0	3.7	13.3	7.7	14.9	13.5	7.9	6.5	11.9	7.2	6.3	8.5	6.3	25.5	7.8	10.3	15.4	8.4	14.5	7.2	17.8	8.3	30.6	11.9	24.3	10.7	15.1	9.6	9.4	5.9	19.9	11.1	15.6	14.0	7.3	13.4	8.9	15.4	9.4	7.7	6.9	10.9	46.8	16.6	21.6	18.7	5.8	5.0	8.3	4.5	37.4	12.1	10.4	10.8	29.2	15.9	8.9	10.4	5.9	5.1	6.4	14.1	9.4	5.1	8.9	13.1	10.2	10.5	6.0	6.1	15.4	5.5	25.7	6.4	8.5	28.5	13.6	15.7	8.2	8.8	8.8	4.8	8.5	13.1	7.4	8.1	10.0	5.0	7.5	13.6	10.5	9.7	11.0	6.0	7.3	11.1	4.2	7.2	16.4	10.0	6.9	19.9	12.1	11.1	13.7	9.4	13.4	12.9	5.9	8.1	14.0	10.9	5.4	15.6	7.8	4.6	14.0	7.3	5.7	6.6	2.5	7.1	6.0	4.4	7.0	3.7	6.5	8.3
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: "	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (9.47e-6)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.3	21.9	16.8	12.0	1.0	1.7	18.5	11.7	11.0	20.7	17.8	11.7	29.8	16.1	5.7	9.0	16.3	14.5	8.8	26.1	24.6	12.1	7.7	19.1	15.7	0.1	15.2	10.5	0.5	1.0	15.9	17.2	13.2	21.1	28.4	20.7	8.4	16.5	10.3	15.9	11.2	16.4	25.7	24.5	7.2	8.7	15.2	16.9	16.9	19.0	14.7	29.2	9.1	6.9	10.3	20.5	20.3	31.4	11.8	21.7	21.3	9.0	11.7	17.1	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4
NFKBIB	"IKBB, TRIP9"	ENSG00000104825	"NFKB inhibitor beta"	Q15653	19	38899700-38908893	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 80.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063734			Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA063734: "	"unprognostic (2.73e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.50e-3)"	7.9	7.1	7.0	12.5	9.8	22.0	6.8	2.9	7.3	3.9	7.6	8.1	7.6	10.8	5.8	5.7	8.6	5.1	7.6	7.1	7.3	5.8	7.9	14.6	6.7	8.7	11.2	5.2	4.3	9.7	4.0	3.9	7.2	7.2	5.0	3.6	5.1	8.6	6.6	13.9	8.0	11.7	5.1	9.9	9.2	12.4	80.2	9.3	6.0	6.6	8.7	8.7	6.6	5.1	3.8	5.4	12.4	5.8	8.7	7.2	2.9	8.0	10.0	1.4	3.6	1.5	0.9	4.8	5.4	2.2	2.9	3.3	7.1	4.4	8.9	6.1	1.2	4.4	3.8	2.6	0.9	27.2	4.8	5.9	1.9	4.0	5.2	6.8	12.6	1.2	3.0	3.2	4.1	1.6	6.9	8.2	1.1	5.2	8.4	6.7	5.1	4.1	11.8	6.2	8.1	1.4	3.2	8.7	5.2	3.4	5.0	3.8	3.0	5.8	3.8	5.0	6.4	8.6	8.3	17.0	15.1	19.0	3.2	7.1	6.1	1.5	4.3	12.4	5.3	5.8	4.1	3.6	3.1	4.5	3.8	3.8	2.3	3.4	9.0	8.7	4.7	5.4	7.2	2.9	7.0	9.8	2.9	7.3	7.3	5.8	11.2	5.2	7.2	9.3
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA005939: , HPA070691: "	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.2	8.7	18.1	15.4	7.0	11.2	7.6	10.5	9.1	8.9	7.5	5.6	6.5	28.8	7.2	14.1	12.9	14.5	6.6	18.7	13.9	4.5	10.6	5.3	5.3	4.1	18.4	30.6	7.7	5.3	15.5	6.4	14.1	2.6	11.8	13.4	13.4	13.9	7.4	2.5	9.6	15.8	33.5	2.0	8.0	13.9	8.4	9.5	13.2	4.0	11.3	7.5	16.4	20.5	22.6	31.4	8.6	11.6	9.5	4.8	19.9	5.9	15.0	12.2	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036999	Approved		Supported	Centrosome,Cytosol			960000	Cytosol	Centrosome	"HPA036999: AB_10672105"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.1	8.9	12.1	6.2	4.1	6.0	9.7	9.2	8.4	11.2	9.9	6.2	5.8	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.8	4.7	4.9	7.6	16.7	5.1	8.5	6.1	3.3	8.0	11.8	9.4	3.1	4.3	4.4	15.0	3.5	4.2	9.7	16.0	6.2	6.9	3.2	5.6	9.6	6.1	7.1	4.4	4.4	6.1	2.5	2.9	3.5	4.9	5.4	8.5	9.6	7.9	7.6	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 40.7;NB-4: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA059120, HPA060405"			Enhanced	Centrosome				Centrosome		"HPA059120: , HPA060405: "	"unprognostic (9.66e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	10.0	5.7	3.4	26.4	7.0	24.9	6.0	1.6	6.2	5.4	7.0	4.2	2.9	4.9	10.8	4.4	6.4	4.9	8.9	3.7	4.3	2.4	5.5	5.5	12.8	21.3	7.0	2.0	3.9	3.6	2.1	20.2	2.3	6.0	5.2	5.6	4.7	8.9	3.0	3.5	10.9	16.1	5.8	7.8	24.6	7.2	1.3	6.3	9.4	5.9	6.6	29.7	7.3	7.0	5.4	1.7	13.2	4.0	2.7	7.0	2.7	4.8	0.9	0.1	0.3	0.3	1.6	0.0	2.7	4.2	8.6	8.4	0.0	8.4	9.9	2.0	4.4	3.2	1.1	0.3	1.0	0.4	0.3	40.7	8.6	0.9	3.0	1.4	2.4	3.2	0.1	7.0	0.7	3.3	0.0	2.0	1.8	0.1	2.2	22.3	0.0	0.9	10.6	3.1	4.1	0.9	0.4	0.3	0.3	5.4	0.5	1.1	0.6	5.3	4.2	4.1	1.4	15.1	2.2	4.0	2.1	10.1	7.4	3.0	0.7	6.4	4.0	13.2	7.0	2.2	4.2	5.4	4.0	6.6	1.7	3.1	2.6	2.7	9.8	2.7	2.5	1.3	4.6	2.7	3.4	7.0	1.6	6.2	4.3	2.4	7.0	2.0	6.0	6.3
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	2488000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: , HPA058320: "	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	125.7	0.0	0.9	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 47.0;CACO-2: 10.8;Hep G2: 10.5;K-562: 13.8;NTERA-2: 16.7;U-266/84: 10.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: , HPA045145: "	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.2	0.8	0.1	0.1	47.0	0.0	0.4	0.3	0.5	10.8	1.2	2.1	0.4	0.0	1.1	0.6	0.5	0.7	0.5	2.0	1.6	1.7	10.5	0.0	0.9	3.1	0.0	0.6	0.5	0.6	0.1	13.8	0.3	0.2	0.2	0.0	1.3	16.7	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.1	1.9	0.3	0.9	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845629-145848953	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.4;granulocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	4.6	3.3	8.3	3.9	13.5	6.7	4.9	8.9	10.9	3.8	3.4	5.1	1.5	1.2	4.6	3.1	3.5	7.0	4.4	8.4	6.6	7.7	3.8	2.6	3.4	9.0	5.9	8.1	6.8	6.2	6.2	4.7	2.2	5.4	4.2	2.9	8.0	6.3	5.8	6.7	4.3	3.3	11.1	5.5	6.0	3.3	7.1	2.2	3.5	5.7	3.4	7.7	4.1	3.2	0.9	18.4	11.5	1.8	0.2	1.1	0.7	4.3	3.1	2.9	1.6	1.6	2.5	3.0	2.1	3.4	2.2	3.0	1.9	3.2	6.3	2.3	3.5	0.8	2.1	1.2	1.5	0.7	3.7	2.4	2.5	2.9	4.7	2.0	8.2	2.6	2.0	1.5	2.4	4.3	5.3	5.9	3.9	6.9	2.1	3.7	2.4	0.3	5.5	1.2	2.0	3.4	1.0	1.4	3.3	1.3	2.6	3.5	14.8	8.8	2.6	2.6	1.7	1.3	0.8	5.2	2.4	1.6	2.4	2.7	1.9	5.8	0.6	11.5	0.6	1.8	0.4	0.9	0.5	0.3	0.6	0.6	1.1	0.8	0.1	0.2	1.1	18.4	0.5	0.7	8.3	13.5	8.9	10.9	6.6	7.7	5.9	8.1	5.4	2.2
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165325-12196144	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome			660000	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavourable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	19.6	22.0	17.4	18.6	21.2	13.5	20.2	15.4	21.4	16.7	20.4	16.1	15.2	17.3	10.0	16.5	25.8	16.3	12.1	10.0	16.2	14.3	26.0	57.1	16.8	22.7	21.7	12.8	12.5	16.9	19.1	35.7	19.9	18.5	13.4	24.2	13.2	16.7	19.7	5.1	20.6	15.9	11.6	17.9	22.4	14.1	8.0	21.5	28.2	19.1	16.5	29.5	16.2	18.6	22.4	45.9	50.1	19.5	16.2	37.0	20.4	37.3	27.6	33.0	30.7	32.0	31.6	29.3	27.7	17.7	32.7	35.1	39.6	35.7	37.4	24.1	22.4	37.6	46.0	42.9	30.0	30.6	45.0	31.1	33.9	58.1	33.4	20.6	21.9	33.2	25.6	35.6	18.2	41.6	41.6	25.6	29.7	34.3	38.6	24.2	28.7	17.2	35.3	12.0	43.4	30.5	12.9	15.9	23.9	33.6	25.9	38.5	44.4	21.3	26.0	13.9	26.7	38.8	33.8	21.6	37.9	50.3	29.3	26.9	10.3	8.1	19.1	33.5	22.8	19.5	26.2	22.4	24.6	26.8	27.0	18.3	17.0	23.0	50.1	16.2	14.8	45.9	37.0	20.4	17.4	21.2	15.4	21.4	16.2	14.3	21.7	12.8	18.5	21.5
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686734-68745809	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: "	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	18.3	12.6	10.2	16.5	13.2	18.7	17.4	20.7	15.2	19.0	12.2	12.1	12.2	9.2	18.6	18.0	14.0	16.6	8.5	12.1	12.2	6.6	12.1	11.1	12.5	21.4	13.2	10.2	19.8	12.5	14.2	16.2	23.5	12.2	12.6	15.3	11.3	13.0	11.8	13.9	14.8	15.8	13.7	12.5	19.7	12.0	20.5	15.9	40.6	12.5	13.1	22.5	17.8	13.1	13.6	7.0	9.5	14.2	20.6	17.0	8.0	17.0	22.0	26.3	19.0	7.8	10.0	28.5	18.7	10.8	28.2	23.6	22.1	14.5	31.3	18.3	8.9	19.7	29.5	13.8	37.6	29.3	21.9	35.7	15.8	18.5	4.9	31.4	12.1	5.2	6.6	22.5	14.8	16.8	42.5	22.6	17.6	20.7	25.8	27.5	28.9	21.6	26.5	31.6	18.8	12.2	18.2	15.5	15.9	20.7	15.6	11.2	23.4	15.2	10.2	15.4	15.7	17.8	22.7	9.9	19.7	37.9	11.8	23.0	18.1	6.3	6.5	9.5	13.1	8.5	17.0	13.5	13.0	14.0	7.0	13.6	16.2	14.5	1.7	20.6	14.2	5.5	13.4	8.0	10.2	13.2	20.7	15.2	12.2	6.6	13.2	10.2	12.2	15.9
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 70.9;BJ hTERT+ SV40 Large T+ RasG12V: 57.8;SK-MEL-30: 27.7;U-266/70: 25.8;U-266/84: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome				Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavourable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	37.9	3.8	4.0	13.9	5.1	9.0	7.2	1.8	4.9	8.5	4.3	7.5	1.2	4.6	9.0	6.9	13.2	3.9	9.6	6.9	3.8	4.4	8.8	9.9	15.6	24.1	5.0	3.7	3.9	1.9	1.2	2.9	22.2	7.3	6.6	4.7	6.9	32.9	1.8	2.2	2.9	8.8	6.4	7.1	36.6	9.7	2.2	3.0	32.4	9.8	8.2	27.4	13.7	5.4	12.0	12.7	2.0	26.8	15.1	17.4	13.2	0.7	0.1	0.0	0.0	0.3	2.6	0.0	0.1	8.0	70.9	57.8	0.1	1.2	17.8	1.7	1.5	0.8	0.1	0.2	2.5	4.4	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.3	4.0	0.0	1.1	0.0	9.3	0.0	0.3	0.5	1.0	0.0	2.5	3.8	0.0	2.7	0.0	6.3	0.0	0.0	0.7	0.2	27.7	0.6	1.1	1.8	0.1	0.0	0.3	0.0	25.8	22.2	2.8	0.6	0.9	0.6	2.0	15.9	1.2	13.4	26.8	16.8	12.0	15.4	15.2	12.7	8.9	15.2	11.2	1.8	15.1	26.0	5.3	17.4	13.2	4.0	5.1	1.8	4.9	3.8	4.4	5.0	3.7	7.3	3.0
OBSL1	KIAA0657	ENSG00000124006	"Obscurin like 1"	O75147	2	219550729-219571859	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 82.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.2;SK-BR-3: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.8;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.7;granulocytes: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036404, HPA036405"	Approved		Approved	Centrosome				Centrosome		"HPA036404: AB_10670437, HPA036405: "	"unprognostic (2.36e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (6.41e-4)"	"unprognostic (7.27e-3)"	"unprognostic (2.89e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.16e-1)"	10.7	26.9	13.4	7.0	11.5	1.2	11.7	18.0	16.2	17.6	8.7	10.3	10.5	3.8	18.2	23.3	7.3	19.9	14.5	30.7	12.8	8.2	19.6	14.5	9.3	3.4	5.5	10.9	82.2	35.6	23.5	16.6	19.3	11.5	15.1	2.3	19.1	25.5	19.1	21.0	14.8	4.8	10.5	8.8	8.2	10.3	15.5	11.5	0.8	34.1	12.4	2.6	10.1	12.1	0.1	2.7	6.8	0.4	0.1	0.2	0.0	9.5	6.5	11.9	24.8	8.3	6.1	45.2	7.2	10.6	9.2	8.6	5.6	15.0	0.0	15.3	9.8	9.8	9.2	5.4	1.9	0.0	16.1	20.8	6.2	28.4	6.2	0.5	0.1	16.5	4.5	2.1	3.5	1.0	8.5	0.2	6.5	23.7	0.0	5.9	28.3	6.7	10.6	10.5	0.0	16.7	9.1	5.2	17.9	8.2	43.9	16.5	4.0	18.0	2.4	9.8	10.6	3.1	2.8	0.0	0.0	0.0	5.7	0.0	9.7	6.8	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.8	0.1	0.4	2.7	0.0	0.0	13.4	11.5	18.0	16.2	12.8	8.2	5.5	10.9	11.5	11.5
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 101.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Centrosome				Centrosome		"HPA001874: AB_1079522, HPA048841: "	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	6.2	4.8	5.6	9.9	6.7	10.2	7.0	14.3	7.7	7.1	5.7	6.7	5.4	4.0	9.7	6.4	5.2	8.8	5.7	5.7	6.3	5.1	4.7	6.7	5.8	8.9	6.2	4.1	6.4	5.1	7.6	18.2	6.0	7.5	6.6	6.0	5.4	5.3	8.3	3.7	7.2	5.3	8.0	5.2	7.3	5.7	101.1	7.1	18.4	5.5	3.7	9.6	6.4	6.4	8.3	8.8	16.0	16.3	11.0	14.6	9.1	14.5	17.7	29.6	33.6	11.8	14.2	23.8	24.6	11.5	20.5	10.8	17.4	10.8	26.2	9.3	19.9	38.4	21.5	14.6	20.9	17.3	10.0	23.3	26.8	14.5	6.8	25.1	29.4	11.6	9.3	21.7	15.4	17.8	27.4	14.8	19.3	44.7	26.6	30.7	11.5	12.8	24.4	28.5	20.3	10.6	11.3	17.8	15.2	23.0	22.1	8.0	20.6	18.3	16.9	25.6	15.8	29.4	23.8	27.7	39.8	18.9	11.7	22.9	22.2	16.0	8.9	9.8	12.4	13.4	14.6	8.3	10.9	12.9	8.8	8.2	7.9	10.0	3.1	11.0	16.3	8.4	8.0	9.1	5.6	6.7	14.3	7.7	6.3	5.1	6.2	4.1	7.5	7.1
OR4N4		ENSG00000183706	"Olfactory receptor family 4 subfamily N member 4"	Q8N0Y3	15	22094522-22095472	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	22	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.7;THP-1: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome				Centrosome		"HPA057442: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome			1100000	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favourable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	20.1	20.4	35.6	17.0	40.8	10.0	20.8	57.1	63.7	22.3	21.5	24.2	13.8	19.2	23.8	21.1	21.9	20.1	19.6	28.8	33.7	38.3	24.7	17.2	23.0	18.2	34.3	47.0	22.4	16.4	37.5	26.2	20.2	46.5	20.9	20.9	14.8	17.6	24.1	41.6	27.2	21.9	27.2	29.9	17.9	19.3	37.2	28.0	25.9	26.9	17.3	22.8	18.6	25.5	7.5	3.5	9.3	5.3	8.7	13.3	3.9	22.1	21.1	32.6	12.1	25.7	30.4	17.0	30.8	27.0	26.9	27.8	25.7	10.3	25.0	25.7	38.0	23.1	28.5	23.0	33.7	20.9	18.1	20.3	21.5	9.8	26.6	14.1	35.7	26.5	29.3	27.1	32.3	23.5	15.0	28.2	33.1	9.1	22.2	10.5	14.6	10.3	15.9	25.2	12.9	23.6	12.4	14.7	24.1	26.7	13.3	24.3	14.2	11.0	33.2	29.5	14.2	23.1	26.5	12.0	18.5	19.6	23.8	13.1	28.4	7.8	3.4	6.5	7.7	4.3	9.7	7.5	10.1	8.3	3.5	5.2	9.5	8.1	9.3	8.7	5.3	2.7	13.3	3.9	35.6	40.8	57.1	46.2	33.7	38.3	34.3	47.0	46.5	28.0
PAOX	PAO	ENSG00000148832	"Polyamine oxidase"	Q6QHF9	10	133379234-133391694	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Cell line enhanced"	"Detected in many"		"A-431: 6.2;U-266/70: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047782			Uncertain	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA047782: "	"unprognostic (3.67e-3)"	"prognostic favourable (6.07e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-2)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.20e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (9.49e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.29e-3)"	6.7	4.1	4.3	5.8	6.7	1.5	4.7	6.8	8.7	3.7	6.0	10.8	5.6	5.6	3.7	1.8	7.4	3.4	2.4	2.5	5.7	2.7	8.9	9.2	2.8	5.2	10.0	3.4	3.6	3.2	1.9	2.5	2.1	4.2	4.8	1.5	2.8	9.9	5.1	3.5	4.4	8.5	2.8	4.7	8.2	7.5	36.7	7.6	0.7	2.4	2.1	5.4	4.6	4.2	4.3	1.1	1.0	1.0	1.7	0.3	0.4	6.2	0.0	0.2	1.2	0.0	0.7	1.6	2.8	1.2	1.4	0.2	1.1	0.1	0.0	0.9	0.6	3.5	0.4	0.8	0.6	4.1	0.5	0.5	0.0	0.2	1.7	0.0	1.0	0.1	0.3	0.9	0.4	0.1	4.9	0.3	0.0	0.1	0.0	0.1	1.2	3.0	4.6	0.0	0.0	0.1	0.0	0.3	2.2	0.9	0.1	0.0	1.3	0.0	2.7	0.3	1.4	1.2	0.0	18.1	3.3	1.7	0.0	0.0	0.1	1.0	0.3	0.0	0.2	1.0	0.0	1.6	0.3	0.2	1.1	4.3	0.0	0.0	0.0	1.7	0.9	0.8	0.0	0.4	4.3	6.7	6.8	6.5	5.7	2.7	10.0	3.4	4.2	7.6
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 16.5;brain: 47.0"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive B-cell: 16.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome			1300000	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	4.5	3.2	18.4	1.1	24.7	4.1	1.5	6.7	47.0	1.8	1.3	7.8	0.0	0.9	1.0	2.1	1.0	1.1	2.4	5.7	15.0	10.0	3.5	2.3	2.3	1.4	21.4	11.0	1.4	2.0	0.7	1.3	0.7	16.6	2.5	1.3	0.0	1.0	5.6	2.0	0.9	1.0	1.2	11.0	1.6	1.7	1.6	18.9	0.7	1.8	0.0	1.4	1.1	0.6	16.5	1.0	2.5	0.0	0.7	0.1	0.2	0.0	9.3	12.4	0.0	3.3	2.6	0.0	1.8	0.1	1.3	0.5	0.0	0.0	2.7	0.0	1.4	0.0	1.0	0.3	0.6	0.0	4.9	0.1	0.1	0.0	3.2	0.3	0.1	6.1	0.3	1.5	2.5	1.0	0.3	0.1	20.3	0.7	5.6	0.0	0.1	1.2	8.5	0.4	0.0	0.2	0.0	1.6	0.6	0.0	0.1	0.1	0.0	0.0	23.6	0.7	0.6	2.9	0.9	3.6	0.0	31.0	5.3	0.0	2.4	2.5	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	16.5	0.1	0.1	0.1	0.7	0.0	1.0	0.0	0.2	18.4	24.7	6.7	24.6	15.0	10.0	21.4	11.0	16.6	18.9
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364311-64387687	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.1;lymphoid tissue: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"T-reg: 24.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 24.2"									HPA047929			Supported	Centrosome				Centrosome		"HPA047929: "	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.8	0.7	24.5	0.8	42.1	2.6	0.4	0.8	1.8	7.7	0.6	1.0	4.6	1.6	2.8	18.8	0.6	4.0	2.2	0.8	1.0	2.5	3.0	4.0	21.8	1.4	0.4	0.9	1.4	0.1	0.6	5.1	0.7	1.6	10.1	0.5	3.1	0.4	0.9	2.8	8.1	1.6	1.9	10.9	4.9	3.0	0.5	78.3	1.2	18.0	20.7	4.3	5.7	2.2	3.2	2.0	0.4	5.2	24.2	2.7	30.4	35.2	30.0	19.1	3.1	11.3	21.9	23.5	20.9	45.3	65.8	39.5	29.0	58.5	8.4	11.9	22.9	74.7	18.2	51.3	37.1	26.8	57.3	37.1	34.0	0.3	37.7	21.2	3.8	1.9	35.8	7.2	34.4	35.2	21.5	52.1	35.1	45.6	84.6	11.1	15.3	59.6	56.8	38.4	21.5	31.5	2.9	15.4	18.6	14.8	10.8	20.9	52.4	4.8	22.5	47.2	27.2	62.7	11.7	40.6	36.6	9.3	83.2	15.1	2.0	0.2	1.2	1.6	0.1	0.2	2.2	4.8	4.5	3.2	0.5	0.4	0.8	1.6	5.2	0.4	0.2	24.2	2.7	0.7	0.8	0.4	0.8	0.8	1.0	1.4	0.4	0.7	0.5
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"				Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.3	21.7	33.4	44.2	18.9	19.7	17.3	17.2	21.2	18.4	20.8	14.7	12.2	26.7	11.9	17.1	14.8	21.3	15.8	31.4	8.8	8.2	45.8	15.4	29.8	21.1	20.0	11.8	17.1	16.9	21.3	23.7	21.1	30.9	20.8	22.4	10.2	42.9	33.2	27.5	6.3	25.9	29.9	9.5	15.2	28.3	25.6	19.3	18.4	10.1	26.4	15.9	29.3	18.8	16.8	13.7	20.5	14.5	8.9	19.6	23.9	14.2	22.1	17.1	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome				Centrosome		"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: "	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.2	7.3	11.3	6.9	5.7	5.8	7.1	7.2	5.0	7.2	6.4	8.8	6.0	9.3	4.6	8.2	6.7	9.1	6.2	5.0	27.0	12.8	24.6	13.6	6.8	1.9	12.4	10.2	3.1	4.7	9.6	4.8	5.5	12.4	14.0	9.8	15.4	12.2	12.8	11.2	5.0	15.2	4.6	8.1	5.6	10.0	13.9	6.2	15.5	9.7	4.7	9.2	9.7	7.5	12.9	6.5	7.3	11.4	12.1	10.1	10.0	8.0	12.2	6.9	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Supported	"Intermediate filaments,Centrosome"			7000	Centrosome	"Intermediate filaments"	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	12.1	7.0	5.6	15.8	28.2	14.9	8.3	8.7	18.8	12.3	14.6	27.4	12.7	4.2	4.8	9.1	10.0	8.5	16.2	7.1	1.2	6.9	9.2	9.6	62.6	30.2	9.2	7.7	12.2	9.4	11.1	8.6	11.3	17.0	8.8	9.1	10.3	10.9	11.4	4.5	7.5	7.2	6.0	15.0	14.7	23.0	7.2	6.6	6.6	36.4	8.5	10.1	21.9	7.6	9.1	6.0	6.8	7.2	5.7	2.4	4.1	9.4	12.4	8.9	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.9;HBEC3-KT: 13.5;HHSteC: 10.2;HUVEC TERT2: 23.8;TIME: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"			35000000	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavourable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	18.5	7.1	1.8	3.0	5.1	2.8	29.2	1.2	2.9	16.5	5.8	2.7	6.3	2.3	15.9	10.5	6.6	8.9	10.3	11.1	2.7	1.8	6.8	3.8	12.0	10.1	3.2	2.1	10.6	3.2	1.7	3.9	15.5	3.7	9.6	1.4	15.5	4.1	5.5	11.4	4.4	4.1	9.6	3.1	12.2	4.1	8.1	1.5	0.6	10.5	5.8	2.1	6.7	11.5	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.2	1.3	0.3	0.0	0.0	1.7	0.0	5.2	8.9	2.2	1.3	0.1	0.2	0.0	0.2	3.9	0.1	0.0	13.5	0.6	0.0	0.0	6.5	0.2	0.3	10.2	0.0	0.0	5.3	0.0	3.0	0.7	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	38.4	0.0	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	1.8	5.1	1.2	2.9	2.7	1.8	3.2	2.1	3.7	1.5
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: "	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.6	3.1	3.0	2.0	2.5	2.5	2.7	4.2	2.6	2.4	5.6	1.5	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	2.2	4.6	5.0	4.1	1.4	3.8	5.5	1.0	2.7	5.6	3.5	2.1	2.6	4.3	3.7	3.4	1.6	3.6	1.1	3.5	3.6	2.6	6.1	3.5	3.2	2.1	5.9	3.8	2.3	5.4	5.3	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19.0	8.3	10.7	6.7	2.0	11.4	11.0	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46.0	8.8	5.8	20.7	12.0	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160904-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;ASC TERT1: 17.2;HSkMC: 12.2;hTERT-HME1: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: "	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	1.9	3.6	2.4	3.5	2.9	2.1	2.5	11.0	2.7	7.6	3.8	4.1	9.0	3.4	3.4	9.8	2.0	7.5	2.1	6.8	1.9	1.8	3.7	1.2	4.6	6.7	4.8	2.1	11.6	2.2	2.1	17.8	8.0	4.6	5.1	1.6	7.9	7.5	9.2	1.4	3.4	5.5	2.5	6.3	6.2	3.0	5.2	4.5	11.7	3.5	1.5	5.2	4.8	7.0	3.5	0.2	1.1	0.5	0.7	4.6	1.0	1.5	0.0	9.5	0.1	13.0	17.2	3.0	4.2	5.5	2.0	0.9	0.6	4.9	0.2	4.1	2.3	0.3	2.6	5.6	2.0	0.1	5.8	6.0	0.5	1.4	2.7	1.9	1.8	12.2	3.1	1.1	12.6	3.7	2.5	0.1	4.2	0.0	0.5	3.6	2.7	1.4	4.7	0.7	3.7	2.6	0.5	0.1	0.0	0.1	0.0	0.3	0.1	1.8	5.6	2.9	3.8	4.7	1.0	1.5	1.1	2.2	3.3	0.7	0.8	1.1	0.1	1.1	0.3	0.1	0.2	3.5	1.0	0.6	0.1	2.0	4.6	4.3	1.0	0.7	0.5	0.2	0.2	1.0	2.4	2.9	11.0	2.7	1.9	1.8	4.8	2.1	4.6	4.5
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: , HPA065323: , HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favourable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	12.8	2.9	17.2	7.8	36.9	11.4	19.8	7.3	29.4	15.2	15.9	67.3	9.3	10.2	31.6	9.9	26.4	19.8	17.5	12.5	24.2	12.8	19.5	16.5	8.4	4.0	40.7	21.6	16.8	22.7	17.9	3.7	22.3	19.5	12.3	12.1	13.6	19.6	31.6	5.9	19.6	10.0	20.7	24.5	16.0	11.5	5.1	40.9	1.2	14.5	6.4	5.3	16.6	17.1	0.0	0.7	16.7	1.9	6.4	12.2	2.9	28.5	13.3	11.1	16.8	1.2	0.0	19.3	3.2	3.8	5.1	4.1	14.0	12.6	0.0	5.8	3.1	27.6	7.5	25.4	1.7	0.0	6.5	12.7	16.4	3.3	1.5	0.4	6.1	1.5	14.8	1.0	9.2	3.3	0.0	0.1	1.7	13.5	0.0	11.6	3.7	14.2	0.1	5.5	1.9	14.0	20.9	3.8	6.8	6.6	9.9	9.5	10.8	2.8	6.4	2.2	23.0	0.1	4.4	0.0	0.0	0.0	0.2	1.3	3.9	4.5	1.9	11.7	12.2	1.1	8.6	0.0	3.7	5.2	0.7	0.0	0.4	2.7	16.7	6.4	0.7	0.0	1.1	2.9	17.2	36.9	7.3	29.4	24.2	12.8	40.7	21.6	19.5	40.9
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"				"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: "	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	55.6	0.1	0.0	0.1	0.1	17.6	9.7	0.1	0.1	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	0.3	0.0	0.0	0.1	0.0	18.7	0.1	0.0	0.4	8.3	0.1	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
PLEKHH1	KIAA1200	ENSG00000054690	"Pleckstrin homology, MyTH4 and FERM domain containing H1"	Q9ULM0	14	67533301-67589612	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.0;thyroid gland: 30.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.9;BEWO: 9.6;RT4: 9.7;SK-MEL-30: 12.0;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047707, HPA051964"	Uncertain		Approved	Centrosome				Centrosome		"HPA047707: , HPA051964: "	"unprognostic (2.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-2)"	"prognostic favourable (8.03e-5)"	"unprognostic (4.74e-1)"	"unprognostic (9.15e-3)"	"unprognostic (8.43e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.03e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.26e-4)"	1.3	4.5	9.7	1.6	33.7	0.5	2.9	8.6	26.8	3.5	6.8	61.0	2.5	11.6	1.9	8.9	1.6	3.8	2.5	1.1	16.2	8.7	2.7	0.8	1.2	0.6	35.8	16.6	0.6	7.7	10.3	3.3	2.0	26.9	10.7	7.0	5.1	20.3	2.9	1.1	4.1	9.0	1.3	38.1	1.3	6.6	2.3	34.4	0.0	30.2	0.0	0.7	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.2	2.0	9.9	0.2	0.0	9.6	0.0	0.0	0.1	0.1	3.1	1.5	0.0	1.6	0.0	2.2	3.5	0.8	0.1	0.3	3.4	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	3.7	0.0	0.0	7.1	0.0	0.2	3.0	0.6	0.1	0.3	1.4	1.1	9.7	2.7	2.5	0.8	1.8	12.0	9.5	2.0	0.0	0.8	3.6	0.9	0.6	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	33.7	8.6	18.1	16.2	8.7	35.8	16.6	26.9	34.4
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome				Centrosome	Vesicles	"HPA037583: AB_10671762"	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.3	0.2	9.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	4.3	0.1	1.4	16.9	0.1	0.2	0.1	1.4	0.1	5.8	0.0	0.0	0.3	0.1	0.0	0.3	3.4	0.1	0.0	0.0	0.0	2.0	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA017327: , HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"			53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"monocytes: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"		140000	Centrosome		"HPA054519: , HPA059935: "	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	15.9	13.5	8.2	15.5	8.9	7.4	19.4	6.6	11.3	15.5	20.2	13.1	10.4	16.4	18.1	19.6	13.9	17.4	23.6	20.1	7.5	6.3	18.8	44.6	14.8	22.2	8.8	6.6	18.3	24.6	19.2	11.3	22.4	7.8	16.0	16.0	16.9	13.3	16.0	13.5	13.3	27.5	20.8	7.7	12.4	12.5	16.5	7.0	12.7	20.1	13.9	13.0	15.7	12.6	2.8	3.9	3.3	16.4	1.7	3.3	3.2	15.0	12.1	10.5	11.5	18.1	17.7	19.7	15.6	18.6	26.4	17.4	36.2	20.4	10.2	23.6	17.4	16.8	10.1	19.3	23.0	5.2	6.3	15.2	11.1	16.4	14.1	13.0	9.7	15.5	15.3	20.0	13.1	14.7	11.4	5.8	18.4	7.4	8.9	10.0	5.4	19.7	7.5	28.0	9.4	8.1	10.0	6.9	8.9	35.9	10.0	13.3	14.8	15.6	12.7	38.4	14.3	24.0	26.5	7.2	9.1	9.4	23.2	45.3	24.2	3.3	4.4	2.1	2.9	12.8	3.3	2.8	2.6	2.7	3.9	2.4	3.3	2.4	0.9	1.7	16.4	2.9	2.7	3.2	8.2	8.9	6.6	11.3	7.5	6.3	8.8	6.6	7.8	7.0
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome				Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favourable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.1	10.9	10.1	14.7	11.1	10.1	6.7	13.6	12.7	23.2	18.7	22.0	5.3	13.8	10.7	22.8	7.4	18.5	22.2	14.6	12.5	22.8	8.2	17.3	10.5	11.5	34.1	14.1	12.6	14.5	30.5	8.2	11.3	17.3	8.9	12.9	15.4	8.7	9.3	7.1	14.2	13.4	7.9	14.3	10.8	9.5	9.8	5.8	17.7	18.0	8.6	7.2	9.7	10.1	13.9	15.0	24.0	18.0	6.7	12.5	20.8	24.2	12.2	13.1	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.9"	"Cell line enhanced"	"Detected in all"		"U-698: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane, Centrosome"	"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favourable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	31.6	7.2	7.1	7.6	9.8	7.7	13.5	14.8	7.1	7.9	8.2	13.6	5.7	7.7	6.3	5.6	7.9	5.0	7.8	4.6	7.4	5.0	10.3	94.9	5.4	6.2	12.6	3.4	8.7	18.5	5.4	19.4	6.7	9.8	4.6	8.5	6.6	8.8	4.0	6.2	6.7	9.4	5.9	8.7	4.2	11.9	28.6	13.9	10.1	6.1	7.2	9.4	6.0	5.1	11.5	14.7	9.9	11.9	14.1	14.3	12.0	12.8	8.6	12.4	8.4	12.5	6.8	12.5	12.7	8.9	9.5	8.7	29.2	13.5	16.3	9.6	8.2	12.2	18.4	10.4	12.2	11.2	5.7	15.9	5.1	12.7	6.2	18.5	12.7	7.7	6.3	10.7	7.9	11.7	19.2	21.7	10.4	4.2	20.0	7.5	15.3	9.4	15.4	8.3	19.9	14.1	14.2	4.1	11.0	11.4	10.5	2.1	12.1	6.9	12.6	11.1	13.4	5.5	8.1	2.3	5.7	59.6	3.9	21.7	14.0	5.4	10.0	9.9	13.7	11.9	13.4	10.4	13.9	12.7	14.7	11.5	12.3	13.1	2.5	14.1	10.7	6.3	14.3	12.0	7.1	9.8	14.8	7.1	7.4	5.0	12.6	3.4	9.8	13.9
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"				"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	11.9	10.4	12.1	10.6	13.1	8.1	10.9	17.5	13.1	11.2	11.4	8.6	7.4	11.5	8.8	7.8	12.0	12.5	9.1	5.3	12.8		12.7	18.1	8.3	13.0	13.3	7.9	10.8	13.6	10.7	11.7	11.1	11.4	9.5	10.6	7.8	9.6	9.1	6.0	11.0	14.4	10.3	11.1	10.8	11.0	8.0	12.3	18.7	12.6	6.2	14.3	11.3	10.0	17.6	16.9	23.9	19.6	20.0	25.3	21.6	19.7	15.4	17.0	14.3	18.2	19.2	23.4	15.9	17.4	13.8	11.8	18.1	19.1	26.8	32.4	15.7	17.2	19.3	13.1	20.7	38.5	8.1	26.7	14.5	24.2	29.5	30.4	22.2	14.8	31.7	16.8	29.1	21.6	25.3	27.2	18.2	23.1	19.6	20.0	16.7	12.2	18.3	25.7	20.2	19.0	20.7	21.2	12.9	17.3	24.0	25.8	15.1	24.7	16.9	21.2	27.2	10.4	21.9	28.1	21.1	10.3	19.8	29.0	22.5	21.2	15.6	23.9	20.4	19.6	23.0	17.6	21.5	21.2	16.9	16.9	25.3	22.0	18.1	20.0	19.3	9.2	21.5	21.6										
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome			8200000	"Nucleoplasm, Centrosome"		"HPA049518: , HPA061796: "	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.85e-4)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.1	47.1	33.7	31.9	45.4	39.2	33.3	31.6	37.6	55.8	47.4	39.6	35.2	27.5	29.5	42.9	30.2	53.8	39.4	53.9	16.8	37.2	17.4	34.4	139.6	35.9	21.1	21.0	43.7	37.0	41.3	34.5	57.6	26.2	15.6	45.6	65.1	12.0	29.0	37.4	76.4	16.2	25.4	18.3	43.3	32.1	43.0	33.5	22.2	45.2	30.3	21.8	27.5	30.9	27.3	27.8	25.2	31.0	13.5	26.8	20.6	21.3	17.1	33.8	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"				"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: "	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (1.09e-4)"	"prognostic unfavourable (3.72e-5)"	"prognostic unfavourable (7.12e-5)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	32.6	16.2	5.8	5.8	11.7	30.4	39.3	27.6	24.1	22.5	11.9	18.9	20.5	2.2	18.2	28.1	23.3	4.0	50.3	18.0	1.8	3.6	0.4	11.9	6.7	16.9	0.5	0.7	14.8	33.0	23.6	26.8	40.0	5.7	3.7	44.0	21.6	2.0	0.7	8.2	56.3	4.8	9.6	2.0	23.1	31.4	9.5	2.8	24.8	7.6	14.9	18.8	2.7	52.7	15.7	17.2	19.5	32.9	4.0	2.2	0.8	45.1	4.9	30.6	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome				Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.1	6.4	8.8	12.7	5.7	7.2	12.4	7.0	7.2	9.4	9.4	7.4	5.1	20.5	6.4	7.8	10.9	13.1	8.5	11.9	9.7	10.0	10.0	6.8	7.6	9.0	22.5	9.0	7.0	13.3	10.0	14.8	6.6	18.0	6.7	7.7	6.9	7.2	11.0	9.2	7.5	19.7	11.3	5.2	10.2	7.1	7.7	7.9	5.6	13.1	10.3	8.6	17.5	6.5	6.7	5.5	7.1	10.8	3.9	5.5	12.0	9.1	15.3	9.9	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7
RAB22A		ENSG00000124209	"RAB22A, member RAS oncogene family"	Q9UL26	20	58309696-58367507	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058894, HPA066920"	Approved		Uncertain	Centrosome				Centrosome		"HPA058894: , HPA066920: "	"unprognostic (4.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.20e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.01e-3)"	12.4	19.3	19.1	9.5	21.5	7.7	12.4	11.9	23.0	12.8	13.2	15.9	5.9	13.0	11.5	15.3	19.3	9.3	10.7	8.6	17.6	17.0	14.2	13.6	11.1	9.9	16.5	10.3	11.3	10.4	27.7	15.1	11.3	18.1	10.4	13.1	6.8	11.3	11.2	7.8	13.8	17.3	11.1	17.1	10.9	12.7	9.9	13.4	11.8	16.0	11.6	12.9	10.7	12.6	4.3	3.6	5.2	5.1	5.8	6.3	2.1	11.0	4.6	5.8	3.8	12.1	11.4	3.4	8.4	9.7	11.6	7.0	7.6	7.7	6.1	10.5	11.7	8.9	3.0	13.2	13.2	4.1	2.9	4.3	6.5	6.0	9.4	5.3	7.6	7.7	16.2	8.2	8.5	7.2	3.7	8.8	12.0	15.8	6.2	5.0	1.4	11.4	3.3	5.7	5.3	7.2	7.1	4.4	6.0	11.8	22.4	9.7	8.2	7.3	11.4	19.2	7.9	11.9	10.0	7.7	10.5	4.1	19.7	5.1	6.5	3.1	2.9	2.1	6.3	3.3	5.8	4.3	4.7	5.4	3.6	3.8	4.4	5.3	5.2	5.8	5.1	2.9	3.8	2.1	19.1	21.5	11.9	23.0	17.6	17.0	16.5	10.3	18.1	13.4
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7"	"Cell line enhanced"	"Detected in many"		"A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"			"Vesicles, Plasma membrane"	Centrosome	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.6	1.0	13.6	0.4	19.9	0.5	0.9	30.5	13.5	2.0	4.1	0.5	1.5	5.7	0.4	2.3	1.2	0.9	1.1	1.2	18.0	6.2	0.7	21.9	0.6	0.6	5.6	9.1	0.6	24.6	3.1	9.2	0.3	2.5	2.2	5.4	0.7	17.7	1.6	1.1	1.2	6.0	0.4	1.9	0.6	5.3	0.6	3.2	0.0	1.2	0.0	1.1	0.9	0.0	0.8	0.2	0.0	0.1	0.0	1.1	0.7	1.1	13.6	0.0	3.5	0.2	0.1	0.1	0.6	1.1	0.5	0.9	0.4	2.7	0.2	0.9	0.8	2.2	0.7	0.2	0.0	1.5	1.4	0.5	14.9	1.2	0.6	0.0	0.4	0.5	0.1	0.1	0.2	0.3	0.3	0.0	1.6	8.9	0.0	0.6	0.8	1.2	1.1	1.1	2.3	5.2	0.9	18.9	3.7	0.3	17.1	0.6	5.6	0.2	0.6	0.0	2.5	0.2	0.2	2.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	13.6	19.9	30.5	13.5	18.0	6.2	5.6	9.1	2.5	3.2
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204074	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 114.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.3	13.0	32.3	2.6	50.5	2.0	2.0	39.1	114.7	2.8	3.1	6.3	0.0	3.6	2.7	2.6	2.4	3.2	2.8	17.0	40.8	32.7	4.1	2.2	2.5	2.4	31.5	35.6	8.0	2.3	5.0	7.5	2.4	38.2	3.8	2.8	5.8	4.2	4.4	7.5	2.5	3.0	2.9	7.0	2.5	2.5	2.2	4.8	0.0	2.9	0.1	2.1	2.9	0.7	4.6	6.0	5.1	3.0	0.7	4.2	2.6	0.9	1.0	2.3	3.2	3.8	1.0	1.4	2.0	1.2	1.4	1.9	0.9	0.5	3.3	2.2	1.6	2.7	10.7	1.3	0.7	0.7	3.4	1.3	3.9	3.7	0.9	2.2	4.1	3.1	1.3	0.8	0.4	0.4	0.7	1.1	1.3	3.2	5.0	0.6	1.9	13.5	3.5	0.2	2.8	1.5	0.5	24.7	11.8	1.0	4.3	2.3	0.9	0.4	0.4	1.2	0.9	17.1	1.1	2.1	4.5	0.8	3.2	1.7	1.1	0.0	3.0	3.8	3.0	2.2	4.0	4.6	3.2	3.0	6.0	2.2	4.1	4.2	5.1	0.7	2.7	5.5	1.8	2.6	32.3	50.5	39.1	95.0	40.8	32.7	31.5	35.6	38.2	4.8
RABL2A		ENSG00000144134	"RAB, member of RAS oncogene family like 2A"	Q9UBK7	2	113627229-113643396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome				Centrosome	Vesicles	"HPA042642: , HPA042700: , HPA044007: "	"unprognostic (7.76e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.77e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.78e-3)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.19e-5)"	2.2	1.7	6.0	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9.0	2.7	29.3	2.8	3.3	7.0	6.0	3.5	3.4	12.9	1.8	4.0	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2.0	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2.0	5.5	2.0	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.5	4.3	5.9	4.7	4.9	7.2	4.5	2.4	2.0	3.4	2.5	3.7	1.6	3.6	10.3	0.8	2.7	3.0	0.3	2.3	5.0	5.7	1.8	0.1	0.5	4.0	0.7	1.3	2.5	5.1	0.7	1.5	2.5	1.7	0.9	2.1	2.1	12.0	0.9	3.3	1.5	2.2	2.3	1.6	2.4	0.6	2.4	8.3	2.3	2.5	2.1	0.5	3.4	0.6	0.4	0.8	0.9	1.6	3.6	3.7	0.8	7.0	2.7	1.2	0.0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8.0	8.6	6.8	0.5	12.2	7.2	9.8	5.0	5.5	6.0	9.5	6.3	20.9	7.0	6.0	4.0	7.5	6.4	4.3
RABL2B		ENSG00000079974	"RAB, member of RAS oncogene family like 2B"	Q9UNT1	22	50767501-50783663	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome				Centrosome	Vesicles	"HPA042642: , HPA042700: , HPA044007: "	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.86e-3)"	"prognostic favourable (5.58e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (4.58e-5)"	"unprognostic (3.14e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.37e-3)"	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13.0	8.4	12.7	12.6	7.9	13.9	59.0	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7.0	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10.0	11.0	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.4	12.3	21.0	16.4	23.6	18.8	15.4	10.1	11.3	8.2	11.3	3.4	11.9	8.7	9.0	14.5	17.7	9.6	11.8	8.9	7.5	13.6	7.5	21.1	8.9	9.8	21.1	8.1	16.0	16.2	10.8	13.6	9.1	5.7	11.0	16.3	17.0	10.5	9.3	8.0	9.2	17.8	12.1	9.1	15.9	13.4	9.0	16.4	12.4	11.0	7.6	10.8	6.6	14.0	7.9	15.8	6.7	6.8	9.3	4.3	4.2	14.9	5.3	11.0	1.0	10.9	9.2	16.8	17.4	12.2	11.2	13.0	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13.0	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.0	25.3	18.1	21.2	7.4	8.4	47.7	17.3	11.1	16.8	12.3	28.2	20.2	27.0	10.9	13.4	41.7	20.2	15.2	5.8	28.0	26.0	16.5	31.6	32.9	13.4	30.5	21.2	9.3	15.8	10.4	11.6	17.4	35.8	13.2	11.5	38.0	32.6	21.1	34.0	21.8	42.7	21.7	26.3	11.1	16.9	59.8	24.8	30.5	35.9	21.3	30.8	30.8	21.1	21.8	19.0	22.9	27.9	11.3	12.9	21.9	18.3	14.9	20.3	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.4;NK-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057169			Supported	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles, Centrosome"		"HPA057169: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	16.7	8.0	28.4	8.8	23.8	51.0	16.3	21.5	34.1	12.6	14.5	11.3	10.4	10.9	12.7	7.3	9.9	10.2	14.1	14.9	23.4	15.3	16.4	20.9	18.1	8.5	14.1	29.6	10.2	13.4	20.7	13.8	26.1	16.9	9.3	14.8	10.0	18.7	9.4	15.7	12.7	11.9	14.0	13.9	19.2	13.7	6.7	14.3	9.3	27.5	8.9	7.8	11.9	13.8	0.4	1.4	9.4	1.4	5.2	1.5	0.3	3.2	4.4	21.1	6.5	8.3	9.4	32.4	6.3	8.0	5.8	4.2	13.6	7.3	18.6	2.3	6.3	3.0	7.1	8.1	6.9	3.1	5.0	28.9	9.3	7.8	6.0	3.5	40.0	5.4	4.6	13.9	4.9	16.5	6.3	17.4	7.1	5.7	8.7	0.5	9.0	4.4	7.1	5.3	0.7	5.2	7.5	6.0	8.0	9.3	4.5	7.7	2.2	2.3	17.5	9.2	9.7	11.7	5.2	19.4	11.5	0.3	10.9	1.5	5.5	2.7	1.4	1.0	0.8	0.8	1.0	0.4	0.7	0.5	0.8	0.3	0.9	0.4	9.4	5.2	0.9	1.4	1.5	0.3	28.4	23.8	21.5	34.1	23.4	15.3	14.1	29.6	16.9	14.3
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635236	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	7.2	7.3	8.4	15.2	11.2	15.7	9.9	34.1	12.7	7.2	6.7	13.7	6.1	5.0	6.9	5.9	6.5	6.1	7.7	6.6	9.4	10.5	6.2	8.4	9.5	24.6	13.1	9.0	8.6	6.2	12.5	9.5	8.0	17.1	7.2	7.8	5.4	6.9	7.9	6.9	8.1	7.3	6.9	10.9	11.3	6.5	19.7	14.5	21.2	7.1	5.5	22.0	7.7	7.2	5.4	1.6	8.7	2.0	5.3	14.2	5.4	6.9	5.0	7.1	6.6	3.7	4.2	6.8	7.7	6.1	6.6	10.0	9.1	4.9	16.2	5.2	5.1	5.6	9.9	8.0	13.4	7.9	5.4	10.2	7.3	4.9	3.0	7.1	10.8	3.1	3.8	9.6	9.3	5.8	5.8	9.8	5.8	3.5	7.3	5.7	3.1	3.8	10.9	10.2	8.6	4.8	5.5	24.5	5.6	8.0	3.6	9.5	5.1	6.2	5.7	8.7	6.2	7.0	8.8	5.7	6.8	17.7	5.0	9.4	7.4	1.4	1.7	6.3	6.3	2.0	10.7	4.5	8.5	6.8	1.4	5.4	14.2	10.1	8.7	5.3	1.5	1.6	9.6	5.4	8.4	11.2	34.1	12.7	9.4	10.5	13.1	9.0	17.1	14.5
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enriched"	"Detected in some"	4	"RH-30: 71.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 43.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	43.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8										
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3;bone marrow: 55.8"	"Group enriched"	"Detected in many"	5	"MOLT-4: 14.8;U-937: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"neutrophil: 81.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 81.3"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	1.6	1.0	0.5	9.8	0.6	55.8	0.6	1.0	0.8	0.4	1.0	0.2	0.0	1.3	1.0	1.0	1.1	1.2	1.8	10.8	0.5	0.5	0.8	1.5	6.7	19.9	0.6	0.0	1.4	1.0	0.0	0.7	0.8	0.5	0.5	0.2	0.4	2.2	0.0	0.8	1.9	4.1	0.0	0.6	21.6	0.9	18.4	0.3	11.1	1.0	0.3	8.9	1.1	3.6	0.9	0.8	81.3	12.0	4.8	17.8	5.8	0.9	0.3	3.4	1.5	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.6	1.1	0.2	0.0	1.6	0.0	0.0	0.0	1.1	2.1	0.5	1.2	0.2	0.0	1.9	2.3	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.5	14.8	2.1	0.2	0.4	5.3	1.2	0.8	0.0	1.0	1.0	1.6	1.0	2.2	0.3	0.7	1.1	1.4	1.9	1.2	1.3	0.6	3.1	0.5	0.7	1.1	34.8	0.9	11.8	0.4	58.6	9.5	2.9	9.8	0.9	12.4	10.9	0.8	0.7	17.8	15.9	81.3	4.8	12.0	0.1	17.0	5.8	0.5	0.6	1.0	0.5	0.5	0.5	0.6	0.0	0.5	0.3
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064685-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;brain: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.3;U-266/84: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA053111: , HPA061001: "	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	1.6	0.6	3.6	2.7	2.0	4.0	2.3	4.0	9.5	0.8	1.1	0.4	1.3	1.1	3.3	2.5	0.9	5.5	1.0	1.4	2.2	2.7	0.9	0.7	2.6	6.8	2.0	5.1	1.0	0.6	0.2	0.7	1.4	1.9	0.5	1.8	0.4	1.0	1.3	0.6	5.6	1.8	1.0	1.2	5.2	1.2	3.0	0.9	2.5	0.8	0.0	3.9	1.0	4.1	3.1	0.9	10.6	1.6	1.3	10.1	1.2	0.9	1.9	1.2	2.8	0.7	0.1	1.1	0.9	2.7	5.0	5.6	1.8	1.6	2.8	0.8	0.2	0.7	0.8	1.0	2.2	16.3	0.1	2.7	1.4	0.9	0.6	1.0	5.7	0.3	0.4	2.5	0.8	1.9	3.4	7.9	1.9	0.8	1.2	6.6	1.8	2.8	2.6	1.7	4.3	0.4	0.1	0.6	1.7	0.7	0.7	4.4	0.3	1.8	1.0	1.5	2.6	3.0	0.9	9.6	32.6	1.6	1.3	4.0	0.6	10.6	0.3	0.7	7.3	1.6	10.1	1.9	3.1	3.9	0.7	3.1	1.0	3.8	0.6	1.3	1.4	0.9	6.1	1.2	3.6	2.0	4.0	9.5	2.2	2.7	2.0	5.1	1.9	0.9
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.4"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: , HPA044083: "	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"				Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favourable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	20.4	20.1	19.0	19.5	18.4	12.2	16.9	10.8	13.3	13.8	22.5	13.9	7.7	16.3	11.6	13.3	21.1	12.4	14.2	44.3	17.6	16.7	35.0	32.5	21.0	23.6	22.2	10.7	11.6	13.0	14.5	15.6	12.7	19.1	12.6	17.2	13.6	12.2	18.9	45.2	18.5	29.0	17.7	23.1	19.2	16.9	14.4	15.3	25.6	29.3	27.1	18.0	14.3	11.2	17.8	22.1	38.6	27.9	15.5	18.0	12.6	21.3	9.3	10.9	6.2	21.5	35.3	13.3	15.7	14.2	12.5	12.3	11.0	13.7	25.6	13.4	13.0	20.9	13.9	15.7	15.0	21.7	10.9	13.4	11.0	27.5	11.5	6.0	0.3	19.1	14.9	16.7	25.9	28.1	14.1	14.1	19.8	19.3	21.3	2.8	5.5	23.4	12.2	15.3	26.3	14.8	13.5	5.1	11.5	13.0	51.9	22.1	29.2	11.3	15.2	14.0	22.7	17.7	9.4	18.3	15.1	19.9	18.3	9.7	18.9	5.6	17.1	38.6	12.3	21.6	14.3	17.8	12.8	14.4	19.5	12.3	10.6	13.7	6.8	15.5	27.9	22.1	18.0	12.6	19.0	18.4	10.8	12.5	17.6	16.7	22.2	10.7	19.1	15.3
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	6	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: "	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.7	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.5	2.6	1.1	0.3	0.0	0.0	0.1	0.3	0.0	1.9	0.0	0.2	0.0	0.7	0.6	0.0	1.0	0.0	1.3	0.0	0.0	0.3	0.4	0.0	1.9	0.3	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.6	0.0	0.3	1.9	8.0	0.7	0.6	0.1	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364636-89412270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.8;SCLC-21H: 14.5;U-266/70: 35.2;U-266/84: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;monocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA068664: "	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	8.1	8.4	9.2	2.6	12.8	8.9	8.8	22.4	16.3	8.7	3.3	7.9	3.1	2.2	2.1	6.6	12.8	11.9	3.7	29.9	8.6	7.4	21.8	5.0	6.4	2.8	8.5	7.9	2.2	6.4	16.0	11.5	3.4	10.7	5.9	2.4	12.8	38.7	4.2	60.0	5.5	2.1	7.5	12.6	4.4	2.3	6.1	9.2	4.1	23.3	13.9	5.2	9.2	9.3	0.1	0.7	6.3	3.9	0.1	0.6	0.3	0.0	0.7	1.9	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	10.5	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.8	7.0	8.3	0.1	0.6	0.0	0.0	0.0	0.2	27.8	0.0	0.7	3.3	3.5	1.5	0.7	7.0	10.1	0.1	2.5	0.2	14.5	0.8	0.2	0.9	11.8	0.3	5.6	0.0	0.8	1.2	5.0	1.3	35.2	16.3	0.0	2.7	5.3	0.8	3.9	1.2	2.6	0.0	1.1	0.1	0.1	0.4	0.0	0.7	0.0	0.3	0.6	6.3	0.1	3.9	0.6	0.0	0.3	9.2	12.8	22.4	9.1	8.6	7.4	8.5	7.9	10.7	9.2
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head 1 homolog"	Q8WYR4	21	42472486-42496354	"Disease related genes, Predicted intracellular proteins"	Meiosis		"Ciliopathy, Disease mutation, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.4;fallopian tube: 85.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;MCF7: 10.8;RPTEC TERT1: 16.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 6.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome				Centrosome		"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.6	2.5	11.5	0.9	16.4	0.7	1.7	1.2	4.7	4.5	2.6	15.9	3.1	4.5	3.6	22.5	1.0	85.5	3.8	0.6	11.6	15.0	3.8	0.8	17.4	0.7	4.8	4.5	12.9	2.2	4.8	21.4	0.6	38.4	2.2	2.5	1.0	0.9	2.4	0.9	2.4	4.1	1.1	4.6	0.6	3.4	21.9	7.7	0.2	4.8	0.0	0.7	1.5	0.2	0.6	6.7	0.5	0.3	0.0	0.3	0.3	1.6	1.2	0.1	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.5	0.1	0.6	0.0	2.0	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	1.0	0.0	0.1	0.0	0.0	0.3	0.0	10.8	0.1	0.2	0.3	0.5	0.0	0.4	0.0	16.2	1.3	2.5	1.0	2.6	3.9	0.3	4.4	0.4	0.2	0.0	0.1	0.1	0.0	0.5	2.5	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.1	0.4	0.3	0.3	0.3	0.6	0.3	0.2	0.2	0.0	0.1	6.7	0.2	0.3	11.5	16.4	1.2	4.7	11.6	15.0	4.8	4.5	38.4	7.7
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993448-49015995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	6.9	5.3	6.7	7.5	7.1	13.4	4.8	8.2	10.4	4.8	9.9	7.6	6.3	11.2	8.3	5.5	16.1	5.5	7.2	9.1	6.9	6.0	7.6	10.3	5.5	8.2	7.7	8.1	6.5	8.7	1.6	6.4	5.5	6.7	6.0	3.2	6.5	10.0	6.6	27.8	7.7	10.0	3.7	7.1	6.9	10.7	59.0	5.8	14.6	8.8	9.4	8.1	6.4	12.9	12.6	16.4	5.6	14.3	11.0	12.5	15.2	28.8	29.7	3.5	20.0	1.5	2.7	9.4	15.6	6.8	17.9	11.8	15.4	12.5	27.1	12.1	3.1	15.3	2.1	10.2	2.1	16.4	12.2	17.7	8.9	7.8	5.0	34.7	12.4	3.1	2.0	4.0	2.1	6.6	30.6	11.5	1.6	5.9	30.6	4.1	10.7	4.4	25.4	16.0	17.4	3.2	11.1	14.2	20.5	15.7	13.1	5.6	11.6	13.3	9.7	11.4	16.7	7.5	38.6	23.4	26.7	28.0	8.4	17.0	16.3	5.6	14.3	4.2	11.1	11.1	11.2	10.9	11.1	9.1	16.4	12.6	12.2	8.0	1.0	11.0	10.8	12.5	12.5	15.2	6.7	7.1	8.2	10.4	6.9	6.0	7.7	8.1	6.7	5.8
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"Serologically defined colon cancer antigen 8"	Q86SQ7	1	243256034-243500092	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome				Centrosome		"HPA025737: , HPA044477: , HPA072495: "	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	13.5	12.6	17.2	10.0	17.7	7.9	13.0	12.3	17.6	11.4	10.5	22.5	10.4	7.5	13.3	17.7	11.6	17.9	17.6	12.8	16.8	13.5	15.2	7.9	14.8	10.4	17.4	12.0	19.9	17.3	18.0	32.4	11.4	14.2	15.5	8.3	10.7	16.8	13.1	15.1	10.2	9.3	11.3	18.9	15.0	11.0	8.0	20.9	17.4	32.7	7.2	10.4	11.8	10.7	9.8	9.9	9.3	10.7	12.5	8.6	5.2	5.4	4.6	0.7	3.4	5.1	2.9	5.6	3.4	2.9	0.6	1.3	4.5	9.8	2.1	5.7	2.9	1.9	0.6	4.1	1.4	3.5	5.5	1.8	3.4	1.9	3.3	1.7	4.6	6.0	3.9	3.0	6.5	4.2	2.6	3.2	2.5	1.5	0.7	4.3	0.6	7.8	2.8	0.8	1.8	6.1	3.5	4.8	4.8	4.1	2.1	7.8	3.6	2.8	4.2	5.9	1.3	1.8	1.9	4.4	2.2	1.0	2.8	3.8	25.9	9.3	10.7	9.0	6.0	10.5	3.8	7.5	6.4	7.8	9.9	9.8	8.6	6.5	6.9	12.5	5.7	7.9	5.0	5.2	17.2	17.7	12.3	17.6	16.8	13.5	17.4	12.0	14.2	20.9
SEC14L4	"dJ130H16.5, TAP3"	ENSG00000133488	"SEC14 like lipid binding 4"	Q9UDX3	22	30488913-30505711	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 35.8;testis: 13.4"	"Cell line enriched"	"Detected in some"	4	"BEWO: 28.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 3.1;neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 3.0"	HPA069748			Approved	Centrosome			44000	Centrosome		"HPA069748: "	"unprognostic (6.98e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.06e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.98e-2)"	0.1	1.1	0.1	0.1	0.1	6.7	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.0	0.1	1.0	0.3	0.2	0.4	0.1	0.1	0.1	0.3	35.8	8.5	0.1	0.1	0.1	0.2	0.2	6.7	0.2	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.5	0.4	13.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.7	0.5	3.1	0.4	0.4	0.4	0.1	1.7	5.4	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.4	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.1	0.4	0.4	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.4	2.6	0.4	0.3	0.5	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: , HPA065969: "	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (5.94e-5)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (4.69e-2)"	8.1	5.1	15.5	3.5	15.5	1.3	5.7	12.9	21.3	5.2	3.8	3.3	2.3	1.9	6.6	6.7	2.7	5.6	3.5	4.9	17.2	12.2	4.8	2.1	8.1	5.1	5.3	16.5	9.1	4.6	13.7	10.2	3.5	7.8	5.2	4.2	3.6	5.0	5.7	3.0	4.9	3.0	7.0	5.7	4.7	4.3	7.2	3.8	2.9	4.7	1.3	4.9	3.5	4.7	2.8	0.2	1.4	0.4	2.5	5.6	2.1	7.1	4.9	5.3	7.5	8.7	4.8	3.3	5.0	10.4	9.1	8.4	2.0	4.1	2.4	5.4	7.9	2.1	7.7	8.5	10.1	6.3	6.6	4.2	2.0	4.0	3.1	0.9	6.7	4.4	7.4	6.1	3.2	3.9	0.3	0.1	5.3	2.1	3.8	0.7	2.9	4.7	0.0	6.9	0.0	7.1	3.4	3.3	8.0	7.2	3.0	9.0	3.5	0.5	4.2	15.5	7.5	3.7	9.1	5.8	5.8	0.3	18.9	0.3	8.3	0.5	0.2	1.4	5.6	0.1	3.2	2.8	3.0	4.9	0.2	2.1	3.3	3.9	0.8	2.5	0.4	0.1	2.2	2.1	15.5	15.5	12.9	21.3	17.2	12.2	5.3	16.5	7.8	3.8
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.6;RT4: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: "	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	5.1	9.2	3.1	2.0	4.3	4.6	9.3	4.2	2.8	1.8	1.9	18.5	26.6	0.8	4.3	5.4	14.9	4.2	11.1	2.7	0.7	2.2	0.6	1.1	9.9	1.6	0.6	1.9	5.2	6.2	4.8	12.6	3.4	1.6	4.4	4.9	8.8	10.3	2.5	4.3	3.2	12.3	2.7	1.4	5.5	25.4	0.2	3.0	3.7	8.7	16.3	3.8	3.2	3.7	5.4	1.5	5.4	5.2	5.7	1.6	13.3	10.2	1.8	22.0	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome			5100000	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	31.6	38.8	21.1	23.5	34.8	17.3	29.6	13.4	20.8	31.8	44.6	35.2	38.1	54.9	30.3	30.3	36.0	35.9	42.4	58.7	21.1	21.3	32.4	20.1	36.2	45.3	33.7	20.4	45.3	85.3	26.5	23.7	38.5	28.5	37.8	30.9	32.6	23.4	32.6	51.0	12.0	85.5	36.6	32.4	41.4	29.9	55.5	28.9	5.9	32.6	34.2	23.7	31.7	24.5	8.4	30.8	34.2	31.3	23.6	18.6	24.0	30.3	19.9	6.6	27.3	17.9	39.9	20.4	28.4	34.5	22.6	26.4	7.0	22.0	0.2	32.8	32.2	46.1	18.2	28.9	21.2	39.9	8.2	17.9	23.8	11.8	31.3	0.3	10.9	22.9	20.3	21.5	5.6	53.4	23.1	0.5	40.1	21.6	0.2	0.3	3.8	38.4	1.9	12.3	25.5	28.4	7.4	0.4	16.8	23.3	3.5	31.5	15.4	14.6	38.2	23.1	8.5	51.2	19.2	0.6	0.1	0.5	17.7	17.9	23.6	13.9	31.3	34.2	16.8	30.4	8.3	8.4	9.5	11.1	30.8	6.9	11.3	18.6	2.8	23.6	24.6	3.1	1.3	24.0	21.1	34.8	13.4	20.8	21.1	21.3	33.7	20.4	28.5	28.9
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129348-109504632	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 13.8;RPMI-8226: 13.2;TIME: 15.3;U-266/84: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA044822: , HPA048444: "	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	17.4	5.6	2.7	3.4	4.4	0.6	18.3	1.7	5.4	5.3	3.6	3.3	2.5	1.0	5.5	2.2	3.4	4.8	5.6	6.4	3.0	2.1	2.5	0.8	6.0	2.9	4.3	1.5	3.0	1.8	0.6	2.6	6.5	3.8	3.4	1.6	4.6	2.4	5.9	6.4	2.9	2.3	4.6	2.8	2.0	2.7	4.3	2.9	1.5	3.4	3.6	4.0	4.6	3.4	0.4	0.4	1.8	0.2	0.0	0.6	0.3	0.0	0.0	0.1	1.4	6.3	4.8	0.0	2.8	8.2	2.1	0.8	0.7	0.0	0.0	2.1	2.0	0.0	0.1	1.2	0.9	0.0	2.8	0.0	0.1	0.0	13.8	0.0	0.0	8.3	1.9	9.6	4.3	7.6	0.0	7.9	4.8	0.0	0.0	4.2	0.7	7.9	1.7	0.0	13.2	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.1	0.0	15.3	2.7	8.2	7.8	3.6	2.7	17.8	0.0	0.0	4.1	3.7	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.6	1.8	0.0	0.0	0.4	0.0	0.3	2.7	4.4	1.7	3.3	3.0	2.1	4.3	1.5	3.8	2.9
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Enhanced	"Microtubules,Mitotic spindle,Centrosome,Cytosol"				Microtubules	"Mitotic spindle, Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.2	5.9	10.7	9.1	0.0	2.3	8.4	15.2	6.4	19.2	13.1	9.8	12.1	15.4	4.5	8.4	10.6	14.3	6.2	21.0	13.1	7.3	20.5	3.9	5.5	0.0	15.8	7.9	0.4	0.4	15.4	5.1	9.4	10.6	6.6	12.7	8.7	24.0	14.2	12.4	11.1	15.8	23.0	7.1	4.3	4.4	13.7	5.0	5.0	7.9	3.2	7.1	12.2	3.7	7.6	11.0	7.1	18.2	4.0	8.4	15.4	1.8	12.4	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol			13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: "	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.6	5.0	9.1	8.9	14.1	17.4	6.4	19.5	25.0	17.6	18.3	4.9	10.7	7.6	12.1	22.4	8.4	37.0	18.4	31.0	6.3	3.8	13.4	7.4	5.6	15.1	12.2	13.7	14.7	27.2	20.3	23.7	10.3	8.5	8.6	17.6	6.4	14.0	10.1	3.8	7.2	8.0	17.7	4.8	15.4	14.0	6.0	7.7	7.9	6.0	8.3	7.5	8.7	13.0	19.3	18.3	12.2	19.9	11.7	12.1	6.5	15.1	14.0	13.8	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 89.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Supported	Vesicles,Centrosome				Vesicles	Centrosome	"HPA073224: "	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.2	89.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.3;U-266/70: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome				Centrosome		"HPA034963: , HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.6	2.8	1.6	8.6	3.7	2.4	2.3	7.0	3.4	2.9	5.0	0.7	0.5	12.0	1.6	10.9	10.6	3.3	0.8	3.0	4.8	1.3	6.2	3.4	7.3	7.9	10.4	5.8	1.1	18.4	3.9	6.1	1.8	4.8	30.3	2.0	3.2	8.8	6.9	1.1	3.4	3.2	0.4	29.7	1.2	1.8	7.3	3.5	4.3	4.0	71.3	4.7	11.5	0.4	4.0	4.8	7.8	4.2	33.3	16.4	29.1	5.9	20.9	21.2	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favourable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	25.6	17.5	16.0	14.0	16.7	11.4	24.9	29.7	16.0	27.9	22.6	17.9	21.3	15.1	28.2	18.8	21.7	20.5	17.5	19.6	15.3	11.5	21.0	22.0	20.1	16.0	17.2	13.3	30.5	25.0	30.0	28.9	30.6	14.2	27.8	17.4	18.4	23.1	22.8	39.7	18.2	23.4	27.6	13.9	21.7	19.3	17.6	18.4	38.8	35.0	13.9	18.1	29.0	24.1	3.6	3.6	3.4	1.8	2.9	4.7	1.3	8.5	11.3	30.7	8.8	12.7	19.6	17.3	15.0	16.5	20.2	25.4	6.9	2.0	14.2	4.5	13.0	14.1	17.2	6.7	21.5	12.3	9.7	9.8	11.3	7.9	12.6	17.1	7.7	8.9	11.4	9.9	14.6	14.6	11.0	13.1	11.9	4.5	10.1	4.9	16.0	7.1	13.2	15.6	13.9	9.7	3.7	19.0	11.3	14.0	2.6	9.3	7.0	10.0	11.0	17.1	7.9	4.3	9.9	19.7	13.7	12.3	11.1	6.7	11.3	0.8	1.8	1.8	3.2	1.1	3.7	2.2	3.3	2.6	3.6	3.6	4.0	4.7	3.4	2.9	1.3	2.9	4.3	1.3	16.0	16.7	29.7	16.0	15.3	11.5	17.2	13.3	14.2	18.4
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638600-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 18.8;pituitary gland: 10.7"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 14.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA066648: "	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.6	3.2	5.2	0.7	6.6	2.7	0.6	18.8	18.7	0.6	0.7	0.4	0.0	0.6	0.7	0.6	0.7	0.7	0.8	0.9	10.9	10.7	2.9	0.7	0.6	0.6	5.7	7.5	0.7	1.8	0.6	10.7	0.6	11.7	0.7	0.8	0.2	0.6	0.6	0.6	0.7	0.7	0.6	4.6	0.7	0.8	0.7	1.4	0.0	0.7	0.0	0.6	0.6	0.0	2.9	4.1	3.0	2.3	0.2	4.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.0	0.0	0.0	3.0	1.9	1.9	3.7	1.3	3.6	2.9	2.3	2.1	0.9	2.9	3.0	4.3	2.1	0.2	2.3	4.1	2.9	0.3	5.2	6.6	18.8	9.7	10.9	10.7	5.7	7.5	11.7	1.4
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 21.3;SH-SY5Y: 13.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	1.2	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.1	0.2	21.3	13.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958618-86963260	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 93.7;RT4: 77.2"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 292.8"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581"	Enhanced	Supported	Supported	"Nuclear bodies,Centrosome"				Centrosome	"Nuclear bodies"	"CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (2.29e-8)"	"prognostic unfavourable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	74.1	78.3	82.3	5.3	20.8	1.0	28.9	12.3	44.5	9.5	5.8	4.6	6.4	4.8	6.1	12.0	11.0	26.5	6.2	9.0	40.0	92.9	4.1	1.9	4.6	4.9	72.9	35.1	15.0	3.5	1.6	1.7	4.9	100.1	11.9	2.7	10.8	10.9	44.4	6.6	8.5	5.4	5.8	35.2	20.2	2.6	2.9	5.3	0.2	3.4	3.3	9.6	76.6	18.3	0.0	0.7	0.0	2.4	0.0	1.8	0.6	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	93.7	0.0	1.9	0.1	7.8	0.0	0.3	0.0	0.0	0.0	0.5	18.2	0.3	0.1	0.0	0.1	0.4	7.3	0.0	0.0	6.6	0.6	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	77.2	0.0	0.0	0.6	1.0	0.1	20.3	0.0	17.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.6	82.3	20.8	12.3	44.5	40.0	92.9	72.9	35.1	100.1	5.3
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 126.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;HMC-1: 26.0;SK-MEL-30: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.6;eosinophil: 2.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, HPA043084"	Enhanced		Supported	"Focal adhesion sites,Centrosome"				"Focal adhesion sites"	Centrosome	"HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favourable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	95.0	6.4	23.0	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45.0	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42.0	20.0	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40.0	5.5	19.3	0.0	4.0	12.7	1.2	63.9	31.4	0.1	0.0	7.6	1.2	0.6	1.0	0.2	0.7	0.6	6.3	1.6	2.3	0.1	0.9	0.2	0.0	0.2	0.0	14.9	5.6	0.0	1.2	0.1	0.3	1.1	0.2	0.1	1.7	2.3	3.6	0.2	8.9	0.8	0.0	26.0	0.4	0.2	0.3	0.1	2.6	5.9	1.2	0.6	0.4	0.0	0.3	2.9	1.4	0.5	2.1	0.2	7.0	9.8	2.7	2.0	0.9	0.3	22.3	1.2	0.2	0.2	0.0	2.2	0.1	1.2	0.8	0.2	0.1	2.7	0.2	6.3	7.6	0.2	2.2	0.7	1.2	1.0	0.1	0.3	0.4	0.0	0.1	0.3	0.1	0.2	0.6	0.2	0.0	0.5	0.2	23.0	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064843	Approved		Supported	Centrosome				Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	8.1	6.3	9.3	13.4	8.6	6.1	11.7	17.8	8.4	14.0	9.6	8.1	20.6	6.4	16.3	9.8	10.2	13.5	11.1	8.3	8.9	4.9	7.8	7.7	11.5	6.6	7.1	7.6	15.3	11.2	12.5	40.4	7.7	8.6	11.6	10.9	7.8	15.0	19.6	5.1	10.2	8.9	11.3	9.9	6.8	10.5	10.5	8.9	17.1	12.9	4.7	10.7	13.2	14.4	8.5	12.0	4.5	5.4	3.2	9.3	2.5	16.0	10.6	13.2	11.3	8.1	9.9	9.3	8.4	5.8	10.2	12.9	8.9	9.5	10.1	10.7	6.9	15.6	6.8	7.9	14.3	6.2	3.6	9.4	10.7	6.2	4.1	17.1	7.1	6.9	7.8	10.6	4.8	7.5	5.7	8.7	4.3	16.7	14.6	8.1	12.9	12.7	11.2	9.8	8.0	4.5	11.3	7.2	12.2	9.0	9.2	5.5	10.4	8.2	7.3	7.4	9.9	5.0	7.1	8.6	5.6	14.4	11.3	10.2	8.3	4.5	5.4	1.9	4.5	3.7	6.9	7.3	6.7	5.2	3.7	8.5	9.3	6.9	2.8	3.2	3.4	12.0	3.2	2.5	9.3	8.6	17.8	8.4	8.9	4.9	7.1	7.6	8.6	8.9
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2354806	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: "	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favourable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	5.4	4.6	5.0	11.7	5.4	11.7	4.0	6.9	6.9	3.4	9.0	7.9	9.6	19.3	4.7	10.0	3.2	5.2	9.8	3.3	5.6		4.2	3.9	3.5	10.3	7.1	4.7	3.4	13.8	6.3	11.0	6.8	7.1	4.7	3.9	6.0	10.5	8.7	7.5	8.7	16.2	5.0	7.0	8.1	13.8	20.1	6.4	9.3	3.0	3.7	5.7	2.3	2.0	14.4	17.4	9.3	7.7	6.2	8.2	5.9	8.3	13.3	5.7	10.2	4.7	4.8	14.7	10.9	3.2	4.0	4.3	9.3	9.5	8.0	10.3	5.1	11.2	1.9	3.7	1.2	9.3	8.3	5.3	20.9	12.5	8.9	9.3	6.9	7.0	4.3	3.8	2.7	5.6	8.5	20.4	2.4	9.2	10.0	11.8	10.7	5.5	16.8	3.0	21.9	4.3	21.0	10.2	9.7	10.9	6.7	8.4	11.1	15.6	12.4	7.3	5.3	18.5	8.5	26.9	9.6	8.3	9.2	10.9	12.7	9.3	7.7	7.0	6.6	7.5	4.8	9.0	6.0	6.5	9.4	14.4	7.8	8.2	3.4	6.2	5.1	17.4	5.9	5.9										
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523518-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome				Centrosome		"HPA042324: AB_10794273, HPA075418: "	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (8.34e-5)"	"prognostic unfavourable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.16e-4)"	"prognostic favourable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	7.7	9.3	5.7	5.5	9.0	8.6	8.2	12.1	7.9	8.1	6.9	10.0	7.2	5.5	10.0	7.8	6.1	7.9	6.0	8.6	5.6	5.9	6.3	7.6	5.7	5.3	6.1	5.1	9.4	11.6	5.2	12.8	6.4	6.3	7.3	8.0	9.4	7.0	9.0	10.2	8.9	6.2	7.9	6.4	5.2	5.8	49.0	7.0	4.6	11.8	4.6	5.6	6.8	7.7	4.2	3.5	0.3	2.1	6.9	5.2	1.9	4.8	1.5	8.6	6.1	11.8	11.7	2.1	6.2	4.7	2.6	3.9	2.7	4.8	2.1	2.5	2.5	3.4	10.1	8.0	4.1	3.1	6.0	5.9	7.5	1.8	6.8	4.9	6.3	2.1	2.0	3.1	6.4	8.6	3.4	6.8	10.9	1.9	2.6	1.9	3.9	5.3	4.2	4.5	0.7	5.4	5.9	6.3	3.9	3.3	4.7	4.4	3.5	3.0	8.3	6.1	6.0	7.9	6.0	1.8	1.3	2.1	5.5	8.0	13.4	0.1	1.8	0.2	2.4	2.1	3.9	4.2	3.6	1.8	1.7	1.8	5.2	2.8	0.3	6.9	1.6	3.5	2.4	1.9	5.7	9.0	12.1	7.9	5.6	5.9	6.1	5.1	6.3	7.0
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: "	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18.0	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6.0	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4.0	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18.0	6.6	8.4	6.2	26.4	11.6	22.0	13.3	10.2	9.0	3.1	0.3	0.0	1.5	1.4	20.7	0.3	1.1	0.1	0.1	8.3	8.2	12.3	5.6	2.0	10.3	23.0	14.4	0.0	10.6	18.8	17.7	7.8	7.8	1.4	37.0	1.4	2.0	8.6	0.0	9.8	4.0	7.8	11.6	3.4	7.9	38.0	34.4	18.4	1.2	27.5	11.4	15.8	9.3	14.5	7.7	8.5	5.4	4.9	0.2	6.3	9.8	0.1	3.7	4.0	11.2	13.2	8.9	14.0	13.7	3.4	40.3	1.8	26.4	5.1	16.6	13.3	6.7	13.0	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10.0	22.0	11.6	2.3	4.0	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387852	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 19.7;brain: 21.1;retina: 31.9"	"Group enriched"	"Detected in some"	5	"RT4: 9.6;SK-MEL-30: 33.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040236	Uncertain		Approved	Centrosome				Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	2.1	19.7	4.8	1.3	7.1	0.4	2.3	21.1	7.7	1.2	1.8	6.2	0.6	1.2	1.6	5.6	1.0	1.3	4.3	1.6	4.9	12.6	6.3	0.6	2.1	0.5	12.1	2.2	5.1	4.2	0.4	8.5	0.7	20.7	2.1	1.1	31.9	1.2	1.8	0.6	2.9	1.1	1.4	12.4	0.8	1.4	2.1	6.9	0.0	15.7	0.5	0.5	4.1	2.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	3.7	9.6	0.9	0.4	0.0	0.1	33.8	0.0	0.0	0.1	0.0	0.6	0.4	0.3	1.1	0.2	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.8	7.1	21.1	2.3	4.9	12.6	12.1	2.2	20.7	6.9
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.5	2.8	5.1	5.6	8.9	7.2	10.3	11.5	6.6	7.0	5.9	6.3	2.6	2.0	3.9	6.9	5.2	9.1	6.7	8.4	6.5	8.7	13.8	9.0	3.5	4.8	5.7	12.3	4.0	5.0	12.2	6.2	10.9	10.3	11.9	9.0	5.6	5.3	4.7	3.6	6.3	5.8	11.1	7.2	7.4	4.0	5.8	4.5	14.1	9.0	5.5	7.8	7.4	12.1	10.9	5.4	8.7	6.3	6.2	7.2	4.3	8.2	10.8	8.6	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7
TBC1D31	"Gm85, MGC21654, WDR67"	ENSG00000156787	"TBC1 domain family member 31"	Q96DN5	8	123041968-123152153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 29.0"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023710	Approved		Approved	Centrosome				Centrosome		"HPA023710: AB_1858819"	"unprognostic (1.39e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.21e-2)"	"unprognostic (3.18e-5)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.33e-1)"	3.8	4.4	6.7	9.7	10.9	7.3	3.6	13.5	7.7	3.2	5.2	4.5	5.2	6.9	3.8	2.4	4.6	7.5	3.6	5.3	7.2	5.7	4.4	3.8	3.9	11.0	5.5	5.6	2.9	5.4	5.5	8.4	2.7	7.5	3.4	6.3	5.6	3.6	4.1	3.7	4.7	5.9	4.8	4.7	7.4	3.9	9.2	4.7	29.0	5.1	5.2	10.3	5.2	4.1	2.4	2.6	3.0	3.3	9.5	16.8	4.0	10.7	4.5	8.1	6.4	2.8	3.1	4.0	5.8	3.5	7.7	7.1	4.3	4.7	5.0	4.5	2.5	7.0	7.8	3.8	10.9	10.3	7.7	11.8	4.9	3.7	4.4	5.4	8.4	2.5	2.3	6.4	6.6	5.5	9.8	12.0	5.5	8.7	16.8	3.6	6.3	7.9	8.2	7.3	5.2	5.2	2.9	7.6	5.9	13.0	39.0	3.9	6.2	4.5	2.9	6.1	12.5	5.0	8.6	9.4	13.6	6.0	5.0	9.8	9.1	2.7	3.1	3.0	8.3	3.3	16.8	2.4	3.8	6.3	2.6	2.3	4.7	5.3	1.6	9.5	1.4	1.6	3.0	4.0	6.7	10.9	13.5	7.7	7.2	5.7	5.5	5.6	7.5	4.7
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA052245: , HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	27.7	11.7	0.0	2.4	3.2	6.3	10.6	0.0	0.0	0.0	1.3	14.1	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	19.9	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.1	1.2	0.1	0.0	14.9	0.2	1.5	0.7	0.3	0.0	0.8	0.0	0.3	0.0	0.3	0.0	3.4	2.1	14.0	0.1	0.2	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA043836: "	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	14.8	19.5	31.4	7.9	32.8	6.6	9.3	34.7	40.4	18.3	11.7	17.7	11.0	5.6	18.8	10.9	8.4	24.5	13.5	19.1	27.7	30.0	14.8	27.5	10.9	9.2	27.2	32.8	30.3	16.1	18.6	17.9	14.7	26.5	16.9	3.2	14.5	17.9	22.3	30.7	10.4	7.8	11.7	18.3	16.2	10.5	32.0	18.9	8.7	15.0	6.1	5.2	10.9	15.4	9.7	3.0	4.4	2.6	3.6	5.5	1.6	7.5	8.2	13.1	22.2	11.7	7.3	5.3	7.9	8.8	14.0	6.7	4.8	13.4	8.6	17.8	9.1	20.2	5.2	6.7	2.7	5.3	10.3	3.2	14.3	12.6	17.4	3.6	4.6	11.3	6.0	3.6	4.6	9.5	5.6	16.2	4.2	16.5	14.7	17.5	8.4	19.8	14.3	9.9	22.2	7.0	5.0	12.9	21.8	8.0	5.5	19.8	15.0	9.0	13.5	25.2	13.3	14.2	4.8	18.9	12.4	4.6	22.4	4.2	5.0	2.4	1.7	4.4	3.6	1.6	1.6	9.7	3.2	2.6	2.1	5.0	5.5	3.4	0.8	3.6	2.6	3.0	5.4	1.6	31.4	32.8	34.7	37.6	27.7	30.0	27.2	32.8	26.5	18.9
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038638, HPA061543"	Supported		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: "	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	8.6	10.4	16.0	11.3	29.3	8.3	9.3	22.9	25.0	10.2	11.2	19.0	7.5	9.9	13.0	10.9	18.3	8.7	8.3	10.3	15.9	11.0	8.5	7.0	10.0	14.5	23.8	13.9	11.3	12.7	12.1	12.1	10.4	18.6	10.7	9.6	11.0	13.4	11.6	10.8	36.1	10.2	15.0	15.9	15.0	10.2	12.5	24.2	10.9	12.0	7.7	15.1	11.4	15.4	3.2	3.3	4.5	5.2	9.2	7.4	4.4	16.3	14.6	7.9	9.5	7.0	7.6	10.7	15.5	8.3	13.6	7.6	9.2	5.8	23.0	4.6	9.1	13.8	8.6	9.8	12.3	12.3	8.5	16.6	9.1	8.9	8.5	22.5	12.8	6.2	12.0	14.3	10.8	12.1	17.9	4.7	11.2	11.2	20.5	22.9	9.5	14.9	18.9	15.6	19.4	6.2	14.7	11.8	12.4	11.4	12.3	11.0	11.1	16.4	13.4	14.0	9.7	8.9	19.8	13.4	17.0	16.5	14.9	18.7	14.5	0.0	4.2	3.4	6.2	2.7	4.3	3.2	5.4	7.4	3.3	2.3	5.4	4.2	4.5	9.2	5.2	2.4	7.2	4.4	16.0	29.3	22.9	25.0	15.9	11.0	23.8	13.9	18.6	24.2
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	3.6	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	8.0	6.4	7.4	14.0	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053786: , HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	6.9	1.7	20.0	22.6	2.9	2.7	7.3	4.0	4.6	9.6	7.2	10.2	8.9	18.7	10.6	3.9	7.2	16.2	10.4	9.4	8.8	5.9	23.4	4.0	13.5	4.6	9.9	5.7	4.2	6.9	2.0	7.4	9.4	11.2	11.5	4.6	9.9	16.8	18.9	16.7	5.0	14.4	23.9	10.2	6.3	4.6	6.0	17.8	1.2	10.6	10.0	12.7	22.1	6.8	1.5	6.3	0.1	7.5	13.2	4.9	17.6	0.1	11.9	7.5	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	15.7	14.9	11.5	18.7	17.6	14.4	18.6	21.2	17.0	18.4	17.0	24.4	16.5	14.9	20.2	23.8	15.5	15.6	13.5	17.2	12.0	11.9	17.8	21.9	13.1	17.9	21.9	14.0	19.3	14.9	19.9	30.9	24.3	17.8	18.3	14.5	17.3	17.0	13.3	20.3	20.8	21.1	18.8	19.2	17.8	13.1	26.5	21.3	18.0	20.4	16.9	15.2	16.5	14.3	10.7	7.1	18.5	8.7	6.8	13.6	6.5	6.8	4.9	10.9	7.6	12.4	12.3	6.2	16.4	8.4	8.6	8.9	6.2	17.1	10.0	8.4	5.3	7.3	9.8	7.8	10.5	11.3	6.8	7.2	8.0	7.9	17.2	9.7	8.2	10.3	13.6	9.8	15.1	4.6	12.4	20.5	9.0	8.0	8.7	6.6	6.2	5.1	8.5	12.0	6.8	8.0	5.8	8.4	8.6	7.7	10.5	9.1	11.4	8.1	5.6	14.7	9.7	16.9	8.4	18.4	9.0	9.4	10.2	7.8	12.3	14.6	8.7	12.2	9.8	7.5	13.0	8.9	11.9	9.2	7.1	10.7	13.6	10.4	18.5	6.8	8.0	5.9	13.0	6.5	11.5	17.6	21.2	16.5	12.0	11.9	21.9	14.0	17.8	21.3
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol			110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: , HPA062797: , HPA070657: , HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	1.7	2.9	5.9	2.5	6.2	1.3	0.9	9.7	16.8	2.1	1.3	3.9	1.6	1.9	1.1	1.9	0.9	2.9	2.5	1.1	5.5	6.3	4.9	4.2	2.1	2.4	5.5	4.8	1.1	1.0	0.8	2.4	0.7	9.1	1.4	1.2	4.9	0.9	1.1	1.5	1.6	1.7	1.2	6.6	2.6	1.0	1.3	2.5	0.7	6.7	0.0	2.0	1.1	0.7	3.0	0.2	4.3	5.7	0.7	6.3	1.3	0.1	0.4	8.3	0.2	0.9	0.1	0.0	0.3	0.2	0.2	0.8	0.4	2.4	0.1	6.1	0.3	0.2	1.1	0.0	0.2	1.2	0.4	2.7	0.1	1.5	1.8	0.2	0.6	0.6	0.6	0.6	0.8	0.0	0.0	0.4	6.7	0.7	0.2	0.3	4.3	0.1	1.5	2.4	0.2	12.2	0.0	10.5	15.1	0.2	0.2	6.0	0.4	1.1	0.1	0.2	0.4	0.2	0.4	1.9	2.0	0.4	1.9	0.2	1.5	1.3	1.8	0.3	2.3	1.5	1.7	2.4	4.0	2.7	0.0	3.0	4.2	1.9	4.3	0.7	5.7	0.2	6.3	1.3	5.9	6.2	9.7	11.5	5.5	6.3	5.5	4.8	9.1	2.5
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11538278-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"bone marrow: 31.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 18.3;U-937: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome				Centrosome		"HPA055134: "	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	10.1	4.8	11.7	6.4	9.6	31.1	6.1	13.5	18.6	3.1	3.3	4.9	2.0	1.6	4.1	5.2	2.5	2.8	3.0	4.5	10.1	8.8	5.9	12.8	8.8	3.5	8.3	8.7	3.9	3.3	5.8	4.2	4.0	8.4	3.4	2.2	4.2	2.5	3.7	8.3	1.8	2.0	4.7	8.2	5.7	2.4	5.2	6.0	4.2	4.4	1.2	2.2	2.7	3.1	0.2	3.2	2.4	2.9	0.1	0.3	0.5	0.7	1.2	7.5	6.7	1.4	0.1	1.5	0.6	1.7	1.0	1.2	0.4	0.4	5.9	3.4	0.4	0.0	8.5	0.5	2.7	1.6	4.3	3.3	0.8	1.0	0.5	5.3	3.5	0.5	0.1	1.1	0.0	0.7	0.2	0.1	1.5	1.1	6.3	9.2	2.1	1.0	3.2	7.2	0.9	0.8	1.5	5.1	4.4	0.4	2.4	2.7	2.4	18.3	0.1	1.4	1.6	2.8	1.7	5.2	10.4	5.3	1.2	13.6	1.8	2.4	2.9	1.5	0.2	1.6	0.1	0.0	0.1	0.1	1.8	0.2	0.3	0.2	1.1	0.1	0.6	3.2	0.0	0.5	11.7	9.6	13.5	13.5	10.1	8.8	8.3	8.7	8.4	6.0
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.8;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 11.6;Karpas-707: 15.6;RPMI-8226: 7.9;SCLC-21H: 21.2;SK-BR-3: 18.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome				Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.4	14.1	3.4	1.0	8.4	1.1	5.2	63.8	16.3	1.5	5.8	1.9	0.0	1.8	0.3	6.8	4.8	0.6	0.5	0.3	3.2	9.7	0.7	0.4	0.9	0.6	4.6	6.0	0.4	6.7	1.2	21.1	1.1	6.6	0.4	4.3	0.9	1.3	0.2	0.8	4.4	2.2	1.1	1.8	3.2	3.1	9.9	1.2	0.0	3.2	0.6	0.6	0.3	2.9	0.1	0.7	2.0	1.7	1.7	1.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	11.6	2.2	0.0	1.6	2.4	0.9	0.0	0.7	0.9	0.2	1.1	0.0	0.0	2.0	0.1	0.0	4.9	0.0	0.1	0.0	0.0	15.6	0.0	5.8	1.6	0.1	0.5	0.0	0.0	0.8	7.9	0.2	0.0	21.2	3.2	0.2	18.8	0.0	1.8	1.0	0.0	0.0	4.0	0.0	0.0	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.5	1.0	0.7	0.1	0.5	0.4	2.0	1.7	1.7	0.0	0.0	0.4	3.4	8.4	63.8	13.0	3.2	9.7	4.6	6.0	6.6	1.2
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome				Centrosome	Midbody	"HPA057689: "	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.4	0.7	1.3	1.8	6.3	2.2	4.7	1.2	1.1	1.7	0.9	1.0	0.6	0.9	11.1	8.8	2.5	5.9	1.2	3.9	3.7	0.8	1.7	2.1	1.3	0.5	6.0	3.5	0.8	2.4	6.4	10.0	0.9	2.4	5.9	2.8	12.5	1.1	5.1	2.1	3.9	1.8	0.8	4.9	2.2	8.3	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17142254-17202054	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome				Nucleoli	"Nucleoplasm, Centrosome"	"CAB009468: AB_2208432, HPA036945: , HPA036946: "	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	6.1	4.4	4.4	8.5	7.7	4.0	6.3	14.0	6.2	5.3	3.8	4.2	4.7	4.1	7.5	14.4	3.9	6.8	5.1	5.0	4.9	4.5	6.7	2.7	5.3	5.3	4.3	2.9	9.6	5.0	12.8	12.6	5.1	6.2	5.0	3.6	8.0	5.6	3.8	4.3	4.4	5.0	5.4	5.1	5.9	4.2	4.2	6.1	19.9	11.5	3.3	5.7	4.0	5.2	6.1	10.5	5.2	4.4	3.5	8.0	3.6	5.1	2.5	10.0	2.6	3.8	2.2	0.0	4.4	3.2	4.7	5.5	4.2	4.3	3.5	0.6	5.0	2.6	6.7	4.2	5.4	7.4	4.3	5.2	3.8	2.5	3.4	3.4	3.9	3.0	2.6	3.2	2.3	6.1	6.5	3.9	7.7	1.6	17.0	0.8	6.3	2.9	3.7	7.8	2.2	2.5	2.8	2.7	3.4	0.0	1.9	3.4	4.8	3.1	3.6	3.4	7.2	6.3	5.1	5.0	4.7	8.9	4.3	4.8	3.4	5.2	4.4	2.4	3.9	2.5	7.2	5.4	6.6	4.9	5.5	6.1	8.0	5.8	2.8	3.5	1.4	10.5	2.2	3.6	4.4	7.7	14.0	6.2	4.9	4.5	4.3	2.9	6.2	6.1
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152342-153339320	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0"	"Cell line enhanced"	"Detected in many"		"AF22: 28.1;NTERA-2: 23.1;RPTEC TERT1: 26.3;SK-MEL-30: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 5.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035853, HPA035854"	Enhanced		Approved	Centrosome				Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favourable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	4.2	9.9	28.4	4.4	35.7	0.6	12.2	28.9	56.9	19.6	17.8	67.0	5.9	13.5	9.7	15.1	8.5	12.9	10.3	6.2	38.9	25.3	22.1	6.4	5.9	2.3	39.4	34.6	10.9	8.2	1.0	10.9	2.5	45.3	11.5	19.2	4.6	30.1	11.8	1.8	3.8	14.4	6.6	44.2	8.8	23.5	1.9	44.7	0.0	38.9	0.6	4.3	7.6	5.5	1.9	0.8	0.3	0.6	0.3	5.4	0.7	4.7	0.2	28.1	12.3	10.6	12.2	0.4	6.3	8.6	1.8	2.6	2.7	0.3	0.2	4.0	10.9	4.3	13.1	2.4	1.8	0.1	4.9	0.2	2.9	0.6	12.4	0.2	0.1	7.9	1.4	3.6	2.3	1.6	0.2	0.1	2.2	0.4	1.3	0.0	23.1	5.6	0.8	5.1	0.0	26.3	6.2	9.1	17.9	3.0	11.4	25.2	1.2	0.2	2.4	7.9	2.3	6.1	3.0	0.1	0.0	0.1	11.8	0.1	9.7	0.3	0.6	0.1	0.1	0.0	0.0	1.6	5.4	0.1	0.8	1.9	1.6	1.0	0.2	0.3	0.0	0.1	2.6	0.7	28.4	35.7	28.9	41.1	38.9	25.3	39.4	34.6	45.3	44.7
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;SK-BR-3: 17.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077996			Approved	Nucleoli,Centrosome				Centrosome	Nucleoli	"HPA077996: "	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	15.9	14.6	2.7	12.2	2.9	1.4	7.3	0.9	3.4	9.3	7.9	6.0	8.5	6.6	15.7	10.6	8.7	7.8	5.6	4.1	3.6	2.2	7.1	4.4	7.9	11.7	2.6	3.9	11.4	5.5	4.5	5.5	8.7	4.7	9.5	6.8	7.8	10.2	6.3	2.0	6.2	14.2	5.8	6.2	16.6	6.1	4.6	4.3	12.5	7.0	5.0	14.3	10.0	7.8	12.8	15.9	15.2	15.9	5.9	9.5	7.8	2.2	1.3	0.5	0.2	5.2	8.1	16.2	3.4	10.0	8.9	8.7	1.0	7.9	8.0	1.6	4.6	3.7	0.3	7.4	4.5	10.4	0.3	4.2	0.4	0.4	2.3	4.6	3.0	8.5	6.4	4.5	1.4	11.5	0.2	0.6	4.2	1.0	4.2	2.7	0.0	0.7	6.2	0.3	0.5	5.4	6.1	0.0	0.0	0.1	17.3	2.5	3.0	2.2	9.2	2.3	0.5	0.9	1.2	0.9	1.0	3.1	6.7	0.6	1.1	8.7	14.3	3.6	5.6	15.9	6.1	12.6	5.4	6.9	15.9	12.8	6.8	5.7	15.2	5.9	13.5	8.1	9.5	7.8	2.7	2.9	0.9	3.4	3.6	2.2	2.6	3.9	4.7	4.3
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"				Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favourable (8.20e-5)"	"prognostic favourable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.3	13.9	3.6	4.5	8.9	8.7	14.5	1.5	3.8	7.9	7.4	5.5	5.6	2.7	4.4	5.2	7.9	1.8	3.5	3.3	1.4	13.7	4.2	7.4	13.8	3.2	5.4	1.9	7.5	2.3	4.4	10.3	1.7	4.0	4.8	1.4	2.7	6.2	4.3	8.2	10.4	7.0	0.1	0.1	3.4	7.1	12.0	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.2	5.2	9.6	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell line enriched"	"Detected in some"	7	"A549: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA077996			Uncertain	Nucleoli,Centrosome				Centrosome	Nucleoli	"HPA077996: "																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	9.9	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: "	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.5	0.0	0.5	0.1	0.2	0.6	5.3	0.2	0.0	0.0	0.0	4.2	0.9	0.2	1.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.5	0.1	13.0	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	5.5	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.7	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	8.0	14.0	7.5	9.9	12.8	13.6	17.4	7.6	6.7	8.1	5.9	7.9	8.6	9.7	5.3	6.2	7.5	12.5	13.0	9.3	7.6	15.6	10.6	18.8	8.1	9.9	16.6	4.1	11.7	15.1	14.8	18.2	6.5	15.6	5.3	9.4	15.1	12.6	7.6	10.6	16.9	9.6	5.2	19.3	12.2	8.2	4.9	8.6	7.0	6.3	5.9	11.4	11.6	5.8	5.2	5.1	7.1	11.7	5.0	12.7	12.0	7.0	16.7	6.5	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1
TTC30A	"FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612992-177618966	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA051714: , HPA052100: , HPA052487: "	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.7	4.1	3.8	1.5	7.1	0.4	5.6	2.2	7.1	4.2	3.4	5.9	7.8	2.2	5.0	10.9	2.4	8.4	4.8	4.4	3.7	4.2	6.9	4.6	3.7	1.4	3.6	6.6	5.5	4.4	11.6	8.1	1.9	4.8	3.9	3.3	5.0	8.1	4.0	3.5	1.9	2.5	3.6	3.0	1.7	3.6	24.5	2.1	2.6	9.6	4.6	1.7	3.1	1.7	0.5	1.6	1.9	1.6	0.2	2.7	1.0	5.7	3.3	3.3	0.0	6.8	5.6	2.4	2.8	8.1	5.0	5.3	1.0	4.2	1.3	5.5	4.9	4.8	2.2	6.2	5.5	0.4	1.8	1.1	1.6	1.4	2.7	1.4	1.3	3.4	4.1	2.8	1.1	2.3	0.8	0.5	3.5	2.9	4.4	2.6	1.8	1.2	2.9	8.8	0.6	6.3	1.5	10.9	7.2	2.5	5.0	3.0	2.8	1.4	2.1	3.1	1.9	3.4	2.3	2.3	2.1	0.4	7.8	0.1	3.0	0.0	1.3	1.9	0.4	1.6	0.1	0.4	0.1	0.4	1.6	0.5	2.7	1.2	0.7	0.2	1.3	0.6	1.0	1.0	3.8	7.1	2.2	7.1	3.7	4.2	3.6	6.6	4.8	2.1
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177553014	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA051714: , HPA052100: , HPA052487: "	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	2.4	4.6	4.4	1.9	4.9	0.7	10.5	3.2	5.1	4.8	4.0	7.7	3.8	3.1	4.9	8.9	3.7	13.2	4.5	2.3	3.9	3.8	10.8	4.3	5.5	2.5	3.1	1.5	6.0	5.2	8.0	7.0	3.3	3.4	3.5	3.7	4.5	4.4	4.2	1.2	3.0	3.7	3.1	5.2	3.1	4.7	11.5	2.9	7.7	10.4	1.6	2.8	3.3	2.2	3.2	3.9	6.5	3.4	1.9	2.2	1.6	2.8	4.2	5.7	1.1	5.1	5.9	3.8	1.7	5.3	4.7	5.0	2.4	7.1	1.1	4.7	3.2	7.0	6.8	7.2	4.5	1.6	3.4	2.0	2.7	2.1	4.2	2.5	3.5	4.9	6.8	4.6	3.5	3.7	2.6	1.0	2.7	4.8	5.0	3.9	2.6	1.1	3.9	4.9	1.1	7.0	3.1	13.8	7.8	2.1	4.9	3.3	5.0	4.8	3.2	2.6	1.4	3.3	1.5	2.6	2.9	0.3	5.9	1.0	4.3	6.5	3.4	2.8	1.7	3.3	1.1	1.4	1.2	1.8	3.9	3.2	2.2	2.2	2.0	1.9	2.2	2.8	1.0	1.6	4.4	4.9	3.2	5.1	3.9	3.8	3.1	1.5	3.4	2.9
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;MCF7: 16.9;SK-BR-3: 52.6;T-47d: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 23.4"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 23.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028098, HPA043440"	Uncertain		Approved	Centrosome				Centrosome		"HPA028098: AB_10601705, HPA043440: "	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavourable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.2	4.9	3.2	6.0	5.5	0.6	23.4	0.7	4.3	8.5	18.0	0.2	8.1	3.3	1.4	10.4	10.4	4.5	17.9	8.3	3.3	7.4	40.4	3.1	12.4	0.5	4.2	2.4	0.9	22.3	6.1	12.1	0.9	10.1	12.3	20.2	3.1	10.1	10.7	2.2	5.6	4.5	0.8	4.9	0.3	18.7	28.2	2.0	0.2	5.5	8.5	6.2	5.0	5.0	0.1	23.4	0.5	0.0	0.0	0.0	0.2	2.2	1.2	0.2	0.1	0.1	0.2	9.3	0.1	0.0	0.0	0.0	5.7	0.9	0.0	4.1	0.1	0.0	1.2	0.0	0.0	21.5	4.3	0.1	0.5	1.1	0.4	0.0	0.2	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	16.9	0.2	0.0	1.6	0.2	0.0	0.0	1.4	9.2	2.9	7.8	0.7	0.1	52.6	0.5	38.1	0.2	0.2	0.1	1.0	0.1	0.1	2.2	2.8	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	23.4	0.0	0.2	3.2	5.5	0.7	4.3	3.3	7.4	4.2	2.4	10.1	2.0
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 9.7;prostate: 20.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;MCF7: 10.5;RT4: 7.3;T-47d: 20.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA069293			Approved	Centrosome				Centrosome		"HPA069293: "	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	0.3	1.3	0.6	0.0	9.7	0.3	0.6	0.2	2.2	0.2	0.0	0.6	0.0	1.3	0.6	0.4	1.0	0.0	0.8	0.9	0.0	7.9	5.6	0.0	0.7	0.4	0.4	0.0	0.0	1.1	0.3	0.1	20.5	0.5	0.0	3.0	1.1	0.0	0.8	1.2	2.5	0.6	0.0	3.8	6.0	0.0	0.0	0.0	0.6	2.3	2.2	4.6	0.6	0.2	0.4	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.4	0.0	2.1	1.2	0.2	0.0	0.0	3.0	0.0	0.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.0	7.3	2.2	0.0	0.0	4.0	0.0	20.2	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.6	0.8	0.9	0.7	0.4	0.1	0.0
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513601	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome				Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	10.7	13.1	8.0	9.7	12.2	12.0	10.7	11.1	13.5	11.0	9.3	11.2	6.4	8.7	11.8	10.9	11.4	10.5	7.3	12.7	9.4	7.5	10.7	14.0	9.3	14.9	10.1	10.5	10.9	9.9	11.7	16.5	9.2	9.6	9.8	9.5	11.4	12.1	8.7	14.8	11.0	10.5	9.8	10.7	14.3	9.7	25.7	9.0	22.9	13.2	7.6	17.1	10.3	10.2	22.1	36.7	19.3	14.6	17.2	19.3	24.0	5.2	9.8	12.8	12.8	9.4	6.8	5.4	7.9	9.0	13.3	13.3	7.5	4.4	15.0	12.0	5.8	9.3	20.5	9.2	11.9	6.7	6.2	8.9	5.8	8.0	10.6	8.2	9.0	5.5	11.8	9.9	9.0	11.5	13.5	11.9	9.2	10.5	24.6	8.6	17.1	6.5	16.8	10.4	7.1	7.3	5.6	15.7	8.3	7.8	7.2	9.6	7.3	6.7	7.5	8.2	7.3	8.5	7.6	6.5	6.3	22.3	8.2	8.3	8.8	10.4	14.1	19.3	15.7	14.0	16.1	19.2	16.0	15.6	11.9	22.1	19.3	18.1	13.0	17.2	14.6	36.7	15.2	24.0	8.0	12.2	11.1	13.5	9.4	7.5	10.1	10.5	9.6	9.0
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.2	25.4	9.4	9.5	10.0	10.9	12.0	14.3	23.3	17.7	17.9	26.4	12.8	13.8	8.1	16.3	12.3	12.5	11.7	7.8	12.9	24.0	8.8	12.5	14.5	12.6	18.8	16.3	11.3	10.3	16.4	20.4	11.6	10.7	11.2	14.2	25.0	10.3	20.9	8.2	20.2	8.2	10.9	6.0	11.6	9.5	6.4	12.7	10.2	11.5	11.5	8.3	9.7	14.0	8.6	7.8	11.3	12.7	11.2	7.6	16.1	34.7	8.5	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4
TUBGCP4	"76P, FLJ14797"	ENSG00000137822	"Tubulin gamma complex associated protein 4"	Q9UGJ1	15	43369221-43409771	"Disease related genes, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043212	Approved		Supported	Centrosome				Centrosome		"HPA043212: AB_10796690"	"unprognostic (1.34e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-1)"	8.2	9.6	10.9	10.4	16.2	9.6	11.6	23.6	19.4	11.6	9.9	9.4	4.3	10.7	11.6	8.4	10.9	10.9	6.8	10.8	9.8	13.1	9.4	12.8	7.9	9.6	11.4	9.2	12.6	15.2	19.4	14.1	8.5	13.3	10.6	12.2	11.8	11.5	9.1	14.6	10.5	9.8	11.4	8.6	8.4	9.1	10.9	11.6	12.6	10.7	8.8	12.1	10.0	9.1	3.9	5.8	14.5	3.3	5.4	4.2	2.5	11.2	3.5	8.6	8.8	8.5	9.2	6.6	6.5	4.7	9.1	9.1	11.3	7.0	7.1	9.9	5.5	18.8	18.0	11.5	10.6	11.7	17.2	18.2	20.1	9.8	7.1	12.5	11.5	5.0	11.6	9.3	13.0	7.3	17.3	6.1	6.6	3.9	10.0	9.7	4.0	14.2	13.6	11.3	10.4	5.9	10.8	23.0	7.9	7.9	15.4	2.7	9.0	9.8	6.0	8.6	8.9	11.8	14.2	6.6	7.5	12.4	8.0	18.2	9.6	0.1	2.7	14.5	4.2	3.3	3.1	3.9	3.2	3.0	5.8	3.6	2.4	3.5	0.3	5.4	1.6	3.1	3.5	2.5	10.9	16.2	23.6	19.4	9.8	13.1	11.4	9.2	13.3	11.6
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: "	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	5.1	5.7	5.7	5.1	8.4	5.5	7.3	4.0	10.4	7.9	4.6	6.0	4.6	4.2	7.4	8.7	5.9	4.9	4.7	6.6	7.7		6.3	6.8	5.6	5.5	6.0	11.0	5.0	10.0	10.2	6.3	4.8	12.9	7.5	5.3	5.3	4.0	7.4	14.5	7.3	3.0	9.3	10.0	4.8	5.3	12.9	5.9	5.4	8.6	7.0	6.1	4.6	0.8	5.3	4.0	1.5	3.3	5.4	7.6	2.5	12.1	12.9	15.3	9.0	11.8	7.7	8.8	15.2	16.8	16.8	14.6	9.8	5.8	9.2	6.5	13.9	12.3	10.0	11.8	14.1	14.2	4.0	16.6	13.0	5.2	3.9	16.9	7.4	12.6	4.5	11.2	10.4	10.0	11.7	15.0	10.6	8.0	11.3	7.3	9.0	11.8	14.0	16.8	1.8	9.7	19.0	5.2	8.9	12.4	8.7	7.9	14.1	7.9	8.6	11.6	7.6	8.9	22.5	11.8	11.8	24.9	15.2	11.2	10.8	0.2	2.3	0.9	4.5	3.3	4.6	3.7	6.7	7.2	3.6	5.3	6.0	7.6	1.5	5.4	3.3	4.0	5.4	2.5										
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	14.8	5.4	15.6	7.7	30.8	27.9	7.2	28.4	35.4	15.6	22.5	5.7	19.6	2.1	14.4	37.5	5.2	15.2	11.2	28.9	5.8	4.3	3.8	4.6	2.8	27.4	2.7	8.0	28.2	9.2	13.1	6.3	24.2	5.8	3.9	40.0	4.5	3.0	3.4	5.1	4.4	5.3	16.0	1.3	17.7	19.9	2.0	5.4	22.3	6.2	6.0	7.0	6.5	20.0	28.7	14.4	26.9	17.7	5.8	5.1	4.0	17.6	3.9	10.1	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179686-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: "	"prognostic favourable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favourable (5.53e-4)"	"prognostic unfavourable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favourable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	22.5	29.4	20.2	19.4	27.5	14.0	17.9	23.2	26.4	20.3	23.7	17.0	23.4	16.6	30.4	24.7	24.2	25.0	24.6	16.4	18.5	13.9	20.9	44.8	19.0	19.9	25.6	13.4	26.5	23.6	31.5	35.9	19.3	21.8	24.6	18.5	20.8	23.9	23.3	16.5	31.0	18.9	28.3	19.9	23.5	21.2	38.4	22.9	17.0	22.8	18.8	26.0	19.3	23.5	8.0	14.3	8.4	12.2	14.2	13.9	9.0	19.7	16.9	17.7	19.8	22.9	30.3	14.3	28.3	22.5	27.4	26.3	18.8	21.5	22.6	11.5	27.4	22.4	24.0	18.6	25.0	25.8	18.6	35.7	24.6	24.6	24.4	25.9	28.4	30.3	25.0	28.9	13.7	21.6	14.5	23.4	22.3	10.9	18.9	16.7	25.7	15.6	22.3	26.8	19.9	18.7	25.2	18.5	19.1	29.3	18.6	30.0	17.2	15.8	22.4	29.0	25.1	38.2	36.0	35.0	27.0	20.5	30.0	35.4	26.7	8.4	9.0	4.5	13.9	9.7	11.9	7.3	9.6	10.3	6.9	8.0	8.4	9.1	1.3	14.2	12.2	14.3	7.0	9.0	20.2	27.5	23.2	26.4	18.5	13.9	25.6	13.4	21.8	22.9
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin domain containing 1"	Q2T9J0	10	70137981-70146676	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;PC-3: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	15.2	8.2	4.7	7.0	6.8	3.0	8.0	6.7	7.3	6.0	6.7	5.9	6.9	10.1	5.3	8.4	13.9	5.4	5.2	3.5	3.7	2.8	7.4	7.4	3.5	7.2	3.7	3.6	5.6	9.0	3.3	4.5	4.7	3.5	6.9	2.7	6.9	8.0	5.7	5.3	12.5	8.5	4.8	4.7	9.0	8.2	40.7	3.4	6.2	8.5	6.6	10.1	6.5	7.6	6.1	1.4	1.2	1.6	2.9	6.3	2.3	9.4	6.7	0.5	4.0	0.7	0.6	2.4	1.2	0.8	1.4	1.3	4.3	6.0	8.4	4.0	0.3	17.7	0.7	2.6	0.3	5.3	6.0	0.5	1.9	2.1	1.6	0.7	0.0	1.2	5.1	1.2	2.1	1.0	0.0	2.6	0.6	4.2	3.2	3.5	2.2	27.2	5.6	1.6	3.7	0.6	1.6	4.9	2.5	4.1	9.3	3.6	6.0	0.7	1.7	1.6	1.1	3.0	5.3	9.6	5.8	4.1	1.9	3.6	1.2	0.0	1.3	1.2	6.3	1.6	4.1	5.1	3.7	4.9	1.4	6.1	5.3	4.4	0.4	2.9	1.1	1.0	4.0	2.3	4.7	6.8	6.7	7.3	3.7	2.8	3.7	3.6	3.5	3.4
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"			9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: , HPA065335: "	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	33.8	11.4	17.6	34.6	9.6	17.8	18.3	24.9	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA063368: "	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favourable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	18.0	15.7	22.2	16.9	22.8	23.6	19.2	17.9	27.4	23.2	18.8	17.6	19.4	22.3	25.9	25.0	15.8	26.1	20.8	20.0	22.4	16.5	17.7	14.0	17.0	28.8	28.7	28.5	22.7	27.6	18.7	21.7	29.7	14.8	27.7	29.5	28.0	17.5	21.1	30.3	26.7	20.2	15.5	23.4	25.4	19.3	22.6	31.6	18.2	34.3	29.4	20.9	43.8	20.6	15.0	16.8	17.7	19.1	33.8	25.0	29.5	16.8	20.3	22.7	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0
UBL3	"DKFZP434K151, FLJ32018, HCG-1, PNSC1"	ENSG00000122042	"Ubiquitin like 3"	O95164	13	29764371-29850684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053772, HPA058781"	Uncertain		Approved	Centrosome				Centrosome		"HPA053772: , HPA058781: "	"unprognostic (2.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (4.23e-4)"	"unprognostic (8.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.84e-1)"	11.9	11.7	27.9	9.1	35.2	10.3	16.7	22.6	32.3	22.9	16.5	28.8	12.2	15.0	24.0	14.8	24.0	15.4	17.5	10.8	32.6	30.5	19.9	22.4	20.2	9.3	36.7	23.6	17.8	30.5	20.6	17.4	13.6	31.2	12.8	15.5	17.1	14.9	13.5	14.7	13.0	17.3	17.5	45.9	12.9	38.4	11.6	30.0	10.8	22.7	8.3	9.9	12.4	15.4	2.7	7.7	8.0	8.4	5.0	23.7	6.3	3.9	2.5	7.9	4.7	11.2	10.8	8.4	32.9	19.4	14.1	11.4	5.9	9.0	3.5	7.4	32.6	4.0	3.6	4.9	40.6	5.4	4.4	3.6	3.4	4.7	3.5	5.3	4.9	6.3	16.0	7.4	4.8	5.0	1.8	2.5	5.9	26.7	3.9	4.5	4.7	3.6	4.6	10.2	3.9	9.2	4.7	9.2	4.6	4.6	16.1	33.1	8.7	9.1	4.3	18.3	4.5	10.0	4.4	5.9	2.3	2.6	6.5	4.6	12.1	5.4	8.2	6.8	8.2	8.0	3.8	2.2	10.4	7.9	7.7	2.7	6.0	7.4	8.0	5.0	8.4	3.6	23.7	6.3	27.9	35.2	22.6	29.7	32.6	30.5	36.7	23.6	31.2	30.0
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.9	23.2	21.0	15.5	39.3	20.3	18.2	17.9	18.9	19.5	17.8	37.0	19.8	13.9	16.8	23.6	15.7	16.4	17.8	18.3	11.5	14.5	31.7	22.4	24.1	27.7	19.4	21.1	18.1	22.9	39.7	38.3	21.3	21.6	12.9	18.5	16.4	9.1	23.7	17.0	13.1	12.8	16.4	11.6	17.6	13.5	14.9	14.8	21.2	12.2	15.2	8.4	15.3	33.0	22.9	14.3	27.1	20.0	15.3	9.2	16.1	15.7	30.0	19.4	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6
UBXN2A	UBXD4	ENSG00000173960	"UBX domain protein 2A"	P68543	2	23927285-24004909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065482, HPA069096"	Supported		Approved	Centrosome				Centrosome		"HPA065482: , HPA069096: "	"unprognostic (5.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (9.26e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.75e-2)"	12.7	10.6	10.8	8.3	10.7	9.6	13.8	16.7	10.6	9.4	14.0	12.2	9.5	12.1	13.4	9.1	11.7	9.2	8.2	17.7	10.0	11.6	9.1	12.0	10.0	7.8	12.7	8.9	9.3	7.8	17.3	13.6	14.0	13.3	9.9	9.1	11.1	9.9	11.4	24.3	10.3	13.3	14.9	11.3	6.8	8.2	7.3	11.9	9.8	9.4	7.5	9.1	12.0	15.0	6.5	7.3	6.9	4.0	8.6	7.1	2.8	10.5	7.1	9.9	6.7	11.5	10.1	5.0	10.9	7.4	10.7	7.4	5.2	4.8	9.2	3.4	7.0	4.6	9.4	7.8	9.5	18.5	9.0	10.8	5.0	7.8	8.5	6.8	4.9	12.2	6.3	9.4	7.2	6.3	12.1	9.3	9.2	8.1	8.9	4.4	7.8	5.1	12.2	24.5	4.0	4.5	8.4	4.9	11.8	10.5	5.2	13.6	3.0	3.9	10.4	7.7	8.1	7.0	7.0	13.3	14.2	13.2	5.9	6.4	7.7	6.9	4.0	4.4	6.2	2.2	6.8	6.5	6.5	5.9	3.1	5.8	7.1	6.5	4.0	8.6	2.7	7.3	4.7	2.8	10.8	10.7	16.7	10.6	10.0	11.6	12.7	8.9	13.3	11.9
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria			12000000	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.3	14.4	13.8	9.3	47.2	61.2	58.0	35.4	29.0	19.1	22.8	36.9	23.3	28.7	10.7	38.0	12.0	16.7	22.2	31.0	19.2	7.1	18.2	10.2	25.2	22.5	16.0	16.1	40.1	40.7	17.9	18.5	26.5	9.1	11.7	79.6	10.8	21.7	15.1	33.1	10.1	17.8	27.4	16.6	33.8	16.0	7.3	6.0	28.3	36.4	13.4	10.4	11.4	36.1	20.0	31.6	29.7	18.6	20.9	9.4	36.4	24.0	25.1	61.0	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026911-41039217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 52.2;kidney: 60.9;liver: 29.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.2;Hep G2: 4.4;RPTEC TERT1: 15.8;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015725	Enhanced		Approved	Centrosome				Centrosome		"HPA015725: "	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	0.4	0.2	0.4	0.6	0.4	0.3	0.5	0.4	0.4	0.4	9.9	0.5	0.4	23.7	0.8	0.8	0.5	0.7	10.2	0.4	0.4	0.1	60.9	29.9	0.9	0.4	0.4	0.4	0.5	17.7	0.1	0.6	0.8	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.6	52.2	0.4	0.4	1.2	15.9	0.6	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.3	1.0	0.7	0.3	0.0	2.4	0.2	0.6	0.3	0.8	1.1	0.2	0.1	0.7	0.0	0.1	0.0	0.0	8.2	0.1	0.1	3.1	0.0	0.2	0.2	0.3	0.1	1.2	1.6	0.8	0.0	4.4	0.1	0.4	0.3	0.2	0.7	0.0	0.5	0.0	0.6	0.5	0.0	0.2	1.0	2.6	0.3	0.2	1.0	0.1	0.6	15.8	0.0	0.7	0.7	0.0	0.1	1.5	0.2	0.2	0.2	0.0	0.5	0.4	0.1	5.2	2.6	0.7	0.0	1.8	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.2	0.7	0.2	0.1	0.3	0.4	0.0	0.0	0.0	0.3	1.0	2.4	0.2	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome				"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	9.0	5.1	8.8	11.0	7.3	13.8	11.4	13.9	7.5	7.2	12.2	5.3	5.4	4.8	5.8	13.3	7.0	6.3	5.3	8.1	7.6	5.5	12.7	24.0	6.1	9.2	6.3	5.6	6.9	10.8	14.4	8.9	4.9	6.5	6.2	6.7	6.4	8.3	5.4	28.7	11.4	14.7	8.3	11.2	12.0	7.3	4.8	6.9	13.3	7.1	11.5	8.9	6.1	6.0	5.9	5.1	6.9	3.7	2.6	3.1	1.4	5.2	3.9	4.9	4.6	12.0	4.6	3.3	2.1	3.4	2.1	2.0	3.7	2.2	9.2	3.8	5.3	3.3	5.3	4.2	3.9	2.8	2.1	6.6	2.5	6.0	3.6	11.9	7.3	6.7	7.6	3.8	4.4	4.9	3.1	4.9	4.4	7.3	6.6	6.7	3.6	4.0	2.8	3.8	3.6	7.4	7.3	2.3	3.5	5.1	2.8	6.0	3.9	8.9	6.7	3.3	7.1	1.8	3.0	5.7	3.2	11.0	3.7	5.0	2.4	4.1	2.4	3.5	3.1	2.8	2.3	2.2	2.2	2.3	1.7	5.9	2.7	2.8	6.9	2.6	3.7	5.1	1.1	1.4	8.8	7.3	13.9	7.5	7.6	5.5	6.3	5.6	6.5	6.9
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: , HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.7	4.5	4.0	6.8	5.2	5.2	2.9	7.6	7.4	7.0	6.0	12.9	7.0	5.9	5.4	6.4	3.8	9.3	7.5	5.8	14.4	6.0	5.4	5.3	2.7	7.2	10.9	5.4	6.3	6.9	7.2	5.8	7.0	11.7	18.5	4.7	7.5	14.2	2.0	3.6	8.7	9.4	5.9	5.6	4.5	5.5	8.1	7.3	5.9	10.3	6.6	6.3	4.1	8.3	6.5	5.3	5.6	7.9	20.7	35.1	10.7	6.6	8.4	5.4	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA023932: "	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	8.8	8.0	4.2	5.5	12.7	9.0	4.0	7.1	7.2	5.5	6.3	4.7	8.4	11.9	2.1	9.5	7.9	6.7	5.9	7.9	8.9	4.8	13.3	7.9	5.9	7.7	4.4	14.3	9.7	8.8	5.9	10.8	5.9	8.9	11.6	8.0	4.3	9.5	7.6	7.9	5.6	6.1	6.5	6.0	7.9	7.0	2.4	4.7	5.5	8.4	6.1	8.6	7.3	11.8	7.2	5.4	6.3	4.7	10.3	5.0	12.8	7.2	6.4	5.4	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7
VPS25	"DERP9, EAP20, MGC10540"	ENSG00000131475	"Vacuolar protein sorting 25 homolog"	Q9BRG1	17	42773436-42779599	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004978, HPA052217, HPA057284"	Uncertain		Approved	Centrosome				Centrosome		"CAB004978: AB_426095, HPA052217: , HPA057284: "	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (7.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.76e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	18.5	22.8	14.0	16.9	17.4	17.9	26.2	11.0	28.2	21.0	28.8	20.9	23.9	25.3	21.5	32.8	45.9	28.7	22.6	18.0	15.5	12.2	48.7	48.0	17.4	22.0	12.7	15.3	21.7	41.3	28.5	15.7	36.7	17.3	21.3	33.3	27.4	32.6	18.7	24.7	26.0	37.9	20.5	11.3	21.2	25.1	26.6	11.5	32.1	29.2	31.9	37.4	18.7	22.8	19.8	33.2	42.4	35.4	31.0	20.2	22.3	17.3	36.1	27.5	16.6	35.1	24.1	25.6	22.0	31.2	45.4	31.8	30.9	20.5	17.4	37.0	32.1	18.2	37.9	48.2	29.5	15.8	47.7	13.1	23.9	45.7	36.3	24.5	17.5	32.6	31.1	40.2	43.2	28.4	44.7	17.6	27.2	24.9	35.3	27.2	21.2	25.4	13.2	33.3	28.1	54.4	19.9	23.4	18.1	12.4	16.1	33.4	37.1	26.1	15.3	28.9	18.6	16.2	23.5	17.4	9.8	25.3	25.4	16.8	21.2	28.8	32.2	42.4	17.1	35.4	17.4	19.8	18.7	20.2	33.2	17.0	19.1	18.1	18.7	31.0	31.2	22.4	17.1	22.3	14.0	17.4	11.0	28.2	15.5	12.2	12.7	15.3	17.3	11.5
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A, ESCRT-I subunit"	Q8NEZ2	8	17246571-17302427	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol				Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	23.5	21.3	15.1	13.5	15.6	12.8	22.1	23.1	18.1	21.3	23.5	15.8	16.4	18.6	19.1	15.1	22.7	13.3	15.5	34.4	15.8	14.9	23.3	25.9	18.4	14.4	16.6	10.4	21.7	15.8	34.2	20.8	31.6	16.1	20.0	16.2	20.7	15.2	22.7	41.8	16.5	27.3	24.4	20.2	16.4	14.9	27.7	14.6	17.3	18.0	16.4	14.8	27.6	22.7	10.1	11.7	25.0	15.2	20.6	15.5	11.4	7.0	11.7	10.2	8.9	22.6	18.0	11.1	25.3	21.5	23.4	20.2	7.8	6.9	6.1	13.8	20.2	7.0	11.4	11.1	27.7	6.2	3.4	11.2	5.9	8.3	26.5	4.3	10.6	17.5	21.6	21.6	22.2	16.6	8.2	15.8	24.6	4.8	13.1	11.1	10.1	6.1	6.4	11.4	7.2	19.6	9.8	12.2	6.5	10.1	10.1	15.6	6.6	9.1	14.1	14.1	7.2	20.2	13.2	5.0	10.2	7.1	16.1	8.3	14.4	25.0	15.2	13.5	12.9	11.3	15.5	9.9	12.4	12.3	11.7	10.1	11.6	13.8	15.9	20.6	10.0	10.8	11.4	11.4	15.1	15.6	23.1	18.1	15.8	14.9	16.6	10.4	16.1	14.6
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666800-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	Nucleoplasm,Vesicles,Centrosome				Vesicles	"Nucleoplasm, Centrosome"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favourable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favourable (3.12e-4)"	6.4	7.8	10.2	6.2	9.1	8.8	6.5	17.2	14.5	7.1	5.2	9.1	2.3	4.9	5.8	6.1	5.9	11.3	5.2	9.2	8.5	8.9	8.1	5.9	6.0	8.3	12.4	11.6	9.2	11.6	9.4	6.7	4.9	9.1	6.9	2.6	7.7	14.6	6.9	4.6	11.3	6.3	3.8	7.0	7.4	7.1	9.2	10.6	11.7	9.2	2.6	5.8	6.0	5.7	8.8	19.4	5.4	11.1	17.6	11.3	8.6	5.0	8.4	4.8	6.6	9.5	3.5	3.9	4.8	4.5	5.8	6.1	9.8	4.4	7.6	7.0	4.3	5.7	5.6	7.4	1.1	7.7	12.3	6.0	5.6	6.1	7.5	8.3	7.1	6.5	6.0	4.7	3.8	5.8	5.3	0.8	2.6	19.1	12.1	6.8	3.8	14.6	8.6	6.2	7.1	5.5	5.9	10.0	6.7	5.2	7.1	4.2	4.0	8.2	3.1	6.5	2.0	5.1	5.0	19.4	13.0	3.4	10.2	6.4	4.2	4.5	11.1	4.6	9.2	9.6	10.7	8.1	8.9	8.6	11.1	8.8	8.7	11.3	5.4	17.6	4.7	19.4	9.8	8.6	10.2	9.1	17.2	14.5	8.5	8.9	12.4	11.6	9.1	10.6
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.9;breast: 24.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.3;CACO-2: 6.5;CAPAN-2: 9.7;EFO-21: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 6.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050101, HPA063569"	Uncertain		Approved	Centrosome,Cytosol	"Secreted to extracellular matrix"			Cytosol	Centrosome	"HPA050101: , HPA063569: "	"prognostic favourable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	25.9	14.1	0.8	1.6	1.0	0.9	24.1	1.8	0.9	3.4	7.6	1.4	0.7	2.6	1.9	6.0	4.7	3.1	3.4	7.2	0.4	0.4	1.2	8.5	4.8	2.3	0.5	0.1	4.3	7.8	0.5	2.3	6.3	2.2	4.0	1.2	1.0	3.4	1.3	11.1	4.5	7.9	3.1	0.3	3.5	0.7	3.7	0.5	0.3	10.8	5.4	0.7	4.6	10.2	0.0	0.0	0.8	0.1	6.6	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.1	20.3	0.0	0.0	0.0	0.1	6.5	9.7	0.0	32.2	0.0	3.0	0.6	0.0	0.0	2.9	1.1	1.6	0.7	1.2	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	1.6	0.2	0.0	1.2	0.1	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.8	1.0	1.8	0.9	0.4	0.4	0.5	0.1	2.2	0.5
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500967	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077591			Approved	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA077591: "	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	8.5	10.5	24.8	6.0	30.7	3.1	63.7	24.8	29.0	36.8	8.1	1.7	1.7	10.6	28.9	2.8	6.1	6.4	7.1	43.4	27.3	7.2	39.6	13.6	5.9	6.0	25.1	19.6	28.7	10.4	6.8	27.8	37.5	32.5	6.8	6.4	1.7	7.7	6.3	29.5	9.5	11.2	5.1	30.4	7.9	6.6	3.4	27.1	1.7	5.4	1.7	4.8	5.8	31.4	12.7	13.7	13.0	12.4	5.4	11.5	10.2	5.1	12.9	9.4	10.3	6.0	6.4	42.5	7.3	8.1	4.3	5.0	16.4	4.6	10.2	8.5	9.7	2.4	8.9	7.6	3.2	12.0	11.9	7.6	11.0	13.9	7.9	4.6	15.9	9.4	6.0	4.5	3.4	10.2	9.6	3.4	8.4	3.6	7.7	3.7	23.1	7.6	6.2	9.3	4.8	7.2	10.1	11.2	11.0	6.2	16.8	11.6	4.6	10.0	13.9	9.3	4.9	5.1	7.9	4.1	0.0	16.9	3.8	6.7	5.2	1.8	11.6	9.7	11.5	12.4	10.3	9.4	6.8	6.5	13.7	12.7	6.6	5.4	13.0	5.4	9.3	10.1	6.6	10.2	24.8	30.7	24.8	29.0	27.3	7.2	25.1	19.6	32.5	27.1
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483237	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"				Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: , HPA049003: "	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	9.6	7.1	6.6	13.8	13.7	16.6	10.1	12.7	11.5	9.5	7.5	11.4	6.8	7.6	9.8	7.5	8.4	8.4	6.4	5.5	7.0	6.8	9.1	6.6	8.5	16.9	11.5	8.8	8.3	8.2	19.1	10.0	12.4	8.8	8.8	8.5	9.6	9.8	9.1	9.7	12.2	11.1	8.5	7.7	13.7	8.6	9.0	12.1	17.4	10.8	5.2	17.1	10.0	10.2	5.7	2.2	1.7	1.5	2.4	5.3	1.0	3.8	4.0	3.7	9.2	6.0	6.1	6.1	4.5	6.2	5.7	6.5	5.6	3.0	16.6	5.9	5.6	5.1	9.3	7.0	8.6	10.3	9.2	13.4	5.4	4.2	4.4	10.9	6.9	6.1	5.8	5.7	10.0	4.6	11.2	9.4	5.8	6.6	15.6	7.4	9.2	4.5	9.8	5.2	6.9	6.9	6.7	6.3	5.5	5.7	6.1	14.2	4.2	11.9	4.6	4.6	4.6	3.8	9.6	4.6	3.5	17.1	6.0	8.7	7.6	0.1	1.2	1.7	1.5	1.1	0.9	5.7	3.0	1.8	1.4	5.6	3.9	2.2	0.8	2.4	1.5	2.2	5.3	1.0	6.6	13.7	12.7	11.5	7.0	6.8	11.5	8.8	8.8	12.1
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	18.9	17.7	12.5	10.8	23.2	14.8	25.8	24.3	25.9	22.8	19.4	8.6	16.0	16.1	21.6	17.9	19.9	20.8	14.4	14.8	12.7	15.8	19.6	26.6	16.2	13.8	14.8	16.2	35.8	35.1	16.0	31.1	12.6	27.4	23.7	18.7	10.3	23.3	18.1	16.9	13.5	20.2	23.7	16.5	17.5	20.3	10.3	13.2	19.0	42.6	16.1	17.0	26.7	21.3	18.5	20.0	6.4	13.9	17.2	25.1	16.8	19.3	6.2	8.6	7.6	11.9	24.0	8.7	11.6	15.7	10.2	13.4	6.8	15.4	19.1	13.8	8.8	13.2	10.0	16.7	15.4	16.0	10.0	10.9	10.5	8.0	21.9	13.3	7.3	19.5	40.2	7.1	69.7	12.7	16.4	27.4	10.5	12.7	16.5	9.6	2.5	19.6	11.3	7.4	8.5	12.8	18.0	8.8	5.7	8.3	5.3	19.0	17.6	9.9	8.1	7.6	11.1	10.8	16.1	10.9	6.7	11.7	9.0	1.2	5.8	6.4	13.9	3.9	11.3	10.2	19.4	18.5	18.5	15.0	20.0	13.4	25.1	18.7	1.4	17.2	11.8	11.6	21.1	16.8	12.5	23.2	24.3	25.9	12.7	15.8	14.8	16.2	27.4	13.2
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	9.6	9.0	16.9	11.5	19.3	7.8	16.2	24.0	19.5	14.2	8.9	18.9	10.4	4.4	15.8	18.2	7.6	14.3	9.5	10.3	15.5	19.8	11.6	7.9	9.6	12.4	16.7	20.5	18.1	8.7	29.1	16.5	8.3	20.0	13.1	9.3	11.4	8.7	13.6	10.0	13.2	8.3	13.6	16.1	13.2	11.2	11.6	19.6	15.8	11.0	3.6	15.5	11.3	9.6	5.8	2.6	7.8	1.9	5.2	8.8	3.0	7.1	7.8	14.7	13.9	13.1	14.0	6.6	6.8	7.8	9.3	10.8	5.5	4.8	7.7	8.8	8.6	6.8	9.0	8.6	10.7	6.7	3.7	1.9	1.5	9.2	10.2	0.0	7.3	12.1	14.2	8.6	12.0	7.4	3.8	2.9	11.4	12.8	7.6	7.4	5.5	5.9	14.1	5.1	5.1	6.4	5.1	16.7	12.7	19.4	1.5	7.3	11.7	10.2	5.3	8.8	5.3	7.4	3.9	5.6	10.4	9.4	2.9	2.7	7.0	7.8	1.7	2.8	6.4	1.9	8.8	5.8	6.0	7.4	2.4	4.1	8.7	7.5	0.5	5.2	1.3	2.6	6.8	3.0	16.9	19.3	24.0	19.5	15.5	19.8	16.7	20.5	20.0	19.6
ZNF112	"ZFP112, ZNF228"	ENSG00000062370	"Zinc finger protein 112"	Q9UJU3	19	44326555-44367217	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023856	Approved		Approved	Centrosome				Centrosome		"HPA023856: AB_1859018"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.65e-3)"	"prognostic favourable (1.54e-5)"	"unprognostic (1.65e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.57e-3)"	5.7	6.5	9.0	1.7	11.4	0.3	8.0	20.5	10.8	6.3	5.7	6.7	3.2	4.8	7.2	7.4	5.0	7.6	4.4	6.1	9.1	5.5	5.5	3.0	4.6	1.5	12.9	5.8	8.6	5.2	9.1	16.4	4.6	8.1	7.8	5.5	5.2	5.2	7.8	3.8	5.2	4.8	5.4	12.7	3.5	5.8	13.1	13.1	1.0	7.8	4.2	2.8	5.2	6.0	1.6	1.8	0.0	1.7	0.4	0.2	0.3	4.0	2.6	7.3	4.3	4.4	3.9	1.7	3.9	6.5	3.6	5.6	1.7	3.0	0.0	2.8	3.3	3.7	4.3	2.6	5.9	0.0	5.3	4.7	4.2	1.7	3.5	0.0	0.0	4.1	4.8	2.8	5.9	4.3	1.7	11.5	4.3	0.9	0.0	0.0	3.9	1.5	0.0	7.8	2.1	3.5	4.5	3.5	5.7	5.1	1.0	2.7	2.1	0.0	5.9	5.9	4.4	16.8	3.2	0.0	0.0	0.1	3.5	0.0	4.6	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.8	1.6	0.0	0.2	0.0	0.4	1.7	0.5	0.0	0.3	9.0	11.4	20.5	10.8	9.1	5.5	12.9	5.8	8.1	13.1
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA063402: "	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.6	6.0	12.0	15.0	12.3	12.5	11.5	8.0	14.5	10.3	10.8	8.1	7.4	9.6	5.6	9.9	15.2	9.9	7.8	15.7	3.6	7.5	9.7	9.0	8.1	11.5	15.3	10.5	13.7	17.4	7.4	11.9	7.4	15.3	8.9	13.5	10.0	5.9	14.2	14.5	9.3	7.8	17.2	5.8	8.4	12.6	11.0	19.5	9.2	16.8	9.6	10.7	17.5	7.3	11.6	14.7	9.2	10.5	8.5	5.5	9.9	9.5	10.4	15.3	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560353-9584533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: "	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favourable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.75e-5)"	13.8	8.9	10.4	11.0	12.3	21.0	14.0	16.1	11.8	10.6	8.9	6.2	12.5	6.7	9.4	10.0	16.5	12.4	7.6	10.3	10.3	5.0	9.2	13.2	14.6	13.0	13.6	6.3	13.8	12.5	22.3	20.2	8.3	11.0	11.8	10.6	5.3	14.1	13.7	9.4	18.6	12.3	12.3	14.8	12.4	11.1	6.2	13.0	12.2	11.3	10.4	12.1	15.8	12.7	6.0	4.6	2.9	4.5	7.1	6.8	1.8	7.6	4.9	5.9	12.3	2.7	3.3	9.1	2.6	2.4	4.0	5.0	8.5	3.4	8.7	7.6	2.1	7.6	12.1	7.0	5.6	4.2	19.6	27.2	12.2	7.6	3.4	13.4	13.6	4.5	6.2	3.9	10.3	2.9	9.7	14.8	2.9	6.4	9.9	30.9	14.6	8.6	6.4	8.1	6.0	3.8	32.5	10.6	5.4	5.2	5.2	3.0	4.2	4.3	4.2	12.7	7.1	4.3	6.8	15.7	8.6	10.3	3.4	7.9	4.3	2.9	3.6	2.1	5.5	4.4	6.8	4.0	4.9	5.1	4.1	6.0	6.1	6.8	2.8	7.1	4.5	4.6	4.3	1.8	10.4	12.3	16.1	11.8	10.3	5.0	13.6	6.3	11.0	13.0
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	8.8	6.3	10.5	4.3	6.7	9.9	10.2	7.3	4.0	8.0	7.2	3.6	6.6	3.0	4.8	4.5	2.5	4.9	10.2	11.2	6.2	38.3	14.3	6.1	5.9	10.8	10.2	23.7	7.8	13.2	9.9	19.1	6.4	10.7	13.8	6.0	5.8	5.5	9.1	10.0	6.1	12.4	2.7	13.2	6.0	3.7	6.8	3.1	9.8	4.3	8.2	10.4	19.3	6.1	4.4	6.6	5.0	8.2	6.3	6.6	10.1	1.9	11.3	9.1	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630181-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	16.5	15.7	10.5	9.2	13.3	22.8	16.5	23.0	18.8	21.1	14.3	14.2	12.6	8.1	21.2	9.0	12.0	18.2	9.9	11.4	10.3	7.0	11.0	14.0	11.4	9.8	11.3	14.9	27.2	16.9	14.4	28.0	12.2	16.9	18.1	12.4	8.5	18.8	11.7	22.0	9.8	11.2	24.8	16.3	11.1	14.6	8.4	14.5	46.3	13.6	8.4	10.0	23.6	19.6	6.1	5.9	10.0	4.1	3.0	4.3	1.8	8.7	5.0	9.2	14.1	9.3	13.1	6.8	13.5	9.6	5.7	6.5	3.5	9.1	14.8	5.7	9.5	6.5	4.6	3.6	6.8	7.5	2.7	1.5	8.2	5.4	9.3	13.2	4.5	8.5	4.9	3.9	5.5	12.3	7.6	17.2	8.6	6.2	8.8	1.5	0.0	4.0	2.8	15.2	10.5	6.6	10.2	7.4	13.5	11.3	7.0	4.3	7.7	12.3	10.8	8.3	12.6	7.6	10.8	9.0	13.5	0.0	9.3	19.7	8.9	10.0	4.1	5.4	3.6	3.7	3.6	6.1	3.4	3.1	5.9	5.5	3.5	4.3	0.6	3.0	3.2	5.9	3.0	1.8	10.5	13.3	23.0	18.8	10.3	7.0	11.3	14.9	16.9	14.5
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.8;lymphoid tissue: 26.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.3;SK-BR-3: 11.0;U-698: 19.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA046940: , HPA049576: "	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	1.4	0.8	2.4	22.8	3.4	10.5	7.3	6.6	1.4	3.0	7.1	0.4	3.2	6.4	1.0	1.2	11.3	1.4	4.0	1.4	2.0	1.7	1.4	1.0	3.4	15.9	1.1	0.1	0.6	2.7	0.3	3.5	0.7	0.8	2.4	1.0	0.8	13.8	3.4	0.8	6.2	10.1	0.6	1.3	16.9	5.5	2.6	0.6	4.3	1.7	9.5	26.2	2.0	2.7	29.8	26.7	14.7	6.2	14.7	3.5	2.6	3.0	2.1	0.0	0.4	0.0	0.2	1.7	0.5	0.0	0.2	0.2	3.4	1.2	16.3	1.9	0.1	5.7	0.8	1.3	0.0	3.4	4.3	4.8	0.9	3.3	0.9	2.7	5.1	0.7	0.6	0.7	0.0	0.4	3.4	5.8	0.0	4.6	0.2	4.5	1.9	4.3	9.1	0.0	9.8	0.4	1.1	3.1	0.3	2.0	11.0	0.1	2.4	5.4	1.1	0.0	1.7	0.1	0.0	6.0	6.0	19.1	0.1	3.4	0.1	14.7	3.6	5.7	3.0	6.2	3.5	29.8	1.6	3.3	8.8	22.4	0.7	1.7	1.8	14.7	5.8	26.7	1.4	2.6	2.4	3.4	6.6	1.4	2.0	1.7	1.1	0.1	0.8	0.6
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: , HPA046692: "	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favourable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	8.8	9.7	7.7	5.4	10.9	0.4	10.1	10.6	15.4	13.1	8.6	7.9	9.5	6.9	12.7	10.8	6.8	9.2	11.5	13.3	8.4	6.9	9.5	7.0	7.9	6.7	8.8	7.0	14.8	6.9	15.0	18.0	8.6	11.8	12.3	8.6	8.6	8.2	15.5	7.7	5.0	7.9	9.7	10.7	8.7	7.6	8.2	12.5	4.3	13.6	6.7	7.2	11.8	8.4	11.2	7.9	10.5	11.2	17.6	11.4	4.9	5.7	4.4	17.3	19.8	11.4	15.2	6.2	7.7	10.2	10.8	13.1	8.5	3.6	7.0	18.6	6.7	7.3	12.8	5.0	13.5	10.8	11.6	12.3	5.7	8.3	12.9	0.0	11.2	9.3	17.7	7.1	8.1	9.3	14.1	7.5	11.8	3.3	8.6	10.3	5.0	5.3	9.7	12.2	9.9	6.7	9.2	14.0	14.8	9.2	8.7	16.2	8.1	8.0	9.2	18.0	7.2	7.3	7.8	7.9	15.8	6.7	3.9	2.0	18.1	3.3	8.7	10.5	11.4	7.4	8.3	11.2	5.8	7.4	7.0	10.5	6.8	9.9	8.3	17.6	11.2	7.9	4.4	4.9	7.7	10.9	10.6	15.4	8.4	6.9	8.8	7.0	11.8	12.5
ZNF616	MGC45556	ENSG00000204611	"Zinc finger protein 616"	Q08AN1	19	52113091-52139922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA062639, HPA071539"	Approved		Approved	Centrosome				Centrosome		"HPA062639: , HPA071539: "	"unprognostic (5.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.32e-3)"	10.5	18.1	9.2	4.9	10.6	2.7	8.6	18.7	10.2	9.1	6.6	6.2	5.6	4.9	9.4	8.6	7.2	9.8	6.0	6.3	8.7	4.8	8.4	8.5	7.6	6.3	12.6	8.1	16.1	10.4	12.7	17.7	9.0	9.1	9.9	8.2	6.1	8.0	11.5	5.4	8.0	6.4	8.0	13.7	7.6	6.7	5.3	10.3	11.9	11.6	4.4	7.2	9.3	12.5	4.7	4.5	4.7	10.9	15.7	6.3	2.5	4.1	3.7	12.5	8.5	15.0	12.3	0.1	5.6	6.6	5.4	8.6	4.2	3.4	5.8	3.9	5.3	2.8	12.9	6.3	8.3	3.9	17.1	10.2	9.6	9.0	8.8	9.8	6.4	8.9	8.9	4.8	17.8	7.3	11.3	2.8	7.8	2.8	9.4	5.1	12.8	11.1	8.3	17.0	8.3	3.9	10.6	12.6	7.0	9.3	4.5	2.9	5.6	3.3	5.9	4.2	5.0	4.7	5.7	5.7	8.4	8.2	3.6	5.8	8.1	3.2	3.5	4.0	6.3	2.3	5.8	3.8	5.8	5.1	3.9	4.7	5.3	4.9	4.7	15.7	10.9	4.5	3.7	2.5	9.2	10.6	18.7	10.2	8.7	4.8	12.6	8.1	9.1	10.3
ZNF620	MGC50836	ENSG00000177842	"Zinc finger protein 620"	Q6ZNG0	3	40505992-40518736	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in all"											"HPA031452, HPA059383"	Uncertain		Approved	Centrosome				Centrosome		"HPA031452: AB_10603939, HPA059383: "	"unprognostic (1.42e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.21e-5)"	"unprognostic (1.28e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.19e-4)"	5.8	5.7	5.2	3.0	8.2	8.0	6.1	15.6	8.5	3.7	5.0	8.9	4.8	4.4	4.0	6.3	3.1	5.3	3.2	4.4	5.6	5.7	6.2	4.5	6.2	3.4	10.3	5.8	4.5	8.1	8.7	15.2	6.3	6.4	5.2	5.9	6.1	3.5	5.7	6.3	2.4	4.7	4.3	5.3	5.2	7.3	3.0	7.4	3.7	9.5	3.7	3.1	4.8	4.5	2.0	1.3	14.2	1.0	3.1	3.9	1.2	2.3	3.5	8.4	3.1	0.9	0.9	4.4	0.6	0.9	4.0	5.8	8.2	5.2	0.0	2.6	0.4	0.6	12.4	1.1	2.9	7.1	9.7	6.0	8.7	4.5	1.5	2.1	1.2	0.5	0.8	2.5	1.1	2.7	3.1	1.0	0.5	4.0	0.4	1.8	9.7	1.9	3.2	3.5	1.1	3.7	8.4	9.9	7.5	0.6	5.8	3.8	7.6	2.3	1.8	0.4	5.7	0.8	2.6	1.3	2.1	0.1	1.3	1.2	1.5	14.2	0.6	1.2	2.6	1.0	3.2	0.8	1.0	2.7	0.6	2.0	2.1	2.7	0.9	3.1	0.3	1.3	3.9	1.2	5.2	8.2	15.6	8.5	5.6	5.7	10.3	5.8	6.4	7.4
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.5"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023106	Approved		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	7.3	5.9	4.3	8.3	4.2	9.3	13.0	7.3	7.4	7.0	13.9	1.3	2.9	12.3	5.7	4.6	9.7	6.2	9.4	5.3	4.3	6.3	2.3	6.8	7.3	9.9	4.8	14.3	4.4	9.1	9.9	7.5	6.6	8.9	3.4	7.6	7.4	6.2	3.9	7.5	3.9	8.1	10.5	7.0	5.7	40.5	8.7	6.7	10.1	5.2	5.0	8.2	6.6	17.4	14.5	10.1	2.8	10.3	15.4	4.1	0.2	0.2	11.8	0.4	4.0	6.2	2.1	7.7	5.9	8.0	7.2	0.0	0.5	0.1	5.8	6.7	0.7	0.0	6.0	2.3	0.2	4.2	0.3	0.5	0.2	10.0	0.1	7.9	10.7	0.0	7.6	0.1	3.5	0.1	0.5	5.3	0.2	6.4	0.2	20.3	2.7	0.1	0.0	0.2	2.3	3.1	0.2	11.2	0.2	2.9	0.2	0.4	0.3	2.2	12.6	0.3	0.2	5.0	0.3	0.1	0.2	0.2	0.3	0.1	10.1	2.2	6.4	5.1	2.8	7.3	9.6	7.2	5.6	6.1	17.4	15.4	10.0	2.6	10.3	1.8	14.5	4.5	4.1	5.9	8.3	13.0	7.0	5.3	4.3	9.9	4.8	6.6	8.7
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: "	"unprognostic (3.82e-2)"	"prognostic favourable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	12.5	10.5	11.0	8.9	12.4	5.7	10.3	13.1	19.4	14.1	11.3	18.5	6.3	9.6	14.3	10.3	8.9	11.8	10.5	13.2	10.3	8.9	11.4	17.0	8.4	9.3	11.5	8.0	13.2	15.5	23.1	10.4	6.2	10.6	14.6	9.2	13.6	11.2	15.3	14.1	11.0	10.5	11.8	9.4	11.4	10.2	12.4	13.3	18.2	11.8	6.7	9.0	12.8	8.8	8.8	8.1	9.0	4.8	6.6	8.9	4.1	3.8	3.7	1.2	6.1	4.9	4.3	6.2	3.2	4.8	4.6	4.5	2.2	4.9	8.3	2.2	3.8	5.7	2.8	4.0	2.0	9.8	6.2	7.2	4.0	3.4	5.4	3.3	10.3	4.9	5.1	3.7	5.8	3.0	2.0	7.2	3.2	4.2	14.8	4.6	7.2	2.5	17.7	0.4	7.6	4.0	2.0	8.6	7.6	4.8	3.2	3.5	6.2	6.6	2.4	5.9	2.7	4.6	0.1	13.7	9.6	4.7	1.2	5.1	6.9	9.0	4.8	6.4	4.5	2.6	5.2	7.4	5.1	5.2	6.0	8.8	8.9	6.6	2.7	6.6	2.4	8.1	3.8	4.1	11.0	12.4	13.1	19.4	10.3	8.9	11.5	8.0	10.6	13.3
ZNF766		ENSG00000196214	"Zinc finger protein 766"	Q5HY98	19	52269571-52296046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044882, HPA063496"	Uncertain		Supported	Centrosome				Centrosome		"HPA044882: AB_10965173, HPA063496: "	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.45e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-3)"	11.9	9.9	9.0	10.5	13.7	16.5	14.9	12.3	13.7	13.1	10.8	8.9	13.1	7.3	12.3	9.8	12.4	11.9	7.7	9.6	8.5	7.3	10.2	7.0	10.2	13.7	13.0	7.3	18.4	10.9	12.6	23.5	11.9	12.8	14.4	10.1	9.9	11.6	12.1	11.3	13.8	10.1	13.7	14.9	14.2	9.7	26.4	13.7	17.5	17.1	7.2	12.9	18.1	11.0	18.8	8.7	22.5	12.1	18.1	27.6	11.5	6.9	11.3	8.2	9.7	8.5	12.3	6.2	6.9	6.6	4.4	8.8	3.0	5.6	11.5	6.4	7.1	7.0	7.8	6.7	7.9	8.9	10.7	11.9	6.6	3.3	5.0	13.2	8.1	9.6	9.8	5.1	12.1	6.8	7.8	6.6	7.7	4.7	17.4	5.7	9.6	12.6	12.1	14.6	10.1	5.7	20.3	10.4	8.7	10.4	8.2	5.8	9.6	7.9	8.2	4.2	5.9	3.7	7.1	11.2	32.3	17.4	4.0	6.9	8.0	22.5	8.6	16.6	16.1	12.1	22.2	18.8	17.5	18.2	8.7	16.2	27.6	21.6	9.2	18.1	12.0	6.1	17.9	11.5	9.0	13.7	12.3	13.7	8.5	7.3	13.0	7.3	12.8	13.7
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favourable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.8	9.2	6.0	5.6	5.5	5.0	4.3	5.6	4.5	4.6	7.1	6.0	3.3	4.3	3.7	2.7	4.1	3.8	3.2	5.1	7.4	5.2	6.8	7.6	5.7	4.9	7.0	5.6	5.2	3.6	4.7	3.9	4.7	7.6	7.3	3.9	2.8	2.8	2.4	4.8	2.9	2.3	10.6	2.5	3.8	10.0	3.7	7.1	8.4	3.2	3.7	4.0	8.5	3.5	5.7	7.6	5.1	4.5	7.2	6.3	4.3	3.6	4.9	3.8	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	6.3	8.2	12.4	9.8	18.8	3.3	10.3	22.2	14.0	8.2	8.5	8.2	11.6	5.7	10.8	12.3	5.5	10.0	6.6	12.5	9.4	7.2	9.4	6.7	5.9	9.7	8.1	10.8	16.6	8.1	10.5	24.7	7.1	11.6	9.7	7.6	9.3	7.9	10.5	6.9	7.1	7.6	9.7	7.8	9.2	7.2	5.0	11.4	8.7	14.0	6.4	9.8	9.1	8.2	4.2	5.9	1.5	3.2	2.3	5.1	1.3	2.6	3.4	5.8	4.0	3.5	2.3	0.0	3.0	2.2	3.3	4.4	6.2	2.4	6.4	2.8	3.1	1.5	4.8	1.9	4.0	5.4	2.4	5.0	6.1	3.9	2.4	7.4	4.2	3.4	1.2	4.6	2.9	3.1	5.2	8.7	3.4	1.2	2.4	1.2	5.7	3.6	3.5	10.2	2.2	1.9	14.2	6.4	6.8	5.3	2.3	1.9	2.7	3.2	5.6	3.3	8.1	5.7	4.6	6.6	8.5	5.0	3.0	3.9	2.7	0.1	3.2	1.5	2.8	2.8	2.9	2.5	3.4	3.3	2.4	4.2	5.1	4.2	0.6	2.3	1.8	5.9	1.9	1.3	12.4	18.8	22.2	14.0	9.4	7.2	8.1	10.8	11.6	11.4